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ABSTRACT 
 
Purpose: The purpose of the study was to evaluate the effectiveness of the 
tuberculosis directly observed treatment, short-course (DOTS) strategy with respect to 
patient centeredness and satisfaction, and propose a model in support of the DOTS 
strategy in Addis Ababa, Ethiopia. 
 
Method: The study was conducted in Addis Ababa, Ethiopia using a mixed-method 
approach. An interviewer-administered questionnaire was used to collect quantitative 
data from 601 randomly selected TB patients who were on TB treatment followup in 30 
health facilities.Three focus group discussions were conducted with 23 TB experts 
purposefully selected from 10 sub-city health offices and health bureau. Moreover, 
telephonic interviews were conducted with 25 defaulted TB patients who had been 
attending TB treatment in the health facilities. The quantitative data were described 
using mean, median, percentage and frequencies. Logistic regression and exploratory 
factor analysis were used to extract associated factors using SPSS version 21 software. 
Thematic analysis was used for qualitative data analysis. Deductive and inductive 
reasoning was used to propose a descriptive model with substantiating literatures. 
 
Findings: Of the 601 TB patients included, 40% of them perceived they had not 
received a patient-centred TB care (PC-TB care) with DOTS strategy. Gender 
(AOR=0.45, 95%CI 0.3, 0.7), good communication (AOR=3.2, 95%CI 1.6, 6.1), 
treatment supporter (AOR=3.4, 95%CI 2.1, 5.5) were associated with the perceived PC-
TB care. Thirty-seven percent of TB patients were following their TB treatment with 
feeling of dissatisfaction with DOTS strategy. Gender (AOR=2.2; 95%CI 1.3, 3.57), 
place of residence (AOR=3.4; 95%CI 1.6, 7.6), presence of symptoms (AOR=0.6, 
95%CI 0.40, 0.94) and treatment-supporter (AOR=4.3, 95%CI 2.7, 6.8) were associated 
with satisfaction of TB patients. TB experts and defaulted TB patients pointed out that 
DOTS strategy is not providing comprehensive PC-TB care except the provision of 
facility choice where to follow during initiation of the treatment. DOTS delivery system 
inflexibility, loose integration, HCPs’ characteristic, communication skill and motivation 
and the community awareness were explored factor with patient centeredness of DOTS. 
DOTS delivery system, incompatible of diagnosis and patient beliefs were the identified 
categories to default. The proposed PC-TB care model core constructs are patient, 
community, health care providers, health care organisation and TB care delivery 
system. The core constructs are directed by policy and monitoring and evaluation 
components. 
 
Conclusion: DOTS strategy is limited to provide fully integrated PC-TB care and did 
not provide full satisfaction to TB patients. Therefore, a support that makes the TB care 
patient-centred are important and the proposed PC-TB care model needs to be tested, 
practiced and evaluated for its performance toward increments of patient centeredness 
of TB care.  
 
Key words 
Patient-centred care, PC-TB care model, satisfaction; treatment supporter and Directly 
Observed Treatment, Short course. 
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CHAPTER 1 
 
OVERVIEW OF THE STUDY 
 
1.1 INTRODUCTION  
 
Tuberculosis (TB) is a chronic infectious disease caused by a type of bacteria referred 
to as Mycobacterium tuberculosis (M tb). Although TB affects almost all organs of the 
body, it mainly affects the lungs. TB transmission occurs through airborne spread, from 
a person that has TB of the lung during coughing, speaking and sneezing of infectious 
droplets (Tiemersma, Van der Werf, Borgdorff, Williams & Nagelkerke 2011:2). The 
main symptoms described by TB patients, specifically cough, night sweats, weight loss 
and tiredness are among the symptoms with high predictive value (WHO 2013a:22).  
 
The risk of infection depends on the degree of exposure to infectious droplets and the 
susceptibility of the individuals. Once an individual acquires M tb infection, he/she 
remains infected for many years, probably for life. Under normal circumstances, only 
10% of the infected persons will develop TB disease at some point in their life. Immune-
suppressive drugs, infections like Human Immunodeficiency Virus (HIV) or other 
diseases sufficiently weaken the immune system and provoke development of active TB 
(Geldmacher, Zumla & Hoelscher 2012:273). 
 
Globally, there are a number of TB diagnostic methods. Sputum microscopic 
examination, molecular techniques, culture, histo-patologic examination, radiologic 
examination are available TB diagnostic methods. The feasibility, efficacy, specificity 
and low cost of sputum microscopic examination have made it an important diagnostic 
tool for the developing world (Balcha, Sturegard, Winqvist, Skogmar, Reepalu, Jemal, 
Tibesso, Schon & Bjorkman 2014:2). The method of case finding in Ethiopia, which is 
based on the recommendations of the Wold Heath Organization (WHO) and the 
International Union Against Tuberculosis and Lung Disease (IUATLD) is passive, that is,  
mainly through direct microscopic examination of sputum specimens obtained from 
persons who present themselves to the general health services (EFMOH 2013:18). 
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Globally, for the last two hundred years TB has killed more than any other infectious 
disease (Paulson 2013:S2). One third of the world’s population, approximately 2 billion 
persons, is thought to be latently infected with M.tb; 9 million persons develop active 
disease attributable to M tb infection annually. In 2015, there were an estimated 10.4 
million incident cases of TB and 1.4 million deaths from TB globally. An estimated 11% 
of incident TB cases in 2015 were HIV- positive. The proportion was the highest in 
African countries, and exceeded 50% in parts of Southern Africa (WHO 2016:15). 
African countries where HIV infection rates are high, TB/HIV mortality rate has 
exceeded 30 times than that of non-African countries with high HIV prevalence (Au-
Yeung, Kanters, Ding, Glaziou, Anema, Cooper, Montaner, Hogg & Mills 2011:21). 
 
The burden of the disease is higher in 30 high TB burdened countries (HBCs) which 
account for 84% of all estimated cases worldwide. Among these India leads with the 
highest number of TB cases, and Ethiopia held the 11th position in 2015 (WHO 
2016:13). In Ethiopia, according to the WHO 2016 report, 137,960 TB cases were 
notified and 26 per 100,000 mortality due to TB was reported in 2015 (WHO 2016:145). 
It is reported that TB is the third leading cause of death in Ethiopia in 2013 (EFMOH 
2014:31). 
 
1.2 BACKGROUND 
 
TB is both preventable and treatable disease. Despite its, preventability and treatability 
with TB drugs and control programmes have been tried; it is a leading cause of death 
among infectious diseases globally, including in Ethiopia (Raviglione, Marais, Floyd, 
Lonnroth, Getahun, Migliori, Harries, Nunn, Lienhardt, Graham, Chakaya, Weyer, Cole, 
Kaufmann & Zumla 2012:1902).  
 
1.2.1 TB control programme 
 
Even though TB prevalence decreased in developed countries before the introduction of 
TB drugs due to improved socioeconomic conditions of the nations, the TB control 
actions mainly relate to the invention of TB drugs and Bacillus Calmette-Guerin (BCG) 
vaccine (Lienhardt, Glaziou, Uplekar Lonnroth, Getahun & Raviglione 2012:409). Apart 
from this, still now deplorably TB affects the poorest persons in both high-income and 
developing countries (Zumla, Raviglione, Hafner & Reyn 2013:745). Globally, after the 
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discovery of Streptomycin by Arnold Schatz in 1944, the first bactericidal antibiotic, and 
Isoniazid by Gerhard Domagk and his team in 1952, the first orally taken antibiotic, TB 
treatment and control become the burly news (Diacona, Groote-Bidlingmaierb & Donald 
2012:4).  
 
In 1974, WHO reviewed the mass TB screening programme that had been practiced in 
Europe and North America in the mid 20th century and then developed policy and 
guideline for TB control. The guideline promotes sputum microscopy examination of 
symptomatic individuals and at risk with ambulatory therapy (WHO 2013b:1). In 
Tanzania in the 1980s the IUATL established a TB control programme model which 
focuses on direct observation of TB patients while on treatment (Keshavjee & Farmer 
2013:933). In 1991, World Health Assembly (WHA) acknowledges that TB is a major 
public health problem and set two targets for TB control, detection of 70% of infectious 
TB cases and cure 85% of such cases (Keshavjee & Farmer 2013:932). 
 
In the mid 1990s, WHO developed and recommended directly observed treatment short 
course (DOTS) strategy. The strategy encompasses political and administrative 
commitment, case detection primarily by microscopic examination of sputum of patients 
presented to health facilities, standardised short course chemotherapy given under 
direct observation, adequate supply of good quality drugs and systematic monitoring for 
every patient diagnosed (WHO 2012:3). 
 
In 2000, the stop TB partnership started to scale up and support global TB control 
programme (WHO 2007a:377). Despite that, the global TB epidemic was growing by 
1% a year until 2006 due to the emergence of drug resistance and HIV epidemic. 
Thereafter, stop TB strategy was launched in 2006 to fight the challenges posed by TB. 
Stop TB strategy aimed to halve TB prevalence and death rate by 2015 compared with  
the situations in 1990, these targets are in line with the Millennium Development Goal 
(MDG) framework. In this strategy DOTS remains a central pillar with high quality of 
expansion and enhancement; addressing TB/HIV, multi-drug resistance TB; health 
system strengthening; engagement of all care provider; empowering people with TB and 
community and enabling promotion of TB (WHO 2012:4-5).  
 
 WHO 2015 global TB report indicates that, except Ethiopia and Uganda, high TB 
burdend African countries did not meet the incidence, prevalence and mortality 
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reduction of TB in MDG framework compared to 1990 (WHO 2015:17). In Ethiopia, 
according to EFMOH 16th National EFMOH (2014a:3) in Annual Review Meeting 
reported that, although there was an average 3.9% decline in TB incidence between 
2005 and 2013, and MDG set target achieved, in 2014, 18 per 100,000 people’s 
mortality due to TB occurred.   
 
In 2013, WHO released post 2015 TB control strategy by envisioning a world free of TB, 
zero death, disease and suffering due to TB by using three pillars and components. 
Integrated patient-centred care (PCC) and prevention, bold policies and supportive 
system, and intensified innovation and research are the pillars (WHO 2013b:2). These 
pillars are the proposed strategies of Sustainable Development Goals (SDGs) for 2030 
and END TB in 2035. The expected reduction of deaths due to TB in 2020, 2025, 2030 
(SDGs) and END TB by 2035 is 35%, 75%, 90%, and 95%, respectively, compared to 
2015 and zero family facing catastrophic cost after 2020 (WHO 2013b:7). To achieve 
these targets globally TB incidence rate needs to be falling by 4–5% per year globally 
by 2020 and the proportion of people with TB who die from the disease needs to be 
reduced to 10% by 2020 (WHO 2016:15), however, between 2000 to 2013 on the 
average TB incidence has declined by only 1.5% per year (WHO 2016:15). In line with 
SDGs and END TB goal, Ethiopia has a plan to reduce TB prevalence by 30%, an 
incidence of 35% and mortality TB by 45% by 2020 compared to the level of 2013 
(EFMOH 2015a:75). 
 
1.2.2 Ethiopian health care system and TB treatment strategy 
 
Ethiopia has set a policy implementation strategic document, the Health Sector 
Development Plan (HSDP), which guides the development of sub national plans and 
sets the rule of engagement with the health sector. HSDP covers from 1997/8 to 
2014/5, and is divided into four phases. Namely: first phase HSDP I, (1997/98–
2001/02), second phase HSDP II (2002/03–2004/05), third phase HSDP III (2005/06–
2009/10) and fourth phase HSDP IV (2010/11-2014/15) (EFMOH 2015b:16).  
 
Recently, following evaluation of the 20 years HSDP, Ethiopia has developed 5 years 
Health Sector Transformation Plan (HSTP). HSTP guides the health sector activities 
from 2015/16–2019/20 (2008-2012 EFY). HSTP envisions seeing healthy, productive 
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and prosperous Ethiopians using 12 guiding principles. Among the 12 guiding principles 
provision of patient-centred quality health service is the core principle (EFMOH 
2015a:71). In addition, HSTP has put TB specific targets to reduce the number of 
deaths due to TB by 35% and incidence rate by 20% compared with 2015 by the year 
2020 (EFMOH 2015a:110). 
Currently, the Ethiopian health system is a three-tier system, which are, tertiary, 
secondary and primary levels. The tertiary level or specialised hospital and secondary 
level or general hospital are likely to serve 3.5–5 and 1–1.5 million population, 
respectively. The primary health care unit (PHCU), comprises health posts, health 
centre and primary hospital. A primary hospital serves a population of 60,000–100,000. 
One Health centre and one health post in rural area serves 15,000–25,000 and 3,500–
5,000 people,  respectively in a rural areas, while in urban areas a health centre serves 
up to 40,000 people and there is  no health post (EFMOH 2015b:142).  
 
The Ministry and the Regional Health Bureaus (RHBs) focus more on policy matters 
and technical support. Lower administrative level from RHB such as zones or subcities 
and woreda (lower administrative level than the zone (subcity), health offices manage 
and coordinate the operation of the health system under their jurisdiction (EFMOH 
2010:7).  
 
In 2013/14 Ethiopia had 2,668 physicians, 5,621 health officers, 6,858 pharmacists and 
6,667 laboratory professionals in government health institutions. The population ration 
of public health facilities’ employee health professionals is 1:32,132, 1:15,252, 1:12,501 
and 1:12,589 physicians, health officers, pharmacists and laboratory professionals, 
respectively (EFMOH 2014b:52-53). The Ethiopian health care system is focused on 
ensuring accessibility of health services which encompasses prevention and promotion 
component in collaboration with stakeholder in democratic and decentralised system. 
The system contains numerous disease control strategies in which TB prevention and 
control strategies are embedded (EFMOH 2010:32). 
 
In Ethiopia, TB control effort began in 1960th with organising TB centres and 
sanatoriums in three major urban areas. Nonetheless, these did not reduce the burden 
of TB as required in the country. In 1976, to reinforce TB control activity, Central Office 
of the National Tuberculosis Control Programme was established in Ministry of Health. 
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The central office was vertically operating with very limited financial and manpower until 
integrated with already well established and strengthen leprosy control programme in 
Ethiopia (EHNRI 2011:3). 
 
Currently, the TB control programme in Ethiopia is fully integrated with a general health 
care system tiers and organised in a hierarchical fashion with administrative ladders 
with varying responsibilities (EFMOH 2012:1). In the ministry level, the TB and Leprosy 
control team is mandated to develop guideline, solicit and coordinate resources, provide 
technical assistance to immediate next lower administrative level, RHBs, and monitor 
the programme performance. At the RHB level, a Regional TB Leprosy Team/Unit 
(RTLT/U) is responsible for the planning, guidance and supervision of TB, TB/HIV and 
leprosy control activities in the region. At Zonal level, lower administrative level next to 
the regions, a Zonal TB Leprosy Expert (ZTLE) is focused on the planning, guidance 
and supervision of TB, TB/HIV and Leprosy prevention and control activities in the Zone 
(EFMOH 2007:15-16). 
 
In Ethiopia since 1992 the standardised TB prevention and control programme was 
piloted and incorporated DOTS strategy, progressive DOT coverage have been 
reported. In 2012, 100% geographic coverage and 95% health institutions level 
coverage of DOTS reported (Addis, Birhan, Alemu, Mulu, Ayal & Negash 2013:168). In 
line with the expansion of DOT, Ethiopia has adopted and developed TB treatment 
guideline to standardise the TB diagnosis and treatment services provision at national 
level. 
 
In 2013, the Ministry of Health of Ethiopia avails the fifth edition of TB, Leprosy and 
TB/HIV guidelines for clinical and programmatic management in Ethiopia. The guideline 
directs the process to diagnose pulmonary TB (Figure1.1) and the TB treatment to be 
taken for at least 6 months in two phases. The phases are: intensive and continuation 
phase as recommended by the WHO TB treatment guideline (EFMOH 2013:56). To 
ensure every patient takes the recommended drugs in the right combinations, on the 
correct schedule, and for the appropriate duration the guideline directs the treatment 
monitoring to be held by HCPs or TB treatment supporter at a health facility or patient’s 
workplace or home. In the intensive phase, for the first two months, patients are forced 
to take the drugs in front of the health care worker observation every day at health 
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institutions. However, the rigid practice of directly observed treatment is difficult to justify 
and it is ethically arguable (Sagbakken, Frich, Bjune & Porter 2013:8).  
 
TB coalition for technical assistance in the international standards of TB care (2014:39) 
recommend options to be provided to patients; where they take their daily dose and by 
whom he/she is going to be supervised for the adherence. In the continuation phase, 
immediately following the intensive phase, the patient is expected to be observed by a 
health care worker or a designated trained TB treatment supporter either at health 
facility or patients’ home (EFMOH 2013:26-27). In Ethiopia, TB drugs are freely 
provided for diagnosed TB patients. Even if medication is freely available, many patients 
are not successfully treated (WHO 2009a:4). The effective treatment of TB requires 
adherence to a minimum of 6 months with multiple drugs (EFMOH 2013:27) but limited 
financial resource and practical help from relatives or friends are mentioned as factors 
in Ethiopia for non compliance to full course of the treatment particularly for the first 2 
months (Sagbakken et al 2013:3). As much as untreated TB threatens the well being of 
an individual and society, defaulting from treatment may increase the risk of drug 
resistance, relapse and death, and may prolong infectiousness (Da Silva Garrido, 
Penna, Perez-Porcuna, De Souza, Da Silva Marreiro, Albuquerque, Martínez-Espinosa 
& Buhrer-Sékula 2012:1). 
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Figure 1.1:  Diagnostic Algorithms for TB in Ethiopia 
(EFMOH 2013:143) 
 
Patient with suggestive symptoms  
Sputum microscopy for AFB 
(three samples) 
Treat with non-specific broad-spectrum antibiotics (excluding TB drugs and 
fluroquinolones) for 7-10 days 
Repeat sputum 
microscopy (three 
samples) 
Examine 2 additional 
sputum samples 
Review after 2-4 weeks 
Chest X-ray and 
physician’s judgment 
Smear-positive Pulmonary 
TB** 
Smear-negative 
Pulmonary TB 
No Tuberculosis: 
Treatment based on 
clinical evaluation 
No Tuberculosis 
2 or 3 positive 3 Negatives 
Both negatives 
Only 1 positive 
No improvement 
All negative 
I
m
p
r
o
v
e
d
  
1 or 2 positive 
1 to 3 
positive* 
  * If initially all three smears are negative but after antibiotics only one repeated smear appears positive, it is advised to carry out two 
additional smears. If one or both are positive, proceed with TB treatment. If both are negative, proceed with a chest X-ray and 
evaluation for conditions other than TB.  
** If the patient has never been treated for TB before (has not taken TB treatment for at least 4 weeks), register and treat as New PTB 
smear positive patient. If the patient has been previously treated for TB or has taken TB treatment for at least 4 weeks, register the 
patient and start regimen for previously treated. 
 
No improvement 
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1.3 STATEMENT OF THE RESEARCH PROBLEM 
 
Currently DOTS is a cornerstone of TB control programme in developing countries (Olu 
2013:227; Diacona et al 2012:1). The DOTS strategy has been considered as an 
efficacious strategy for TB treatment and is being advocated to be continued to better 
treatment adherence of TB treatment (Jassal & Bishai 2010:S163). Moreover, Moonan, 
Quitugua, Pogoda, Woo, Drewyer, Sahbazian, Dunbar, JostJr, Wallace & Weis (2011:3) 
states that DOTS is associated with decreased probability of acquiring and transmitting 
drug resistance. However, review of TB cost shows that DOTS expose the patients to 
heavy financial burdens (Tanimura, Jaramillo, Weil, Raviglione & Lonnroth 2014:1770). 
Lack of social support, adverse drug reactions and personal factors are associated with 
non-adherence to TB treatment in DOTS strategy, and even in industrialised countries 
30% of TB patients do not take their treatment properly (Marais 2013:88). 
 
In Ethiopia, the DOTS strategy was assessed at different times based on TB patient 
treatment outcome. In a retrospective data analysis in 2013, Getahun, Ameni, Medhin & 
Biadgilign (2013:521) reported 82.7% treatment success rate (TSR) with significant 
differences among the health institutions in Addis Ababa. A retrospective study 
conducted in Bahrdar, Ethiopia shows that only 26% TSR with the highest 68% 
transferred out and significantly different treatment outcome by the residence of TB 
patients (Biadglegne, Anagaw, Debebe, Anagaw, Tesfaye, Tessema, Rodloff & Sack 
2013:85). Another study conducted in Dilla, Ethiopia reported that 85.2% TSR and the 
study concludes that DOTS has brought better treatment outcome (Gebrezgabiher, 
Romha, Ejeta, Asebe, Zemene & Ameni 2016:1). 
 
The studies conducted in Ethiopia, did not account for the patients’ satisfaction and 
centeredness perspective of the DOTS strategy except the Nezenega, Gacho & Tafere 
(2013:110) report that good TB patients’ level of satisfaction with DOTS at Sidama 
Zone, Southern Ethiopia. However, health care delivery system fitness with patient 
satisfaction and perceptions has a paramount effect on the effectiveness of DOTS 
(Onyeonoro, Chukwu, Nwafor, Meka, Omotowo, Madichie, Ogbudebe, C, Ikebudu, 
Oshi, Ekeke & Paul 2015:25). 
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Satisfaction measurement is a core component to design and evaluate modern health 
care services and delivery system (Dansereau, Masiye, Gakidou, Masters, Burstein & 
Kumar 2015:9). Patient satisfaction with health care provision captures the patients’ 
experience of health care outside of direct effect on health and acknowledges the role of 
the patient as partners in health care; this reflects the patient centeredness of the care 
provided. Patient-centred health care approaches reduce patients’ symptom burden, 
improve health status and adherence to treatment (Van der Eijk, Nijhuis, Faber & Bloem 
2013:925).  
 
With regard to clients’ perspective, quality is addressing clients’ concern and it is as 
essential as technical competency in good quality of care. Moreover, there is lack of 
published evidence for the effectiveness of the WHO recommended TB control 
strategies in low and middle income countries level (Cobelens, Van Kampen, Ochodo, 
Atun & Lienhardt 2012:1) including in Ethiopia (Hamusse, Demissie & Lindtjorn 
2014a:3). Thus, evaluating DOTS strategy helps to improve the provision of TB care 
delivery in Ethiopia and other countries.  
 
1.4 AIM OF THE STUDY 
 
1.4.1 Research purpose  
 
The purpose of this study was to evaluate patient centeredness and satisfaction 
component of DOTS strategy and propose a model that supports the DOTS strategy in 
Addis Ababa, Ethiopia. 
 
1.4.2 Research objectives 
 
The research objectives were to 
 
 determine level of patient centeredness’ of DOTS strategy. 
 determine level of satisfaction of TB patients’ with DOTS service provision. 
 describe factors related to TB patient centeredness and satisfaction with DOTS 
strategy. 
 explore TB experts and defaulted TB patients’ perception about DOTS strategy 
patient centeredness and satisfaction level of TB patients. 
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 explore defaulted TB patients’ driving factors to default from TB treatment. 
 propose a descriptive model that will support the DOTS strategy with regards to 
patient centeredness and satisfaction. 
 
1.4.3 Research questions  
 
The study’s research questions were: 
 How much the DOTS strategy is patient-centered in Addis Ababa, Ethiopia? 
 How is the TB patients’ level of satisfaction with DOTS in Addis Ababa Ethiopia?  
 What are the factors that affect TB patient centeredness and satisfaction with 
DOTS strategy? 
 Why TB patients default their TB treatment in Addis Ababa, Ethiopia? 
 What is the perception of TB experts and defaulted TB patients about DOTS 
strategy patient centeredness and satisfaction with TB patients? 
  What model will support the DOTS strategy with regard to patient centeredness 
and satisfaction?  
 
1.5 SIGNIFICANCE OF THE STUDY 
 
The study could contribute toward a better understanding of international and national 
level policy makers about DOTS strategy patient centeredness and satisfaction level of 
TB patients with DOTS strategy and the reason TB patients default from the treatment. 
The researcher discovers that internationally different health care institutions have been 
implementing DOTS. However, until recently, there have been limited studies conducted 
to evaluate the effectiveness of DOTS with the perspective of patient centeredness and 
the satisfaction level of TB patients.    
  
The findings of this study inform the Ethiopian government on the status of DOTS 
patient centeredness, satisfaction level of TB patients with DOTS, reasons to default 
from TB treatment and further the proposed model needed to enhance its 
implementation. The result would help the government to evaluate the extent to which 
the DOTS is providing satisfaction to the patients, and its patient centeredness. The 
findings would provide the government with a baseline data describing how the DOTS 
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strategy is patient centred. The researcher develops a model in support of the TB care 
delivery that would increase the patients’ satisfaction and patient centeredness.   
 
The study informs about the gaps related to the DOTS strategy, particularly related to 
patient centeredness, satisfaction and reason of TB patients to default from the TB 
treatment to health care administrators and providers. The health care administrators 
could apply a proposed model to enhance the TB-care delivery. The findings also offer 
background information to other researchers to continue the study on a larger target 
population. 
 
1.6 DEFINITION OF TERMS 
 
Evaluation is a process that critically examines a program. It involves collecting and 
analysing information about a program’s activities, characteristics, outcomes and 
impacts. The evaluation type can be a formative evaluation, process and summative 
evaluation. Formative evaluation is a method for judging the worth of a program while 
the program activities are forming (in progress). Process evaluation is when the 
evaluation focuses on implementation of the programme. Summative evaluation is the 
evaluation  that determines the outcome or impact of the program (Perrin 2016:10-1). In 
this study evaluation refer assessing DOTS startegy patient-centredness and level of 
TB patients satisfaction with it.  
 
Patient-centred care: care that “honors and responds to individual patient preferences, 
needs, values, and goals. 
 
Patient satisfaction: patients’ emotions, feelings and their perception of delivered 
health care services ((Al-Abri & Al-Balushi 2014:4). In this study patient satisfaction 
means the feeling of TB patients and their perception on received TB care services with 
DOTS strategy. 
 
TB patient: one in which a health worker has diagnosed TB and has decided to treat 
the patient with a full course of TB treatment. 
 
Defaulters: patients who took treatment for at least one month and discontinue it for 
more than eight consecutive weeks. 
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TB experts: are health profesional  who lead, support and direct the HCOs TB control 
and prevetion activities.  
 
1.7 PARADIGMATIC PERSPECTIVE OF THE RESEARCH 
 
Paradigm described as a worldview of a way of thinking about and making a sense of 
the complexities of the real world. It is a set of action that guides how to interpret and 
understand our environment (Ross 2012:34). The paradigm tells us what is important, 
legitimate and reasonable. Existing reality (ontology), the way to identify the reality 
(epistemology), and the way to go about (methodology) of the research are 
characteristics of research paradigm (Easterby-Smith, Thorpe & Jackson 2012:17-18).  
 
In Ethiopia the DOTS strategy has been implemented for the last two decades. 
However, the objectives stated above were not completely addressed to the perspective 
of TB patients, defaulted TB patients and TB experts’ view. Hence the researcher 
beliefs that the stated objectives were answered from different perspectives in mixed 
approach in two phases in consideration of the following ontological, epistemological 
and methodological assumptions. 
 
1.7.1 Ontological assumptions 
 
Ontological assumption deals with the inquiries about what are existing reality, form and 
what is known about a given phenomena (Ross 2012:35). The ontological assumption 
explains the reality and known facts about DOTS strategy and TB in relation to the 
study objectives. 
 
Ethiopia has been implementing DOTS strategy since the mid 1990s to treat TB 
patients and control TB. However, the country holds the 11th position of 30 high TB 
burdened countries (WHO 2016:145) and multi-drug resistance TB (MDR-TB) is 
increasing at an upsetting rate from a 1.6% among new TB cases in 2005 to 2.3% in 
2014 (EFMOH 2014a:4).  
 
The DOTS strategy is resource-intensive for health care services and requires time and 
effort from patients (Lienhardt & Odgen 2004:835). In Ethiopia the study by Yimer, 
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Bjune and Holm-Hansen (2014:4) show that in addition to delay in reaching health 
institutions, the time from reaching at a health institution until a diagnosis of TB cases 
takes more than two weeks. However, TB diagnosed patients are obliged to collect their 
drugs every day at health facilities for at least two months (EFMOH 2013:31).  
 
PCC places the patient at the centre of the delivery of care, and redirects activities in 
order to do the right job effectively by the right person at the right time. Moreover, PCC 
improves continuity of care and integration of health professionals collaborating on 
behalf of their patients by minimising the back and forth of patients in health care 
organisation (HCO) and provide autonomy to patients, and empowering staff members 
to plan and execute their work in ways that are the most responsive to patient needs 
(Pelzang 2010:913).  
 
PCC offers a higher level of quality health care and improves the patient’s health care 
experiences, and can even serve to compare providers’ ability to care for patients 
(Porter 2010:2478; Mkopi, Range, Amuri, Geubbels, Lwilla, Egwaga, Schulze & Van 
Leth 2013:101). In addition, patient centeredness is indicated as one of the indicators to 
measure quality of health service delivery (Luxford, Safran & Delbanco 2011:513). 
Moreover, PCC approach is considered as a key factor of treatment success (Srivastav 
& Mahajan 2014:117).  
 
The PCC ensures the satisfaction with the patient. This is not only readily legitimised by 
the principle of PCC. It is a useful marker for evaluating quality of care (Heidenreich 
2013:2). In health care process, evaluation of patient satisfaction helps to measure the 
quality of care and identify the areas that need improvement (Al-Abri & Al-Balushi 
2014:4; Dansereau et al 2015:9).  
 
1.7.2 Epistemological assumptions 
 
Epistimological assumptions deal with the question of how and what we know and the 
content of the truth (Easterby-Smith et al 2012:18). This study evaluated DOTS strategy 
with perspective of patient centredness and satisfation level and propose a model that 
support patient centerdess and satisfaction of TB care delivery.  
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According to Picker Research Institute, PCC encompasses respect for the patient’s 
values, preferences, and expressed needs; provision of information and education; 
access to care; emotional support; involvement of family and friends; continuity and 
secure transition between health care settings; physical comfort; and coordination of 
care (Greene et al 2012:50). 
 
The HCPs perceived empathy, technical competency, and non-verbal communication to 
the patients are factors to patient satisfaction at primary health care level (Birhanu, 
Assefa, Woldie & Morankar 2010:1). Patient-centred communication is a basic 
component of HCPs and facilitates the development of a positive care provider-patient 
relationship and it is a factor the patient's perception and evaluation of health care 
services. Perceived professional care, perceived time spent with HCP, perceived 
accessibility, perceived technical competency, perceived convenience and perceived 
consultation and relational empathy are also considered as predictor of patient 
satisfaction and adherence to TB treatment (Nezenega, Gacho & Tafere 2013:7). The 
PCC and satisfaction framework integrates mutually beneficial partnerships among 
health care providers, patients and health institution has profound implications for 
patient satisfaction. In the PCC quality of communication between patients and care 
providers, it is  important to have common understanding about clinical characteristics, 
complexity and way of managing the disease and the patient’s expectations, 
preference, attitude and perceptions about the disease. The good communication is 
playing pivotal role in adherence to the treatment (Jayadevappa & Chhatre 2011:21). 
 
Patient satisfaction comprises attitudes, quality, accessibility, cost and efficacy of the 
care, availability, and convenience of the environment in the health care setting. 
Patients’ satisfaction with their treatment captures the patients’ experience of health 
care outside of direct effects on health and acknowledges the role of the patient as 
partner in health care, and as such reflects the patient centeredness of care. The level 
of satisfaction of patients is related with many factors that can be categorised as patient 
characteristics which includes age, education, awareness, income, marital status, 
knowledge, experience, attitude, perception and preference. Other categories are health 
care system, health care policy against the specified diseases, clinical convenience of 
the disease and Its management, and communication between HCPs and patients 
(Jayadevappa & Chhatre 2011:15). In addition, waiting time to get the service, 
treatment, availability of service or drug, accommodation, acceptability and 
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communication with care provider are contributing factors for satisfaction (Chimbindi, 
Barnighausen & Newell 2014:1).  
 
1.7.3 Methodological assumptions 
 
Methodological assumption deals with the question of how the researcher or the inquirer 
can go about finding out what he or she expects (Easterby-Smith et al 2012:19). Hence 
the following methodological assumptions were followed to find the answers to the 
stated objectives. 
 
The DOTS strategy evaluation with respect to patient centeredness and level of 
satisfaction research used both quantitative and qualitative approaches. A quantitative 
approach is assumed to be appropriate to generate statistics from the sample 
characteristics’ to make inference about the total population in the study area for 
quantitative approach. The data collection tool was based on wide concept of WHO 
people centred health care framework. To augment the quantitative approach, focus 
group discussions (FGDs) with TB experts and telephonic interview with defaulted TB 
patients were held. This approach enabled the researcher to explore the DOTS strategy 
patient centeredness’ and satisfaction level to the perspective of TB control programme 
management and the deviant from the service, respectively. In addition, the enrolment 
of defaulted TB patients in telephonic interview enabled to exploration of the cause to 
deviate from treatment follow-up. Both qualitative and quantitative outcomes were used 
for the development of patient-centered TB care (PC-TB care) model. 
 
1.8 RESEARCH METHOD AND DESIGN  
 
1.8.1 Research design 
 
Bhattacherjee (2012:35) describes that a research design as the arrangement of 
conditions for collection and analysis of data in a manner that aims to combine 
relevance to the research purpose with economy in procedure and control over the 
hindering factors. A good research design facilitates research operations by yielding 
maximum information with minimal expenditure of resources. Qualitative research 
enables the researcher to explore attitudes, behaviour experiences and in-depth opinion 
from participants. On the other hand, quantitative research generates statistics by which 
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the sample characteristics can be inference to the total study population (Oliver 
2010:77). Therefore, this study used mixed method to take advantage of both 
approaches. 
 
1.8.2 Study setting  
 
This study was conducted in Addis Ababa, Ethiopia, which has a surface area of 540 
Square kilometres. According to projection of Central Statistics Agency (CSA) of 
Ethiopia, in the year 2014 its population was about 3.2 million (CSA of Ethiopia 2013). 
The population density is 5646 persons per km2 (AACAFEDB 2013:15). Administratively, 
Addis Ababa is divided into 10 sub-cities, which are in turn divided into 116 weredas, 
(the smallest government administrative units).  
 
In year 2012, the primary health service coverage of Addis Ababa was 67%. The health 
institutions found in the region are 48 hospitals, of which 34 are private, 11 public and 3 
nongovernmental. Among 11 public hospitals, 6 are owned and managed by Addis 
Ababa City Administration Health Bureau (AACAHB), 3 by Federal Ministry of Health of 
Ethiopia and 2 Police and Defence Minister (EFMOH 2012:2). In addition, Addis Ababa 
contains 93 health centres which are managed by AACAHB and they are mainly 
focused on primary health care, and 647 private clinics mainly engaged on clinical 
service for profit (AACAHB 2015:18). According to the 2014 Annual Report of Addis 
Ababa Health Bureau, among the available health institutions in the region 40 private, 8 
non governmental and 88 governmental health institutions provided TB treatment by 
DOTS strategy (AACAHB 2015:23).  
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Table 1.1: Population of Addis Ababa by sub-city and gender in 2014 
Sub-city  Male Female Total 
Akaki Kaliti 102,959 108,421 211,380 
Nefas Silk-Lafto 172,907 195,976 368,883 
Kolfe Keraniyo 240,983 259,180 500,163 
Gulele 150,174 161,922 312,096 
Lideta 111,731  123,515 235,246 
Kirkos 120,120 137,915 258,035 
Arada 115,088 131592 246,680 
Addis Ketema 144,954 152,839 297,793 
Yeka 187,540 216,796 404,336 
Bole 168,545 191,842 360,387 
Total  1,515,001 1,679,998 3,194,999 
(Source: CSA 2013) 
 
1.8.3 Study site selection 
 
At the time of data collection, the list of health facilities which implement DOTS strategy 
in Addis Ababa was requested from AACAHB TB department.  Then it was categorised 
based on the ownership of the facilities, namely: private for profit, government, non 
government and non government for not profit. A total of 30 health facilities were 
randomly selected from the categories. The determined sample size was allocated to 30 
randomly selected health facilities proportionally based on their TB case load. The 
detailed allocation is described in Chapter 4. 
 
1.8.4 Study subjects  
 
The study subjects in this study were TB patients who on TB treatment follow-up, 
defaulted TB patients at selected health facilities and TB experts at sub-city health 
offices and AACAHB.  
 
1.8.5 Sample size and sampling methods 
 
Among all TB patients that were on follow-up of TB treatment by DOTS strategy in 
Addis Ababa during the study period, the sample size was determined based on the 
following formula:  
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Sample size (n)=(z α/2)2 p (1-p)/ (d) * 1.5 
 
Where p is 50% expected patients’ level of satisfaction, 0.05 error allowance (d), 1.96 
two-sided critical value for 95% confidence level (z), 0.05 level of satisfaction 
significance (α), 1.5 for design effect compensation and 5% contingency for non-
response rate. 
 
Therefore, Sample size (n)=(z α/2)2 p (1-p)/ (d) * 1.5 
 
N=(1.96)2 0.5(0.5)/0.05)2=384 * 1.5=576, by adding 5% contingency the sample size 
was 605. This calculated sample size was allotted proportionally to 30 randomly 
selected health facilities.  
 
For qualitative approach participants, there was no pre-defined formula to quantify the 
desired number of study participants. However, larger number of participants provides 
better assurance in a study’s findings (Yin 2011:89). The study data saturation were 
reached with 25 defaulted TB patients and 23 TB experts participation during the 
interview and discussions, respectively (Bhattacherjee 2012:115). 
 
1.8.6 Data collection 
 
Questionnaire, focus group discussions (FGDs) and interview guide were developed 
and used to collect data. Questionnaire was developed based on WHO people centred 
health care policy framework and Donabedian quality of health care model. FGDs and 
interview guide were prepared based on literature review. Questionnaire, FGDs and 
interview guide were used to collect data from TB patients who were on follow-up of TB 
treatment, TB experts and defaulted TB patients, respectively.  
 
The questionnaire collected information related to TB patients’ level of satisfaction and 
centeredness of DOTS strategy. The questionnaires were pretested before the actual 
data collection and filled by face-to-face interview with TB patients by trained nurses. 
The TB patients who were following their treatment at least for 15 days were randomly 
recruited  during the study period. 
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Defaulted TB patients’ telephone addresses were traced from DOTS register at selected 
health institutions and were contacted. After describing the objective of the interview, 
their willingness to participate in interview was confirmed. For those who were willing to 
respond, the interview was continued based on the guiding questions with researcher.  
 
The FGDs were facilitated by the researcher using lead questions translated into 
Amharic. The communication medium was Amharic, the country’s official language. The 
FGDs included purposely-selected 23 TB experts who were willing to participate (2 from 
each 10 sub-city health offices and 3 from RHB). When the selected expert was not 
willing, the next best fit was included. With this, the total numbers of FGD participants 
were 23. Considering 8 and 7 participants at a time, 3 FGDs were conducted, recorded 
and notes were taken. 
 
Data collection followed the explanatory sequential procedure as TB patients were 
interviewed using interviewer- adminstered questionnaire first, followed by qualitative 
data collection using probing questions with defaulters  and lastly, the FGDs were held 
with TB experts. 
 
1.8.7 Data analysis 
 
Collected quantitative data were checked for completeness and consistency by the 
researcher. Double entry into Statistical Package for Social Science (SPSS) version 
21.0 for Windows (Chicago, IL, USA) was carried out by two Data Clerks. The Data 
Clerks were well familiar with the software. Descriptive and inferential statistics were 
analysed and used to describe the factors and their relationships.  
 
The qualitative research data analysis was started at the beginning of data collection 
(Marshall & Rossman 2011:208). Data collection and interpretation were done 
concurrently. The data were compiled, dissembled, reassembled, categorised the codes 
into themes and themes narrated and concluded (Yin 2011:170). The detail of the data 
collection, analysis and combining the quantitative and qualitative findings are described 
in Chapters 4 and 5 and model development is describe in Chapter 7.  
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1.8.8 Validity, reliability and trustworthiness  
 
The credibility, reliability and transferability of the the study findings were enhanced in 
many ways. In order to increase the rigor of the study, the data were collected from 
multiple sources and using more than one method, and triangulated. This study 
included TB patients who were on treatment follow-up, defaulted TB patients and TB 
experts.  
 
The participants were informed that they would not face anything that hinders 
her/histheir treatment by having this interview at the time of data collection, during their 
treatment and beyond so as to describe their real feeling. Study sites exhibited varied 
TB case loads and the data taken one time from one respondent. Only few numbers of 
respondents’ responses were collected per day for three months to reduce single day’s 
episodic feeling and recruit adequate number of participants. 
 
In order to keep instrument validation, questionnaires were pre tested before the actual 
data collection was launched and a standardised scale was used. To increase the 
quality of data, (a) the data collectors were nurses who have proximity with TB 
treatment strategy, (b) a one day training was given for data collectors before starting 
data collection. The training was on how to fill in the questionnaire (c) the overall 
activities of data extraction were monitored by the researcher and there was strict 
supervision during data collection, (d) all completed questionnaires were examined by 
the researcher for completeness (e) double entry was done during data entry by two 
data clerks who are experienced in data entry into SPSS software. Data entry was 
carried out after the Data Clerks had gone through orientation of the data entry 
Template.  
 
Moreover, verbatim translation of FGDs were shared to the participants to increase 
acceptability and dependability of the discussions, and each stage of research was 
communicated and provided to PhD supervisor of University of South Africa (UNISA) for 
comments before the final document was prepared. 
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1.9 ETHICAL CONSIDERATION  
 
Ethical clearance to conduct this study was sought from institutional research and 
Higher Degrees Committee from UNISA (Annex B). AACAHB wrote a letter to Subcity 
health offices (Annex C). Official cooperation letter was written from the sub-cities 
health offices to respective health facilities. Data collectors received training on ethics 
related to data collection and research to make sure the data were ethically collected. In 
order to ensure confidentiality of the information, names or identification numbers of 
study participants were not included. Written consent was taken from the participants.  
 
 
 
1.10 SCOPE OF THE STUDY 
 
This study was conducted at governmental and non governmental health institutions 
which implement DOTS strategy in Addis Ababa, Ethiopia. The study used both 
quantitative and qualitative approaches. Quantitative approach was used to capture 
view TB patients’ who were on follow-up, while the qualitative approach was used to 
explore the view of defaulted TB patients and TB experts. The study described, 
explored and evaluated DOTS strategy patient centeredness’, level of TB patients’ 
satisfaction, and the driving force to default from treatment follow-up from different 
perspectives. Moreover, developed PC-TB care delivery model that supports the TB 
care delivery system. 
 
1.11 STRUCTURE OF THE THESIS 
 
The overall report of this study contain seven chapters and described as follows: 
 
Chapter 1 Over view of the study 
Chapter 2 Literature review  
Chapter 3 Conceptual framework 
Chapter 4 Research approach, design and method 
Chapter 5 Data presentation and analysis  
Chapter 6 Discussions, conclusion and recommendations 
Chapter 7 Model to enhance TB patient centeredness of TB care 
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1.12 CONCLUSION  
 
Chapter 1 discussed the general overview of the study which includes background to 
the study, the research problem, definition of key terms, and pragmatic, method and 
design with the purpose and specific research’s objectives. Further, the significance, 
scope and ethical considerations were dealt with. The next chapter will discuss the 
literature review which is relevant to this study.   
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION  
 
Chapter 1 presented overview of the study, which includes TB control programmes, 
Ethiopian health care systems and TB control strategies, the research problem, 
purpose, objectives, significance, paradigm of the research and brief methodology with 
more emphasis to the statement of the problem and TB control programmes.  
 
This chapter deals with literature, which involves thorough reading of different studies 
and scientific material. Literature review includes a critique of studies related to the 
topic. The relevant documents were accessed online through Medline, EMBAS, Pub 
med and Google scholar database using key words such as PCC, TB care, TB patient 
satisfaction, risk factors separatly and jointly.  
 
2.2 TUBERCULOSIS  
 
As described in Chapter One TB is a chronic infectious disease caused by a type of 
bacteria referred to as M tb. Although TB affects almost all organs of the body, mainly 
affects the lung. TB transmission is airborne from a person who has TB of the lung 
during coughing, speaking and sneezing of infectious droplets (Tiemersma et al 
2011:2). Once an individual acquires M tb infection remains infected for many years, 
probably for life. Under normal circumstances only 10% of the infected persons will 
develop TB disease at some point in their life (Young, Perkins, Duncan & Barry 
2008:1255-1265). 
 
2.2.1 TB risk factors  
 
Although any person can get TB infection, review of the risk factors to acquire and 
transmit TB indicates that there are many factors which could change the probability of 
transmission and prognosis of TB. The risk factors can be categorised as factors related 
to TB index cases (TB suspected or confirmed), individual, institutional, socioeconomic, 
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behavioural, demographic and health system issues (Narasimehan, Wood, MacIntyre & 
Mathai 2013:3).  
 
2.2.1.1 TB index cases 
 
A person who presents for assessment as a confirmed or suspected case of TB is 
known as an index case for TB. The degree of risk is dependent upon the duration and 
frequency of exposure of an individual with index case and is influenced by the degree 
of infectiousness of the index case (Narasimehan et al 2013:2).  
 
Bacillary load in the sputum and proximity to an infectious case are positively correlated 
with the infectivity of the TB patient. Smear positive TB cases are more infectious than 
other types of TB cases due to the presence of increased number of bacilli. An 
untreated sputum positive patient can infect approximately 10 individuals per year and 
each smear positive case can lead to two new infections. Hospital employee, prisoners, 
inner city residents and care givers are at high risk to be infected with M tb and develop 
primary active TB at a higher probability than those people far away from index cases 
(Narasimehan et al 2013:2). Nearly, 20% of household contacts with active TB cases 
develop an infection (Gabriel & Mercado 2011:2170).  
 
2.2.1.2 Individual factors and co-morbidity 
 
Evident factors known for the development of TB at the individual level are co-morbidity 
with communicable and non-communicable diseases, immune suppression and 
nutritional status. Individual with communicable diseases include HIV/AIDS, sexually 
transmitted infections, viral hepatitis, bacterial, viral and fungal pneumonias, empyema 
and Helminth infestations are documented. Patient with non communicable disease: 
Diabetes mellitus, chronic lung diseases, chronic kidney disease or end-stage renal 
failure, autoimmune hepatitis, gut malabsorption syndromes and malignant disease are 
predisposing factors to develop active TB (Marais, Lonnroth, Lawn, Migliori, Mwaba, 
Glaziou & Zumla 2013:438). In addition, the risk of acquiring TB increases with the age 
15−49 years compared to adolescent age groups (De Lima & Tavares 2014:13). 
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 A study conducted in Ethiopia demonstrates that diabetes has increased the risk of 
individuals to smear positive pulmonary TB and the TB burden increases with 
productive age groups (15-49 years) (Amare, Gelaw, Anagaw & Gelaw 2013:5). 
 
Stressed and undernourished individuals have increased risk for the development of TB 
because of an impaired immune response. TB disease can itself lead to 
malnourishment because of decreasing appetite and changes in metabolic processes 
(Narasimhan et al 2013:5). 
 
2.2.1.3 Gender  
 
Scholars (Sarpal, Goel, Kumar & Janmeja 2015:63; WHO 2014a:58) stated that TB 
prevalence between genders are different. However, the cause of the difference is in 
argument either due to true epidemiologic difference of TB or pronounced barriers to 
notification and prevalence of TB between genders (De Lima & Tavares 2014:13). A 
systematic review indicates that the gender disproportion of TB notification is from 
epidemiologic difference rather than gender pronounced confounders. A high proportion 
occurrence of TB with men is related to differences in social roles, risky behaviours and 
activities, which are conducive to transmission, such as more social contacts and 
engagement in professions associated with a higher risk for TB, such as mining 
(Nhamoyebonde & Leslie 2014:102-103). 
 
Moreover, a recent longitudinal study shows that the lower notification of female TB 
cases is due to the low TB prevalence among females than males (Sarpal, et al 
2015:63). The recent WHO 2014 Global TB report shows that globally females account 
for low proportion of notified TB cases, male to female ratio of 1.6 (WHO 2014a:58). 
Similarly the Ethiopian TB prevalence survey conducted in 2011 report that a lower 
proportion of females are suggestive of TB with X-ray examination (10.2% male and 
6.5% female) among 24,878 females and 21,819 males who had an X-ray examination 
(EHNRI 2011:45). 
 
Apart from this, other scholars argue that the disproportionate TB notification between 
male and female is perceived to have arisen from the barrier to get TB diagnosis and 
treatment services. The barriers are more pronounced among women than men mainly 
because women experienced financial and physical dependence, lower general literacy 
  
27 
and household stigma (Krishnan, Akande, Shankar, McIntire, Gounder, Gupta & Yang 
2014:11). 
 
2.2.1.4 Socio-economic factors and behaviour 
 
Poverty, poor housing, ventilation of domestic and workplace, crowded living conditions 
(eg, prisons, refugee camps, homeless shelters, mass gatherings, shanty compounds), 
alcohol or substance misuse and smoking have  been documented as risk factors for 
TB development and even for recurrence of TB after treatment completion (Yen, Yen, 
Lin, Lin, Shih, Li, Chou & Deng 2014:492).  
 
Indoor air pollution is thought to contribute to 26.2% of the TB burden in 22 high TB 
burdened countries. A study conducted in Nepal shows that there was a higher TB 
prevalence in people who primarily used biomass for cooking (Pokhrel, Bates, Acharya, 
Valentiner-Branth, Chandyo, Shrestha, Raut and Smith 2015:161). However, a study 
conducted in Southern Ethiopia does  not support the association of biomass fuel usage 
as it has increased risk to acquire TB (Woldesemayat, Datiko & Lindtjorn 2014:67). 
 
2.2.1.5 Health system related factors  
 
Consultation, diagnosis and treatment delay that are pertinent to the health care 
delivery system are risk factors for transmission of TB from infectious cases to other. 
The delays amplify the severity of illness among TB patients, in turn, elongate 
infectiousness time and add to bacilli transmission from TB cases to close contacts and 
the community (Yimer et al 2014:1). Moreover, the delays retract the TB control effort 
given that DOTS strategy is based on passive case finding approach and treats 
infectious cases (Narasimehan et al 2013:6). 
 
In many developing countries, the delays are unacceptably high and occur due to 
repeated visits to the same level of health care and difficulty in accessing better 
diagnostic and management services for TB. In Angola the median health care system 
delay is 7 days (Lusignani, Quaglio, Atzori, Nsuka, Grainger, Palma, Putoto & Manenti 
2013:1) while in Wakiso, Uganda is 11 weeks (Buregyeya, Criel, Nuwaha & Colebunder 
2014:5) and in the Afar region of Ethiopia is 33.5 days (Belay, Bjune, Ameni & Abebe 
2012:5). In Addis Ababa, Ethiopia, the median delay of TB patients from the patient 
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feels TB symptoms to the initiation of treatment is 60 to 90 days  (Storla, Yimer & Bjune 
2008:1).  
 
2.2.2 Multi-drug resistance TB (MDR-TB) 
 
MDR-TB is a type of TB caused by strains of M tb that are resistant to first line TB 
drugs, Isoniazid and Rifampicin, it is believed to be man-made.  MDR-TB occurs when 
patients do not complete their full course of treatment; when HCPs prescribe the wrong 
treatment, the wrong dose, or length of time for taking the drugs; when the supply of 
drugs is not always available; or when the drugs are of poor quality (Keshavjee & 
Farmer 2012:931). 
 
Global trend of MDR-TB since the year 2008-2013 shows that the MDR-TB occurrence 
is unwavering (WHO 2014a:70). Globally in 2013, 3.5% MDR-TB among new and 
20.5% among previously treated TB cases were estimated. In the same year 136,000 
MDR-TB patients were detected and reported; 97,000 treated by second line TB drugs 
and only 48% of treated MDR-TB patients had successful treatment outcome (WHO 
2014b:2).  
 
The prevalence of MDR-TB in Africa estimated to be 2.4% among new TB patients and 
13% among previously treated TB patients (WHO 2014a:73). In Africa, in 2013,  44,000 
MDR-TB cases were reported, which constitutes 74% of estimated MDR-TB cases, of 
which only 44% MDR-TB patients were enrolled in the MDR-TB treatment (WHO 
2014a:83). 
 
In Ethiopia 1.6% of new and 12% of retreatment TB cases were estimated to be MDR-
TB patients (WHO 2014a:73) and have shown increasing trend until 2014 with clear 
geographic disparity, with the highest prevalence rates in major urban settings such as 
Addis Ababa (EFMOH 2014a:6).  
 
The MDR-TB in addition to Isoniazid and Rifampicin, may be resistant to other TB 
drugs. When MDR-TB resists any of the fluoroquinolones (such as ofloxacin or 
moxifloxacin) and to at least one of three injectable second-line drugs (amikacin, 
capreomycin or kanamycin) is referred as extensively drug-resistant TB (XDR-TB) 
(WHO 2014a:6).  
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WHO 2014 report indicates that globally on average an estimated 9.0% of patients with 
MDR-TB had XDR-TB and has been reported by 100 countries in 2013 (WHO 
2014a:75). Even though no study was conducted on the prevalence of XDR-TB in 
Ethiopia, laboratory report indicates that the existence of XDR-TB (EFMOH 2014b:6).  
 
2.2.3 Tuberculosis treatment  
 
Successful treatment of infectious cases of TB is essential to prevent the spread of 
infections. Standardised treatment of active TB cases is one of the five components of 
the DOTS strategy. The current  recommended first line drugs for the treatment of TB 
are Rifampicin (R), Ethambutol (E), Isoniazid (H), Pyrazinamide (Z) and Streptomycin 
(S) (Zumla et al 2013:749).  
 
A provision of the TB treatment bases on registration groups of TB patients, which 
differentiate new TB patients from those who have had prior exposure of TB treatment 
(relapse, default and failure). WHO and International standard for tuberculosis (ISTC) 
care recommend HRZE for the first two months and RH for the later four months for 
new TB patients presumed or known to have susceptible TB (TB Care I 2014:10).  
 
Previously treated TB patients or priorly exposed to TB drugs should have culture and 
drug susceptibility testing (DST) at or before the start of treatment to choose the 
appropriate drug based on a DST patern (WHO 2010b:32). It takes 6-8 months duration 
divided in two phases. Phases are an intensive and continuation phase; with at least 
five drugs, Pyrazinamide and other four drugs to which the organisms are susceptible 
including an injectable agent during in the intensive phase of the treatment. In the 
continuation phase, at least 3 drugs to which the organisms are known or presumed to 
be susceptible to 18-24 months after culture conversion (TB Care I 2014:46). The MDR-
TB treatment require 18−24 months with second line TB drugs. It is difficult and costly 
than drug susceptible TB treatment (Keshavjee & Farmer 2012:931). 
 
In Ethiopia the WHO recommended TB drugs are in use as fixed dose combination 
(RHZE 150/75/400/275 mg, RHZ 150/75/400 mg RH 150/75 mg and EH 400/150 mg) 
and their loose form to treat active TB cases. The selection and recommended regimen 
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by the current guideline for clinical and programmatic management of TB, Leprosy and 
TB/HIV in Ethiopia described in Table 2.1 (EFMOH 2013:28). 
 
Table 2.1: Selection of TB treatment regimen for TB patients 
TB patient type  Recommended regimen  Additional action(s)  
New  2RHZE/4RH Send sputum for culture and 
DST if a contact of known 
MDR-TB case 
Previously treated  
Treatment after failure Treat as retreatment: 
2RHZES/RHZE/5RHE 
Send sputum for culture and 
DST while treating the 
patient 
Treatment after default Or relapse 
after one course of treatment 
Treat as retreatment: 
2RHZES/1RHZE/5RHE) 
Send sputum for culture and 
DST while treating the 
patient 
Relapse after second or 
subsequent courses of treatment 
Failure of retreatment 
Wait for DST result  Send culture and DST and 
refer patient to MDR 
treatment initiating centre  
Transfer in Continue the same 
regimen  
Consider DST, if available  
Others  
Previously successfully treated 
patients coming with PTB-ve or 
EPTB 
Treatment as new: 
2RHZE/4RH  
Send sputum/specimen for 
culture and DST if a contact 
of a known MDR-TB case  
Defaulted patients coming with 
smear negative TB, EPTB, or 
previously treated patients with 
unknown treatment outcome 
Treat as retreatment: 
2RHZES/RHZE/5RHE  
Send sputum/specimen for 
culture and DST while 
treating the patient  
2=Two months, 5=Five months, 1=One month R=Rifampicin, E=Ethambutol, H=Isoniazid, 
Z=Pyrazinamide, S=Streptomycin, DST=Drug Susceptibility Test. 
(Source: EFMOH 2013:28) 
 
2.3 DIRECTLY OBSERVED TREATMENT, SHORT COURSE (DOTS) STRATEGY  
 
In 1991, the 44th WHA recognised TB as an emergency and a major public health 
problem. Cognisant of this, two targets were set; detecting 70% of infectious TB cases 
and treating 85% of detected cases by the year 2000. However, to achieve these set 
targets, poor adherence to TB treatment, prolonged infectiousness and drug resistance 
to treatments were identified challenges. The DOTS strategy was designed to tackle 
these challenges by focusing on observing the person, whether taking the treatment 
correctly with the right amount at the right time by health workers or trained volunteers 
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i.e. direct supervision and patient support are a central component of the strategy 
(Lienhardt et al 2012:409). 
 
The DOTS strategy is a central part in stop TB strategy with other prongs (Table 2.2) 
which target to eliminate TB from being considered as a public health problem (<1 
case/106/year) by the year 2050. The components of the strategy to achieve the targets 
are depicted in Table 2.2 (WHO 2012:4).  
 
Table 2.2: Components of the stop TB strategy 
1. Pursue high-quality DOTS expansion and enhancement  
 Secure political commitment with adequate and sustained finance 
 Ensure early case detection, and diagnosis through quality-assured bacteriology 
 Direct supervision and patient support 
 Ensure effective drug supply and management 
 Monitor and evaluate performance and impact 
2. Address TB/HIV, MDR-TB, and the needs of poor and vulnerable populations 
 Scale up collaborative TB/HIV activities 
 Scale up prevention and management of MDR TB 
 Address the needs of TB contacts, and of poor and vulnerable populations 
3. Contribute to health system strengthening based on primary health care 
 Help improve health polices human resource development, financing, supplies, service 
delivery and information 
 Strengthen infection control in health services, other congregate settings and 
households 
 Upgrade laboratory networks, and implement the practical approach to lung health 
 Adapt successful approach from field and other sector and foster actions for social 
determinants of health 
4. Engage all care providers 
 Involve all public, voluntary, corporate and private providers through public-private mix 
approaches 
 Promote use of the International Standards for Tuberculosis Care 
5. Empower people with TB, and communities through partnership 
 Pursue advocacy communication and social mobilisation 
 Foster community participation in TB care, prevention and health promotion 
 Promote use of the Patients’ Charter for Tuberculosis Care 
6. Enable and promote research 
 Conduct programme-based operational research 
 Advocate for and participate in research to develop new diagnostics, drugs and vaccines 
(Source:WHO 2012:4) 
 
Globally, until 2005, 187 countries have implemented the DOTS strategy to control TB 
(WHO 2006). In Ethiopia since the DOTS strategy was piloted, it has shown increasing 
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geographic and facility coverage. At 2011, the coverage reached to 100% geographical 
and 95% health facility (Mekonene 2014:2). 
 
Although the DOTS strategy provides limited options for prompt diagnosis and cure for 
MDR-TB cases (Keshavjee & Farmer 2012:933), the DOTS strategy supported TB 
control activities to avert 7 million deaths that would have been occurred due to TB and 
50 million TB patients to be treated from mid 1990th to 2008 (Marais 2013:89).  
 
The Centre for Disease Control and Prevention (CDC) of the United States of America 
(USA), recommends that DOTS provision should not interfere with the patient’s work 
schedule and can be provided at any place, either in or outside the health institutions; 
where the patient and HCP agreed upon as long as the location is convenient and safe 
(CDC 2014:33). In line with CDC-USA recommendation, the Ethiopian guidelines for 
clinical and programmatic management of TB, TB/HIV and Leprosy provide options 
where direct observation can take place; at a hospital, at a health centre or at a health 
post, at the patient’s workplace, or at the home of the patient (EFMOH 2013:36). 
 
2.3.1 DOTS and treatment outcome 
 
The treatment outcome of TB patients is categorised and reported in a proportion of 
cured, treatment completed, failed, died, lost to follow-up and not evaluated (no 
treatment outcome is assigned) among the cohort of TB patients. Cured and treatment 
completed jointly defined as TSR. The TSR is among WHO recommended outcome 
indicator of DOTS treatment (Getahun et al 2013:526). 
 
According to WHO 2014 report, in 2013, global TSR by DOTS strategy was 86%, 65% 
and 68% among new, previously treated and HIV positive TB patients, respectively. The 
highest TSR, 95% reported in China and the lowest in the Russian Federation. In the 
same report, 91% of newly registered and 43% of retreated TB patients had a 
successful treatment outcome in 2012 (WHO 2014a:147).  
 
Globally, among 2011 cohort of MDR-TB and XDR-TB cases started a second-line 
treatment, 48% of MDR and 16% of XDR TB cases were successfully treated (WHO 
2014b:165). These TSRs have increased to 52% for MDR-TB and 28% for XDR-TB in 
the 2013 cohort (WHO 2016:1). 
  
33 
 
In Africa, 81% of new and relapse cases, 48% of previously treated cases, excluding 
relapse, 68% of HIV-positive all types TB cases registered in 2012 had successful 
treatment outcome by DOTS strategy. In Kenya and Mozambique 87% and 89% TSR 
were reported among 2014 registered TB patients, respectively (WHO 2016:149).  
 
In Ethiopia among a cohort of 2014 bacteriologically confirmed TB patients, 89% of TB 
patients had successfully treated. In the same year, 69% MDR-TB TSR was reported in 
Ethiopia however, still the death rate due to MDR-TB remained high, 12% (EFMOH 
2015a:21). 
 
In Ethiopia across the regions at different times varied proportions of treatment outcome 
were reported. A medical record review of smear positive pulmonary TB patients in the 
Tigray region in 2011 was 89.2% TSR reported with a significant difference between 
those who were employed and unemployed pulmonary TB patients (Berhe, 
Enquselassie & Aseffa 2012:7). Another study conducted in Azezo, North-West 
Ethiopia, 80.5% TSR in 2012 (Addis et al 2013:168) and in Addis Ababa with slight 
increasing trend from 2005 to 2009 and 87.3% TSR was reported (Getahun et al 
2013:525).  
 
The unwanted treatment outcomes of TB patients in Azezo, Ethiopia were reported as 
8.5% death, 0.21% failed and 1.7% lost to follow-up from their TB treatment (Addis et al 
2013:169). Getahun et al (2013:521)  report that the unwanted treatment outcome in 
Addis Ababa was 3.7% death, 5.1% lost to follow-up and 0.4% failed under DOTS 
strategy.  
 
2.3.2 DOT at health facilities and in the community 
 
DOT at health facilities poses an economic and social burden. Cognisant of these 
burdens Gabriel and Mercado (2011:2178) evaluate task shifting from health facilities to 
the community. According to their findings, DOT in the community was equally effective 
and efficient as DOT at health facilities. A review demonstrates that community based 
DOT through community health workers improves access, service utilisation and routine 
TB recording and reporting systems (Arshad, Salam, Lassi, Das, Naqvi & Bhutta 
2014:27).  
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A comparative study conducted in Botswana, compared DOT at the facility against at 
home, shows that no statistical difference in the treatment outcome of TB patients 
between DOT at the facility against at home. However, it is slightly difficult to trace the 
indexed case contacts at home based care (Mash & Kabongo 2010:5). Another study in 
the same country in 2013, reaffirms that TB patients who get their treatment in the 
community shows better treatment outcome than treatment provided at health facilities 
(Mugisha, Semo, Ledikwe, Ncube, Firth, Achoki, Lere, Machao, Mwangemi, 
Makadzange & Mabreaden 2013:93). A study conducted in Oromiya region of Ethiopia 
compared the TSR of the TB patients who follow their continuation phase of the TB 
treatment in the community against health facilities. The findings demonstrate that the 
TSR is similar in both settings (Ketema, Raya, Workineh, Klinkenberg & Enquselassie 
2014:S15). 
 
A systematic review of literature by Weiss, Chen, Cook and Johnston (2014:7) indicate 
that community-based TB treatment even for MDR-TB patients had a similar outcome 
with the facility-based treatment provision schemes. The lessons from the studies lead 
to argue that DOT at health facilities and in the community is yielding a similar treatment 
outcome, however, DOT at the facility is resource demanding compared to DOT at the 
community.  
 
2.3.3 DOT and self-administered treatment (SAT)  
 
Studies compared DOT against SAT based on mortality and treatment completion rate 
of TB patients. A study conducted in Taipei, Taiwan indicates that the probability of 
death is lower among patients treated with DOT than those who treated on the SAT 
after adjusting other predictors. However, the study is subjected to retrospective study 
limitation as it was based on a review of documents and secondary data. The study 
participants were not randomly assigned either to SAT or DOT groups, and numbers of 
participants had significant difference among the groups (Yen, Rodwell, Yen, Shih, Hu, 
Li, Shie, Chuang & Garfein 2012:178-180).  
 
A study conducted in Brazil, Rio de Janeiro compared the treatment completion rate of 
TB patients with DOT against SAT. the study shows that the treatment completion rate 
at facility DOT is better rate than SAT (Steffen, Menzies, Oxlade, Pinto, Castro & 
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Monteiro 2010:1). Similarly, a study conducted in conflict areas of India report that 
smaller proportions of patients under DOT were lost to follow-up compared to SAT. 
However, numbers of participants, particularly for the SAT’s group were limited (Das, 
Isaakidis, Armstrong, Gundipudi, Babu, Qureshi, Claes, Mudimanchi, Prasad, Mansoor 
& Abraham 2014:1). Another study conducted in Iran demonstrates that DOT has better 
treatment outcome than SAT. Based on the outcome of the study, Moosazade, 
Jamshidi, Amiresmaili and Nezammahalleh (2012:878) recommend DOT to be 
continued to achieve TB related MDG set goals and to reduce acquaintance of MDR 
TB. 
 
However, the study conducted in Homa baya, Kenya suggests that SAT allows 
achieving appropriate adherence to TB treatment, the main reason of DOT, even in a 
high TB and HIV burden area (Nackers, Huerga, Espie, Aloo, Bastard, Etard, Sitienei, 
Varaine, Chakaya & Bonnet 2012:1). Furthermore, a meta analysis of ten randomised 
and observational studies which included 8,774 patients concluded that DOT is not 
significantly better than the SAT in preventing microbiologic failure, relapse, or adverse 
drug reactions (Pasipanodya & Gumbo 2013:30). The scholars are in arguments either 
DOTS or SAT is supporting in reduction of mortality, and lost to follow-up, and treatment 
completion rate. 
 
2.3.4 DOT and treatment supporter  
 
In the DOT strategy, the treatment supporters’ role ranges from watching a TB patient 
whether swallow every single dose to manage and report when side effects observed 
and the health status of the patient (EFMOH 2013:24). Studies assessed and compared 
different types of treatment supporter whether they are helpful to better treatment 
outcome of TB patient or not. A study conducted in Rawalpindi District, Pakistan on 
treatment outcome of TB patients using different treatment supporters, shows that a 
significant difference among different treatment supporters. TB patients who had 
women health workers treatment supporter had better treatment outcome than TB 
patients who had family members and community volunteers as a treatment supporter. 
However, the study lacks proportionality on allocation of treatment supporter (Soomro, 
Qadeer, Khan & Morkve 2012:15). 
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Another study conducted in Zimbabwe compared TB treatment outcomes of TB patients 
using three types of treatment supporter: HCPs, trained community member and family 
member. The study shows that the treatment outcome of the participants has no 
significant difference among the three treatment supporter groups (Mlilo, Sandy, 
Harries, Kumar, Masuka, Nyathi, Edginton, Isaakidis, Manzi & Siziba 2013:147). 
Similarly, a study conducted in Nepal shows that treatment outcome of TB patients has 
no significant difference among different types of treatment supporter of TB patients 
(Mirzoev, Baral, Karki, Green & Newell 2008:1). The studies can reveal the type of 
tratment supporter may not have special advantage one type over the other with regard 
to ttreatment outcome.  
 
2.4 PATIENT-CENTRED CARE (PCC) 
 
PCC has attracted leaders in visionary HCOs, research institutions and public policy 
centres who advocate that patients’ interests and concerns should be at the centre of 
their own healthcare experience. PCC has become a central discussion of the quality 
health care provision and is at the time to be included in the health care delivery system 
(Epstein & Street 2011:101). The health care policy direction that includes patient 
centeredness of the health care delivery is  needed to be standing position not only for 
improving the quality of health care delivery, but also to reduce the challenges posed on 
people by chronic diseases (Mirzaei, Aspin, Essue, Jeon, Dugdale, Usherwood, & 
Leeder 2013:1). Moreover, even a study conducted in developing countries such as 
Ethiopia recommended the introduction and implementation of PCC in the national TB 
control program to combat the challenges posed by daily observation of TB patients at 
health facilities particularly in the patient perspectives (Fiseha & Demissie 2015:7). 
 
2.4.1 PCC as a dimension of quality health care 
 
PCC has been raised as a dimension of quality indicators of health care and safety of 
health services. Despite its newness, as health quality indicator, necessitates a change 
in the way policy makers and regulators think about the quality of health care (ACSQHC 
2011). The WHO quality health care dimension focuses on effectiveness, safety, 
efficiencies, accessibility, equitable and acceptability of the health care. PCC have been 
quoted as substitute under the acceptability of the care (WHO 2006:9-10). In addition, 
assessing quality interventions need to consider the level of right, involvement and 
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share responsibility of service user and patients. These components of patient 
centeredness are also included in the dimension of WHO recommended health care 
quality (WHO 2006:33). WHO indicates that patient centeredness is one of the 
indicators for measuring the quality of health service deliver (WHO 2008:14). 
 
Reviews show and recommend that patient centeredness of health care delivery to be 
considered as quality indicator since it ables to reflect improvement the quality of patient 
care (Berwick 2009:w555; Pelzang 2010:908). PCC, beyond quality indicator for low- 
and middle-income countries, is an essential component for quality health care. It is 
timely to promote and optimise PCC beyond micro scale interaction (HCP and patient 
communication), integration in the macro level (health care system) of both low and 
middle income countries to gearing up for universal health coverage (Mahendradhata et 
al 2014:5).  
 
2.4.2 PCC and health policy  
 
Across the world, there is a growing recognition and acceptance of PCC approaches in 
the health care delivery. International organisations such as the WHO, Health 
Foundation, Piker Institute of Health Care, and International Alliance of Patients’ 
Organisations are lobbying PCC to be an integral part of health care policy and delivery. 
In addition, governments emphasise the need for health care to be more explicitly 
patient-centred on the needs of the individual patient. PCC care is a patient-focused, 
individualised care delivery process that supports the building of trust within a provider-
patient relationship, fosters the patient’s participation in care design, and reinforces 
patient expectations and perceptions of quality and equity (Kitson, Marshall, Bassett & 
Zeitz 2013:5).  
 
Cognisant of PCC as a pillar of quality health care delivery, developed countries such 
as Australia, Australian Commission on Safety and Quality in Health Care have been 
inserted PCC to be implemented at policy and service level across the country in 2010 
(ACSQHC 2011) and US Department of Health and Human Services in 2008 (Kitson et 
al 2013:5). However, its application is limited to developed countries, and not well 
entertained in developing countries (Epstein & Street 2011:102). However, Indian’s 
health care delivery and treatment guideline strongly advocate the PCC approach even 
for TB patients under DOTS strategy (Gupta 2015:35). 
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In developing countries, PCC is strongly recommended to be integrated in health policy 
since PCC can result in tremendous savings compared to expenses incurred with 
treatment with traditional methods. The potential implementation of PCC in developing 
countries is particularly interesting because the health system becomes more efficient 
when it focuses on the person, not solely on the diseases. Moreover, it is believed to 
increase the satisfaction of patients and reduce disparity among the patients who may 
be in different socio-economic status (Otero, Luna, Marcelo, Househ, Mandirola, 
Curioso, Pazos & Villalba 2015:33). 
 
2.4.3 PCC and TB 
 
PCC in TB control strategy is not a new concept, even in introduction of DOTS strategy, 
it was considered as important component (Grant 2013:3). In the stop TB strategy, a 
component that provide emphsis on empowering people with TB and communities is a 
light of PCC importance in TB control programme at different level. It emphasises the 
establishment of social support programmes, communication and partnership between 
health sector and local community particularly with TB patients and collecting their 
experience to provide responsive health care services to their needs for themselves and 
their fellows (WHO 2012:4). 
 
Sustainable and effective PCC TB treatment strategy is promising for TB control (Mkpi 
et al 2013:7). Post-2015 TB control strategy and Standard nine of the ISTC described 
the patient-centred approach as core pillar of all TB control and care activities (WHO 
2013c:10). Incognisant of patient-centred TB control strategy’s input to make a world 
free of TB, Tuberculosis Coalition for Technical Assistance (TBCTA) designed five 
strategies that reinforce PCC. The strategies are to engage all stakeholders, recognise 
the patient’s rights, enable partnerships, empower and activate patient and 
communities, and monitor and document the activities by actively involving the patient 
and the communities (TB care I patient-centred approach strategy 2015).  
 
A systematic review conducted on 60 articles suggests that PCC is associated with 
improved patient outcome. The improved patient outcomes associated with PCC are 
adherence to treatment and quality of life of TB patients (Kuntz, Safford, Singh, 
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Phansalkar, Slight, Her, Lapointe, Mathews, O’Berien, Brinkman, Hommel, Farmer, 
Klingler, Maniam, Sobko, Bailey, Cho, Rumptz, Vandermeer & Hornbrook 2014:310). 
In a qualitative study conducted in Uganda with HCPs, TB patients and their family 
demonstrates that PCC is not only for drug susceptible TB but also for MDR-TB is to be 
an ideal approach at national level for Uganda. This approach supports the TB program, 
beyond treatment adherence, facilitating psychosocial support and allowing more free 
time and earning potential for patients and care givers (Horter et al 2014:1). 
 
A study conducted in Tanzania on a cohort of TB patients, provision of choice for TB 
patients where to take a medication and treatment supporter, was used as a PCC 
intervention. As a result, the study explains that PCC intervention has brought better 
treatment outcome significantly (Egwaga et al 2009:9).  Apart from this, a study 
conducted in Nicaragua shows that PCC on TB patients has no significant difference 
with regard to treatment outcome, rather it suggests as way to internalise stigma related 
to TB over the direct observation of TB treatment (Macq et al 2008:7). 
 
Although there are limited evidences to conclude PC TB care superiority over the 
traditional TB-care provision with regard to treatment outcome, findings show that the 
promising features of PCC not only to a better treatment outcome, but also to improve 
wellbeing and financial risk protection by improving adherence to TB treatment, 
benefiting patients and society as a whole (Toczek, Cox, Du Cros, Cooke & Ford 
2013:306; Sripad Castedo Danford Zaha & Freile 2013:45). 
 
2.5 PATIENT SATISFACTION  
 
Al-Abri & Al-Balushi (2014:4) defined patient satisfaction as patients’ emotions, feelings 
and their perception of delivered health care services. Satisfaction also defined as 
psychosomatic thought of individuals on judgment regarding any object or event after 
gathering some experience over time. Most scholars recognise satisfaction as a 
cognitive response whereas some others consider as emotional attachment of 
individuals (Chakraborty & Majumdar 2011:150).  
 
Patient satisfaction is defined as the extent to which the person’s observation of the 
health care service or the manner in which it is delivered by the provider as helpful, 
effective or beneficial (Medical Dictionary 2012). It is a junction between patent’s prior 
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expectations and the perception of care in reality received from the services (Mishra & 
Mishra 2014:627).  
 
Satisfaction measurements with health system play an important role in evaluating 
performance at national level and beyond. Moreover, patient satisfaction is often viewed 
as a variable that is influenced by quality of care. It is a predictor of future health-related 
behaviour and has been found to be sensitive to a large number of factors, including 
certain experiences with health service delivery (Papanicolas, Cylus & Smith 2013:734).  
 
Currently, the HCOs are recognised as a social institution. Their only reason to exist is 
patient. Therefore, measuring patient satisfaction level has been increasingly becoming 
a measure to evaluate health care services directly provided to the patient 
(Mosadeghrad 2014:85).  
 
2.5.1 Predictors of patient satisfaction 
 
Among socio-demographic characteristics of the patient’s gender, socioeconomic status 
and age are perceived factors for satisfaction with health care service they received. 
Young and middle-aged males from poor socioeconomic class and rural set up were the 
least satisfied with the health care in the study conducted in Pakistan (Ahmad, Nawaz & 
Din 2011:40).  
 
Patient expectations, health status, patient-provider relationship, facility setting, and 
urgency of admission are also a predictor for patient satisfaction (Pefoyo & Wodchis 
2013:9). Moreover, educational level of the patient reported as a predictor for 
satisfaction. More educated patients have reported less satisfaction scores. The reason 
for less satisfaction scores is due to the high expectation of highly educated patients or 
they are more critical in their evaluation of the care they received (Rahmqvist & Bara 
2010:90; Pefoyo & Wodchis 2013:3).  
 
A study shows that the different attributes of patient satisfaction from the side of HCPs 
are attitude, communication skills, technical skills and responsiveness to patient needs 
(Ahmad, Nawaz, Khan, Khan, Rashid & Khan 2011:184). 
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A study was carried out, which considered timely services, reservation system for clinic 
appointments, treatments and procedures, provision of care on time, acceptable waiting 
time, and time-efficient for payment as dimensions for convenience. Convenience was 
reported as a strong predictor of patient satisfaction (Ham, Peck, Moon & Yeom 2015:5; 
Yan, Wan & Li 2011:388).  
 
Other studies used waiting time as a standalone predictor. Affirmed waiting time to get 
the service has been associated with patient satisfaction scores; lower waiting time with 
a high satisfaction score and lower score with longer waiting time (Bleustein, Rothschild, 
Valen, Valatis, Schweitzer & Jones 2014:393; Yimer et al 2014:7).  
 
In HCPs-patient communication, paying undivided attention, listening, inviting questions, 
and validating concerns are the reported factors which have an immense impact on 
patient satisfaction in both directions (Shirley & Sanders 2013:2). Good communication 
between HCPs and patients is reported as a cause for higher patient satisfaction level 
(Cousin, Mast, Roter & Hall 2012:193). 
 
2.5.2 TB patients and satisfaction 
 
Treatment outcomes of the patient have power on, and are influenced by, patient 
satisfaction with the treatment processes they have gone through it. Worsen outcome 
may arise from dissatisfaction of patients from the service they received due to 
divergence with the treatment plan (Mindaye & Taye 2012:4). 
 
At different places, studies on TB patients’ satisfaction level with the TB treatment 
service have been conducted. In Rio de Janeiro, Brazil, a community-based survey was 
conducted on patient satisfaction with the TB control programme, shows that high 
satisfaction with TB control programme in general population. DOT treated population 
were more satisfied than those who were on self-administered. In addition, the study 
shows that lower satisfaction level among younger patients (patients who were less 
than 30 years old) and those with university education (Portela, Lima, Brito, Ferreira, 
Escosteguy & Vasconcellos 2014:505).  
 
Another study conducted in Nigeria, compared the satisfaction level of TB patients with 
DOTS at home against at health facility, the participants who received DOTS at home 
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were reported to have more satisfaction scores than those who received care at the 
health facility (Adewole, Oladele, Osunkoya, Erhabor, Adewole, Adeola, Obembe & Ota 
2015:783). 
 
A study conducted in Uttar Pradesh, India, reports that only 15% of the TB patients 
were dissatisfied with TB care they received. The reported reasons for dissatisfactions 
were non suitable opening time of DOT centres, rude behaviour of the HCPs, long 
distance of the DOT centre, non availability of HCPs, long waiting time and feeling that 
private treatment is always better than government. Apart from these, the causes for 
satisfaction were easy availability of the medicines nearby their homes or working place, 
motivation and health education about the disease (Gupta 2015:36).  
 
A study conducted in KwaZulu-Natal, South Africa, 97% of TB patients reported, that 
they were satisfied with the health care services they received. However, about 40% of 
participants agreed that some HCPs did not treat them with sufficient respect and 
reported long waiting times (Chimbindi, Barnighausen & Newell 2014:3).  
 
A study conducted in Southern Nations Natoinality Peoples Region (SNNPR), Ethiopia, 
shows that 90% of the TB patients were satisfied with TB treatment service they 
received. Patient perceived on professional care, time spent with HCPs, accessibility, 
technical competency, convenience (cleanliness) and consultation and relational 
empathy were reported as independent predictors for overall patient satisfaction 
(Nezenega, Gacho & Tafere 2013:1).  
 
 
2.6 CONCLUSION 
 
While conducting an extensive review of literatures with the DOTS strategy, the 
existence of knowledge gaps on PCC and TB patient satisfaction level reinforced the 
requirement of this study. The most common gap observed in the review is no common 
PC-TB care model that can support TB care delivery, particularly in the context of 
developing countries except the inclusion of the few copmonents of PCC in Tanzania. 
Further, the review identified that the presence of limited information about DOTS 
strategy patient centerdeness and TB patient satisfaction with DOTS strategy. The 
different TB treatment provision modality: SAT, community based treatment, home 
based and facility based treatment remained in an argument about the superiority of 
  
43 
one another to provide better treatment outcome of TB patients. Hence, although PCC 
implementation of TB treatment is limited, patient-centred TB care that keeps the patient 
preference and value may complement the weakness of the existed modalities of TB 
treatment provision since patient-centred practice improved health status and increased 
the efficiency of health. 
 
Moreover, the reviewed literature agreed on the fact that there is an impact of 
measuring patient satisfaction on quality improvement of care. Patients’ satisfaction 
level is a realistic indicator to provide opportunity for improvement, enhance strategic 
decision making, reduce costs, meet patients' expectations, frame strategies for 
effective management, monitor health care performance of health plans and provide 
benchmarking across the health care institution.  
 
The next chapter, Chapter 3 will explain the framework and model utilised to execute 
this study.  
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CHAPTER 3 
 
CONCEPTUAL FRAMEWORK 
 
3.1 INTRODUCTION 
 
Chapter 2 presented literature review on TB, DOTS, PCC and its predictors, and patient 
satisfaction with possible predictors from different data bases. The review also shows 
the presence of limited information about DOTS strategy patient centeredness’ and TB 
patient satisfaction with DOTS strategy. Moreover, the review identified lack of PC-TB 
care model that can support TB care delivery particularly in the context of developing 
countries.  
 
George (2010:4) describes that conceptual framework is a thought that could shape 
perceptions, reality and an enquiry. It is useful to identify how concepts and theories are 
related; and the propositions that explain the relationships between different and or 
similar concepts. According to Burns and Grove (2011:239), in every quantitative driven 
study, conceptual framework that guide and depict the interaction of variables is 
inevitable. 
 
3.2 REVIEW OF PCC FRAMEWORKS 
 
The term PCC is often used in health literature at different times and is defined  
differently by authors. Redman (2004:11) describes PCC as caring for the patient as an 
inimitable individual and is also defined as a criterion of practice that demonstrates a 
respect for the patient as a person (Schaller 2007). PCC definition is, beyond the 
respect of the individual, a care that respect and take action to individual patient 
preferences, needs, values, and goals” (Greene et al 2012:49). 
 
PCC focuses on considering the patient’s point of view, situations in the decision-
making process and goes far beyond simply setting target with the patient. Most PCC 
descriptions and definitions’ core concept rotates on patient’s value. The patient’s value 
is considered as a goal of health care delivery with defined treatment outcome even 
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with complex conditions. PCC is asserted as a care, which respects and reacts to 
individual patient preferences, needs, values and goals (Greene et al 2012:49). 
 
In addition, PCC takes into account respect, compassion, concern, shared decision 
making and communication. It regards patients as a complete person with biological, 
psychological and social needs, thus PCC approach required to be an integrated part of 
the health care system (Pelzang 2010:913).  
 
Patient-centeredness refers to an approach of health care provider-patient encounter 
explained by responsiveness to patient needs and preferences, using the patient’s 
informed wishes to guide activity, interaction and information-giving, and shared 
decision-making (Scholl, Zill, Harter & Dirmaier 2014:3).  
 
Patient centeredness is supposed to improve the quality of patient care, reduce the cost 
of care, and increase satisfaction among HCP and patients through strengthening 
professional practice and maintaining the values of the patient and health care providers 
(Pelzang 2010:916). PCC offers a higher level of quality health care and improves 
patients health care experiences. Measuring its value adjusts risks that may face and 
used for relevant comparisons among the patients’ results, including comparisons of 
providers’ ability to care for patients (Porter 2010:2478).  
 
Patient centeredness is one of the indicators used to measure quality of health service 
delivery (WHO 2008:14). Patient-centeredness is beyond quality indicator for low and 
middle-income countries, it is an essential component of quality health care. It is time to 
promote and optimise patient centeredness, beyond the micro scale interaction (HCP 
and patient communication), integration at the macro level (health care system) of both 
low and middle income countries to gearing up for universal health coverage 
(Mahendradhata, Souares, Phalkey & Sauerborn 2014:5).  
 
 
3.2.1 Models and dimensions of PCC 
 
At different times, different models and dimensions of PCC have been proposed and 
used. Mead & Bower (2002:60) propose Bio psychosocial perspective, patient-as-
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person, sharing power and responsibility, therapeutic alliance, and doctor-as-person as 
five dimensions of patient centeredness in health care setting.  
 
The Picker Institute of Health identified and projected eight dimensions of PCC. The 
dimension included access; respect for patients’ values and preferences; coordination 
of care; information, communication and education; physical comfort; emotional support; 
involvement of friends and family; and preparation of discharge and transitions in care 
(Shaller 2013).  
 
Similarly, the Institute of Medicine (IOM) in the United States has put in place six 
measurements: values and preferences; coordination of care; information, 
communication and education; physical comfort; emotional support; and involvement of 
friends and family (Little, Everitt, Williamson, Warner, Moore, Gould, Ferrier & Payne 
2011:909).  
 
In 2014, a systematic review and concept analysis on existing patient-centeredness 
model was done by Scholl et al (2014:5-6), as a result they propose an integrative 
model of patient-centeredness. The proposed model encompasses 15 dimensions of 
patient-centeredness classified into principles, enablers and activities. Acknowledged 
dimensions in principles are essential characteristics of clinician, clinician-patient 
relationship, clinician-patient communication, patient as a unique person and 
biopsychosocial perspective. Enablers are clinician-patient communication, integration 
of medical and non-medical care, teamwork and team building, access and coordination 
and continuity of care. The Provision of information to the patient, involving the patient 
and patient’s relative or friends to the degree that the patient prefers are considered 
activities that facilitate informed decision in PCC. Further, emotional and physical 
support with recognition and active support of the patient’s ability and responsibility to 
self-manage his or her disease are stated in the activity category of the dimension 
(Scholl et al 2014:5-6).  
 
Although no universally accepted conceptual framework or model of PCC existed, 
health promotion, communication and partnership have been considered in the 
framework or a model across multiple areas of clinical practice to avail PCC (Constand, 
MacDermid, Dal Bello-Haas & Law 2014:7).  
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Researchers used different PCC models, which they considered appropriate for the 
representation of PCC for TB treatment. Provision of the TB treatment at home (Horter, 
Stringer, Reynolds, Shoaib, Kasozi, Casas, Verputten & Du Cros 2014:3), in the 
community (Gabriel & Mercado 2011:2178) and self-administering (Yen et al 2012:179) 
were considered the PCC intervention model for TB treatment by different scholars. 
 
Moreover, provision of information, choice where to take treatment and enough time to 
patients and treatment supporter choice were also considered as components of PCC 
of TB treatment strategy (Mkopi et al 2013:3).  
 
A study conducted in Tanzania on TB control programme, provision of choice where  
either HCPs or family member, types were considered as PCC intervention  dimensions 
to DOTS strategy (Egwaga, Mkopi, Range, Haag-Arbenz, Baraka, Grewal, Cobelens, 
Mshinda, Lwilla & Van Leth 2009:3). Another study that assessed the level of 
internalised stigma and TB treatment outcome used TB patients’ home visit to increase 
power sharing between the health personnel and TB patients as an intervention of PCC 
provision (Macq, Solis, Martinez & Martiny 2008:2). 
 
The concept of PCC is described in many ways. The term PCC described as consumer 
centred care to engage people as partners, in health sector this term seems active and 
aligns with clients (Silow-Carroll, Alteras & Stepnick 2006:10). Redman (2004:11) 
describes PCC as caring the patient as an inimitable individual. PCC is a criterion of 
practice that demonstrates a respect for the patient as a person (Schaller 2007:). 
 
WHO uses the term ‘responsiveness’ in preference to ‘PCC’ to describe how a health 
care system meets people’s complaints.  The response to the complaints is based on in 
recognised or acceptable rules, standards and ethical norm regarding respect for 
people and their wishes. In addition, the responses consider waiting time of patients and 
good communication between health workers and patients. 
 
PCC focuses on considering the patient’s point of view and situations in the decision-
making process and goes far beyond from simply setting a target with the patient 
(Ponte, Conlin, Conway, Grant, Medeiros, Nies, Shulman, Branowicki & Conley 
2003:83). PCC is a care, which respects and reacts to individual patient preferences, 
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needs, values and goals and considers a patient as a complete person with biological, 
psychological and social needs (Greene et al 2012:49). 
 
Most PCC descriptions and definitions’ core concept rotates and focuses on patient’s 
value. Patient’s value is recommended to be a goal of health care delivery with defined 
treatment outcome even within a complex health conditions. PCC offers a higher level 
of quality health care and improves patient health care experiences. Measuring patients’ 
value adjusts risks and can be used for relevant comparisons among the patients’ 
results, including comparisons of providers’ ability to care for patients (Porter 
2010:2478; Pelzang 2010:917).  
 
The existed PCC models and frameworks which focus on individuals consider respect 
and values for patients’, preferences and expressed needs as a core notion (Gertels 
Edgman-Levitah, Daley & Debanco 1993; Piker Institute of Health 2001; WHO 2000), 
while the PCC frameworks that focus on system approach, consider structural, process, 
the outcome of HCO as components of the PCC (McCormack & McCane 2006).  
 
The existence of organisational self-care and partner involvement scheme recognised 
as the axles that determine the patient centeredness of a care (Flarey 1995). Whereas, 
some of the PCC frameworks give high attention on the communication of HCP with the 
patients and HCPs’ characteristics to provide PCC by disregarding the technical 
competency of HCPs and convenience of the premise of HCOs (Jayadevappa & 
Chatter 2011:21; Greene et al 2012:50; Scholl et al 2014:7) without integrating and due 
attention to the outcome of the model and predictors of PCC.  
 
Despite the similarity of the core concepts among the models and frameworks of PCC, it 
is difficult to get a single framework or model that could fit with TB care delivery at HCO 
due to lack of clarity and homogeneity of the existed PCC models toward TB care 
provision (Constand et al 2014:8). The details of the reviewed models and frameworks 
are described in Table 3.1. 
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Table 3.1: Comparison of PCC dimensions, frameworks and models 
Authors  Focused dimensions  Remarks 
Dimensions of 
PCC (Gertels et 
al 1993) 
 Respect for patients’ values, 
preferences and expressed need. 
 Coordination and integration 
 Information, communication and 
education 
 Physical comfort 
 Emotional support and alleviation of 
fear and anxiety 
 Involvement of family and friends 
 Transition and continuity of care 
 Patients’ side dimensions 
are well explored   
 Not categorised to system 
level and interactions are 
not well explained  
 Not well linked to the 
outcomes 
Systems model 
of PCC (Flarey 
1995) 
 Organisational self-care 
 Masters of change 
 Partners in care 
 Patient involvement  
 Less emphasis patient’s 
value and need 
 Lack informed decision 
 Mainly focused on 
organisational 
sustainability 
 No outcome indicator 
stated  
Dimensions of 
PCC (Piker 
Institute of 
Health 2001) 
 Respect for patients’ values, 
preferences and expressed needs 
 Coordination and integration of care 
 Information, communication and 
education 
 Physical comfort 
 Emotional support and alleviation of 
fear and anxiety 
 Involvement of family and friends 
 Transition and continuity 
 Well explored dimensions 
 Technical competency is 
not considered 
 Do not consider 
environment of the HCO 
 
A framework for 
measuring 
responsive-ness 
(WHO 2000) 
 Dignity  
 Autonomy 
 Confidentiality 
 Prompt attention 
 Access to social support  
 Quality of basic service 
 Choice of care provider  
 More emphasis is provided 
to non-technical aspects of 
the care  
 Ignores the medical parts 
 Communication and 
interaction of patients and 
HCPs not considered. 
A system theory 
of patient-
centred care 
(McCormack & 
McCane 2006)  
 
 Structure component  
 Process component  
 Outcome component  
 Integrated with heath 
system  
 Provide outcomes  
 Patient centeredness is 
embedded in other 
outcome 
People centred 
health care: 
policy frame 
work (WHO 
2007b) 
 Health practitioners  
 HCOs individuals, families and 
communities 
 Health systems 
 It is good to assess nation’ 
whole health care system 
since it provide more 
emphasis at macro/nation 
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Authors  Focused dimensions  Remarks 
 level and policy level 
 It is not explicit, 
overarched to inplace in 
HCO 
Conceptual 
model of PCC 
(Jayadevappa & 
Chatter 2011:21) 
 Provider and patient characteristics 
 Outcome(satisfaction, improved 
survival, health, cost reduction,  
 Clinical characteristics and 
convenience  
 Integrate the outcome and 
predictors  
 Lacks interlinking 
dimensions  
Dimensions and 
attributions of a 
patient-centred 
health care 
system (Greene 
et al 2012:50) 
Nine (9) dimensions categorised to: 
 
 Relationship  
 Provision of care  
 System  
 Categorised to system and 
care provision 
 The outcomes are not 
clearly stated  
Integrative model 
of patient-
centeredness 
(Scholl et al 
2014:7) 
Fifteen (15) dimensions categorised to: 
 
 Principles 
 Enablers  
 Activities  
 Explored maximum 
dimensions compared to 
the other models  
 Outcomes are not stated  
 
 
3.3 CONCEPTUAL FRAMEWORK OF THE STUDY 
 
Considering the purpose and specific objectives of the study the following frameworks 
were selected: WHO’s people centred policy health care framework (WHO 2007:1-14) 
to guide patient centeredness of DOTS strategy and Donabedian’s quality of health care 
model (Donabedian 2005: 672-679) to guide TB patients’ satisfaction level. 
 
3.3.1 People-centred health care policy framework 
 
People-centered health care policy framework is intended to provide general principles 
and guidance for countries and areas in identifying and adapting policy reforms and 
interventions to their unique settings at national and local levels in the broader health 
care challenges. The framework contains four domains of dimensions. The dimensions 
are individuals, family and community; health care delivery system; HCPs and HCO 
(WHO 2007b:7). 
 
 
  
51 
3.3.1.1 Individuals, families and communities 
 
Individuals, families and communities are the framework’s dimension, placed within a 
service delivery context that supports universal, equitable, people-centred and 
integrated health services. These are delivered through integrated networks and 
linkages within the health sector, as well as direct inputs from communities (WHO 
2007b:9). 
 
The construct that reflect the PCC in Individuals, families and communities dimension 
include health literacy, communication and negotiation skills and patient capacity for 
self-management and self-care. A capacity of the volunteer, and promoting social 
infrastructure that supports community participation explain patient centeredness’ level 
to the patient side in the framework (WHO 2007b:10). 
 
Patients cannot access health service and make informed decisions without being well 
informed. Safe and equitable PCC services need health literacy of a patient to meet and 
achieve quality health services (Brach, Dreyer, Schyve, Hernandez, Baur, Lemerise & 
Parker 2012:2). Health literacy of people can increase through active community and 
mass media education campaigns; skills-oriented health education programmes; written 
information in conjunction with verbal information in clinical consultations; and evidence-
based health education (WHO 2007b:10). Moreover, empowerment of the community 
and TB patients throughout their treatment follow-up time is one of the recommended 
approaches to improve TB treatment outcome (Boateng, Kodama, Sata, Bonsu & 
Osawa 2012:364). 
 
Communication skills are one of the core components which pave a way to put in PCC 
services. Communication skills existed almost in all framework or models of patient 
centeredness in common (Constand et al 2014:1). Among PCC’s fundamental 
components, communication skills account for a major share. These skills help to foster 
healing relationships; exchanging and know what patients want and need; responding to 
patients’ emotions; engaging in informed and collaborative decision and enables 
patient’s self-management (Levinson, Lesser & Epstein 2010:1311). Communication 
skills has a positive impact, beyond making a health service patient centred, on 
important PCC outcomes, including patient satisfaction, adherence to recommended 
treatment and self-management of chronic disease (Levinson et al 2010:1312). 
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Building patients’ capacity to manage and care for themselves through training and 
health education are a determinant of existence of PCC in health care service 
organisation. Self-management and care can reduce symptoms; improve physical 
activity and less need for medical treatment. Building the capacity of the volunteers who 
support the patient and the community can strengthen the patient centredness of the 
care (Bensberg 2007:17). 
 
3.3.1.2 Health care providers (HCPs) 
 
The ability and commitment of HCPs for holistic, ethical and compassionate care are 
required components to provide PCC services. HCPs need to understand their patients 
within a broader context, beyond clinical findings and patient’s illness, by exploring each 
patient’s unique biological, psychological, and social context (Scholl et al 2014:3). The 
communication skills of HCPs help to extract information beyond clinical findings and 
convey the information which helps the patients to make informed decisions.  
 
Relationship building capacity of the HCPs with patients and families gives a way to 
understand on what problems the patient is most concerned with and how the patient’s 
illness or has affected his/her life beyond the clinical manifestations. The relationship 
also required Inter professionals to put in a team based PCC approach in health care 
provision (Constand et al 2014:2-3). 
 
Respect for the patient’s values, preferences, and expressed needs; provision of 
information and education; being accessible to care; emotional support; involving family 
and friends; continued support and securing transition between health care settings are 
expected from HCPs (Pelzang 2010:914). 
 
3.3.1.3 Health care organisations (HCOs) 
 
Health care environment design is expected to provide comfort and safety to the 
patients. HCOs are expected to provide access to social, emotional and spiritual 
support for patients. Appropriate and flexible visiting and risk management policies that 
protect the public, patients and staff; waiting rooms and other public spaces within the 
premises of health care facilities for health education are required to provide PCC 
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(WHO 2007b:12). Patient centeredness is associated with patients’ perceived 
conducive and comfort of HCO such as cleanliness and reduced noise level of the 
HCOs’ premises to receive care (Locatelli, Turcios & Lavela 2015:24).  
 
Scholl et al (2014:6) states that effective and efficient coordination of front-line patient 
care with ancillary support services can ensures continuity of care to patients. Strong 
coordination and collaborative health care service is a root to implement cost effective 
PCC and overcome the ever-increasing PCC demand (Carver & Jessie 2011:4). The 
framework also include transparent, accessible and understandable service protocols 
that improve patient flow; appropriate scheduling of appointments; reminder notices for 
specific interventions; public announcements, lose or wall-mounted printed materials 
and signage to guide health service navigation; hand-held patient health records  and 
protocols for discharge and referral (WHO 2007b:12). 
 
The presence of multi-disciplinary care team which has a formal job description with 
delineated and functional communication channel is one of the requirements to provide 
PCC (WHO 2007b:13). Multi-disciplinary care team in HCO should be a high-performing 
team able to provide truly PCC to reliably work together with patients, respond to an 
individual’s need, preference value, and experience in managing beyond clinical care. 
Multi-disciplinary care team includes teams which address the psychosocial context, 
financial and support resources, ability to self-manage, and barriers to self-care (Sevin, 
Moore, Shepherd, Jacobs & Hupke 2009:25). In addition, the presence of 
multidisciplinary care team in HCOs helps the patients to get and stay well, and reduce 
back and forth of the patients (Parish 2015:2). 
 
The HCOs need to fulfil staffs’ requirement. They also need to have targeted monitoring 
and evaluation of individual and team performance for continuous quality improvement. 
They should ensure that their staffs are getting competitive and performance based 
incentive packages, including opportunity for continuing medical education, training, and 
recognition and awards (WHO 2007b:14). 
 
Enhancing leadership capacity of health services managers through training and one 
another experience sharing is required strategies to foster PCC in the health care 
facilities. Strong and committed senior leaderships are a strong attribute to 
implementation of PCC (Luxford et al 2011:513).  
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3.3.1.4 Health care delivery systems  
 
The health care delivery system should be able to develop a health workforce and put 
financial incentives that induce positive attitude among HCPs and health care system to 
achieve better health outcomes. Ensuring rational use of technology, strengthening the 
monitoring of professional standards, and addressing patient concerns about health 
care quality and assisting people who have experienced adverse events in the health 
system with protection of patient information should get attention to implement and 
sustain PCC. The health system monitoring approach greatly covered augmented by 
patient satisfaction survey as indicator for its patient centeredness of the care (WHO 
2007b:15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 adopted diagrammatic representation of People-centred health care policy 
framework 
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3.3.2 Donabedian’s Model of Health Care Quality 
 
Donabedian’s Model of Health Care Quality bases on three interrelated domain in the 
context of quality of care. The domains are structure, process and outcome.  
 
‘Structure’ was described as the fixed part of the practice setting and consists of 
providers, resources, tools and organizational structures where the care is provided. 
The structure is the main determinant of the care that the health organization is able to 
give (Donabedian 2002:50).  
 
‘Process’ is the activities that are constitute the health care such as diagnosis, 
counselling, treatment and education that are being provided by HCPs. The process is 
directly linked with the outcome and the structure domain of the model (Donabedian 
2002:52). 
 
‘Outcome’ refers to changes (desirable or undesirable) in individuals and populations 
that can be attributable to health care. Outcome variables include changes in death or 
alive and satisfaction of patients and their family members with the quality of health care 
services they received (figure 3.2) (Donabedian 2005:691-696). 
 
Donabedian suggests that a good structure increases the likelihood of good process; 
good process increases the likelihood of good outcome, such as patients’ satisfaction 
(Donabedian 2002:46).  
  
 
Figure 3.2 Diagrammatic representation of Donabedian’s Model of Health Care Quality 
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Donabedian’s Model of Health Care Quality presents a multidimensional framework for 
quality of health care and services in health institutions and is still considered as a 
bench mark of health care field (Haj, Lamrini & Rais 2013:28).   
 
One of the objectives of the study is evaluation of satisfaction level of TB patients with 
the DOTS. Patient satisfaction is seen as both an outcome and an indicator, and may 
offer a simple first step into understanding quality of health care. The model has been 
widely recognized and applied in many health care fields. It is the most comprehensive 
model used for health care evaluation. Further it has received substantial imperial 
support of ability to generate information from which can be drawn quality of care. 
Hence the study adopts the Donabedian Model of health care quality to drive the 
satisfaction section of the study. 
 
3.3.3 Relevance of the frameworks  
 
The WHO people centred health care framework emphasises the people’s involvement 
in their health care and makes them the centre of their care. Moreover, it provides 
respect to people’s value, culture, informed decision and partnership. It embraces four 
dimensions in it that are required to fulfil people centred health care delivery as 
described in Section 3.3.1. 
 
TB patients need to be informed, respected and participate in decisions, and choose 
their preferences of health institution, time and place to get prompt diagnosis and 
treatment. If these values and preferences fulfilled they will be well informed and 
knowledgeable about TB. In turn, patients will be cooperative, participative to accept 
and adhere to TB treatment for required time, overcome the barriers such as cost, 
inaccessibility lack of knowledge; as a result good treatment outcome can be recorded 
and health related quality of life improved. 
 
HCPs, HCO and health care delivery systems play an important role with respect to 
capacitating the TB patients and provision of PCC. Interacting with each other and 
integrating segment of activities with patient expectation are emphasised components in 
WHO’s people centred health care framework. These are the required patient 
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centeredness dimensions beyond patients’ concern to guide the level of TB patient 
centeredness of this study. 
 
Satisfaction arises from and influenced by structure, process of health care delivery 
system and the outcome of the process. Donabedian’s Model of Health Care Quality 
focuses on structure, process and outcome of health care delivery system. The 
structure embraces all the necessary medical equipment, availability of TB drugs, HCPs 
and types of health facilities providing the services. The process encompasses the TB 
diagnostic, reception, registration system, refill of TB drugs, while outcomes are 
physical, psychological well-beings of TB patients which imply good levels of 
satisfaction with the DOTS strategy. Hence, Donabedian’s Model of Health Care Quality 
is considered appropriate as long as the three model’s approaches fit one of the study 
purposes, determining level of TB patient satisfaction.  
 
Patient centeredness is an indicator of quality health care deliver and is considered and 
perceived as benchmark for quality that is required by HCPs to deliver distinguished 
patient satisfaction (McKerns 2007:1). Patient satisfaction is significantly higher among 
HCOs that implement effective PCC. The patient satisfaction questionnaire is 
considered to be a significant quality  improvement  tool. In other way round, excellent 
ratings of patient satisfaction give a clear picture of the HCO gaps to plan and act to 
improve the quality of service delivery (Nelson, Helfrich, Sun, Hebert, Liu, Dolan, Taylor, 
Wong, Maynard, Hernandez, & Sanders 2014:1353). WHO people centred policy 
framework focus on the Health care delivery patient centeredness while Donabedian’s 
Model of Health Care Quality focuses on patient satisfaction as an outcome of HCO. 
Although they have similar components, complement each other to provide full 
evaluation of the study particularly the completeness of the quality service provision.  
 
3.4 CONCLUSION  
 
This chapter described the selected proxy guidance for this study, namely: WHO’s 
people centred health care policy framework and Donabedian’s Model of Health Care 
Quality. WHO’s people centred health care policy framework was used as a guide to 
extract level of patient centeredness ot DOTS. While Donabedian’s Model of Health 
Care Quality used to determine the level of TB patients’ satisfaction with DOTS 
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strategy. Further described their relevance with the study purposes and briefly reviewed 
the accessible PCC frameworks. 
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CHAPTER 4 
 
RESEARCH APPROACH, DESIGN AND METHOD 
 
4.1 INTRODUCTION  
 
Chapter 3 discussed the conceptual framework of the study and the gaps within the 
existed patient-centred frameworks and models. In addition, it described the framework 
and model the study based on and the relevance of the framework and the model with 
the study. The WHO’s people centred health care framework guided to evaluate TB 
patient centeredness and the Donabedian health care quality model guided to 
determine the level of satisfaction of TB patients in the DOTS strategy.  
 
This chapter describes research approach, design and methods of the study to achieve 
stated objectives. The first section of this chapter discusses the research approach, 
design, methods and ethical principles of the study, while the later section describes the 
internal and external validity of the study and the procedures that were applied to 
ensure quality of the study and trustworthiness.   
 
This study was divided into two phases based on the nature and purpose of the study. 
In Phase I, the researcher collected quantitative data from TB patients’ on follow-up to 
describe centeredness, satisfaction and associated factors of the DOTS strategy. In 
phase II, the researcher explored the driving factors, which default TB patients from 
their treatment follow-up from defaulted TB patients and perceptions of TB experts 
about patient centeredness and satisfaction with DOTS strategy. 
 
 
4.2 RESEARCH APPROACH  
 
A research approach is a plan and research procedures extent carried out from 
assumptions to interpretation. Basically, there are two research approaches, 
quantitative and qualitative research approaches. The quantitative approach involves 
the generation of data in quantitative or numeric form which follow rigorous quantitative 
analysis in a formal and rigid method. While qualitative research approach is concerned 
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with subjective assessment of attitudes, opinions and behaviour of the research interest 
(Kothari 2004:5).  
 
Quantitative research approach conceptualise realities in terms of variables, measure 
these variables and look for their relationships (Punch 2014:206). The quantitative 
approach mainly relies on numeric data such as scores and readily realises them and 
test statistically differences among the variables. Moreover, quantitative approach 
outcome adds more precision and clear understanding of the phenomenon of interest 
(Bhattacherjee 2012:103). 
 
Qualitative approach is more suitable in the exploration of poorly conceptualised 
phenomenon. This approach gives bases to develop theories when partial or 
inadequate theories exist for certain populations and samples or when existing theories 
do not adequately capture the complexity of the phenomenon (Creswell 2012:48).  
 
The complexity of a phenomenon under a study may need mixing qualitative and 
quantitative approaches. Mixing helps to generate unique insight into a complex social 
phenomenon that is not available from either qualitative or quantitative type of data 
alone (Bhattacherjee 2012:35). A research approach that combines both qualitative and 
quantitative approach is known as mixed methods approach (Yin 2011:281). Mixed 
methods approach combines qualitative and quantitative data collection and analysis to 
achieve complementary strength and reduce weakness of separate approaches (Punch 
2014:309-312).  
 
The researcher chose the mixed method approach to take advantage of qualitative and 
quantitative approaches; as the study determine and explore the phenomenon under 
the study. Furthermore, the study generalized the study findings to the similar settings 
and included different set of study populations. With this regard, mixed method 
approach improves the scientific rigour, increase the generalisability and validity of the 
research through cross-validation of data from different sources (Creswell 2012:49).  
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4.3 RESEARCH DESIGN 
 
Research design is a way of guidance and answering the research questions of the 
study. The research design focuses on increasing the control over of hindering factors 
of the research outcome (Bhattacherjee 2012:35). The research design explains the 
logic involves to link the research objectives’, the data to be collected and the strategies 
for analysing the data in a manner that helps to reinforce the validity of the study (Yin 
2011:10). The research design varies based on the purpose of the study. Either the 
researcher starts at observation and attempts to rationalise the observations and 
formulate a theory, or the researcher starts from theory and attempts to test or validate 
the theory (Bhattacherjee 2012:3).  
 
Sequential explanatory research design is a phase-based mixed research approach 
design in which the researcher first collects and analzes quantitative data, followed by 
the qualitative data collection and analysis. The qualitative data outcome may either 
help to explain the salient findings of the statistical outcome from quantitative data or 
extract in-depth view of study (Punch 2014:313). The study objectives to be fully 
achieved, the real-life experiences with the DOTS strategy of TB patients’ who were on 
follow-up and defaulted from the TB treatments were required. In addition, contextual 
influences and multi-level perspectives of the strategy from TB experts who lead the TB 
control programme were demanded. These enriched the study and helped to explore 
the specific features of different study population groups (Baran & Jones. 2016:80). 
Furthermore, even if the quantitative and qualitative approaches of the study intended to 
achieve different objectives, the expanded synthesis of both quantitative and qualitative 
findings used to develop the model (Bhattacherjee 2012:15). Hence, this study used 
sequential explanatory mixed design in two phases to guide the way of achieving the 
purposes of the study as described in Table 4.1.. 
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Table 4.1: Summary of objectives, approaches, method and study participants 
in sequential mixed design of the study 
Objectives Study 
phases 
Approaches Method 
Study 
participants 
Determine patient centeredness’ of 
DOTS strategy 
Phase I QN Questionnaire 
TB patients 
on follow-up 
Determine level of satisfaction of TB 
patients’ on DOTS service provision 
Phase I QN Questionnaire 
TB patients 
on follow-up 
Factors related to TB patient 
centeredness, satisfaction with 
DOTS strategy 
Phase I QN Questionnaire 
TB patients 
on follow-up 
Explore driving factors to default 
from TB treatment Phase II QL 
In-depth 
telephonic 
Interview 
Defaulted TB 
patients 
Explore TB experts and defaulted 
TB patients perception about DOTS 
strategy patient centeredness and 
satisfaction level 
Phase II QL FGDs TB experts 
Descriptive model development  Synthesis of both QN and QL data findings  
 
4.4 RESEARCH METHOD  
 
The research method describes data collection procedures, tools, population, 
participants and sampling procedure utilised in the research process (Johnson & 
Christensen 2012:90). In this section, population and sampling, data collection and 
analysis for each phase of the study, and ethics related to sampling and data collections 
of the study are described. 
 
4.4. Phase I, quantitative approach  
 
Population, sampling, sample size and data collection methods employed and Data 
management and analysis in the phase I study are illustrated in the following sub 
sections.  
 
4.4.1.1 Population  
 
Population is the group of individuals or matters the research project make statistical 
inferences based on their sub group or sample outcome (Yin 2011:99). The study 
population of phase I was TB patients who were on follow-up of TB treatment in Addis 
Ababa.  
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4.4.1.2 Sampling  
 
Sampling is the procedure of choosing a subset (called a “sample”) from a population of 
interest. Limitations of financial, human and time resources are barrier to study all the 
population of the research interest. They are driving factors to draw a sample from the 
population. Sampling is required to make observations and statistical inferences about 
population of interest (Bhattacherjee 2012:65).  
 
Addis Ababa was purposively selected among other regions of Ethiopia due to its 
intense population concentration in the country (Adugna 2014:7), since crowd is one of 
the risk factors for TB (Yen et al 2014:492). In addition, about 90% TB case detection 
rate was reported in 2013 (EFMOH 2014b). All 121-health facilities which were 
providing TB treatment with DOTS strategy in Addis Ababa were listed. Then listed 
health facilities were categorised into government, private for profit and nongovernment 
not for profit. Among grouped health facilities, to obtain study site, by rule of thumb 
(Gebrekidan, Tesfaye, Hambisa & Deyessa 2014:3) approximately 25% of the facilities 
from each group was randomly selected by lottery method. A total of 30 study health 
facilities were selected. 
 
Consented TB patients who were on follow-up of TB treatment at 15 days, aging 18 
years and above at randomly selected health facilities during the study period were 
randomly recruited until the proportionally allotted sample size (Table 4.2) reached. 
  
64 
Table 4.2: Selected health facilities, TB case load and allotted sample size 
(N=605) 
Study site 
facility  
Type of 
facility 
Sub-city 
TB case 
load 
Ownership 
Alloted 
sample size 
SS1 Health centre Adisketema 69 Gov 23 
SS2 Health centre Adisketema 45 Gov 15 
SS3 Health centre Akakikality 69 Gov 23 
SS4 Health centre Arada 99 Gov 33 
SS5 Health centre Bole 102 Gov 34 
SS6 Health centre Bole 33 Gov 11 
SS7 Health centre Gulele 36 Gov 12 
SS8 Health centre Gulele 48 Gov 16 
SS9 Health centre Kirkos 102 Gov 34 
SS10 Health centre Kirkos 63 Gov 21 
SS11 Health centre Kolfe K 114 Gov 38 
SS12 Health centre Kolfe K 54 Gov 18 
SS13 Health centre Lideta 105 Gov 35 
SS14 Health centre Lideta 90 Gov 30 
SS15 Health centre Nifas L 36 Gov 12 
SS16 Health centre Nifas L 30 Gov 10 
SS17 Health centre Yeka 78 Gov 26 
SS18 Health centre Yeka 105 Gov 35 
SS19 Hospital Arada 57 Gov 19 
SS20 Hospital Kirkos 69 Gov 23 
SS21 Health centre Arada 36 Gov 12 
SS22 Health centre Bole 72 Gov 24 
SS23 Health centre Gullele 48 Gov 16 
SS24 Clinic Arada 69 NGO 23 
SS25 Clinic Lideta 21 Private 7 
SS26 Hospital Arada 60 Private 20 
SS27 Hospital Bole 15 Private 5 
SS28 Hospital Bole 30 Private 10 
SS20 Hospital Kirkos 45 Private 15 
SS30 Hospital Yeka 15 Private 5 
Total    1815  605 
SS: study site; Gov: government; NGO: Non-government not for profit  
 
 
 
 
 
 
  
65 
4.4.1.3 Sample size 
 
Sample size is a number of study participants included in the study. The sample size for 
Phase I study participants, TB patients who were on follow-up of TB treatment, was 
determined based on the following formula. 
 
Sample size (n)=(z α/2)2 p (1-p)/(d) *1.5.  
 
Where p is 50% expected TB patients’ level of satisfaction, or who perceived as patient-
centred TB treatment received or level of TB treatment adherence, since no prior study 
determined the levels of each objectives, 0.05 error allowance (d), 1.96 two-sided 
critical value for 95% confidence level (z), 0.05 level of satisfaction significance (α), 1.5 
for design effect compensation and 5% contingency for non-response rate. 
 
Therefore, Sample size (n)=(z α/2)2 p (1-p)/ (d) *1.5. 
 
N=(1.96)2 0.5(0.5)/0.05)2=384*1.5=576, by adding 5% contingency the total sample size 
was 605 TB patients who are on follow-up of TB treatment. Determined sample size 
was proportionally allocated based on selected study site’s TB caseload. Included 
sample size, study site TB case load, type of health facility and ownership are illustrated 
in Table 4.2. 
Sample size at each facility     =        total sample size* caseload at each site 
Total TB caseload at selected sites 
 
4.4.1.4 Data collection  
 
Data collection is a means of gathering required information in detail from different 
sources (Yin 2011:49). The relevant data in the 1st phase, and the quantitative data 
were collected using pre-tested interviewer-administered questionnaire from TB patients 
who were on follow-up of TB treatment. 
 
4.4.1.5. Development and testing of the data collection instrument 
 
The questionnaire was developed in English based on conceptual frameworks of the 
study as well as the extensive review of literatures by the researcher. The questionnaire 
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was given to PhD supervisor and statistician for comments and piloted on 27 TB 
patients at two heath facilities which provides DOTS but not included in the selected 
health facilities for the main study before the actual data collection launched.  
The final version of the questionnaire was translated into Amharic language, the official 
language of Ethiopia, and also the Amharic questionnaire was translated back to 
English to check for consistency.  
 
4.4.1.6 Characteristics of the data collection instrument 
 
The questionnaire designed for TB patients who were on follow-up contains items that 
enables to collect information about patient’s socio-demographic characteristics, patient 
centeredness of the strategy and satisfaction level of TB patients with the strategy. The 
questionnaire had three parts; part one instructions how to fill the questionnaire, part 
two information about the study and part three questions divided into three sections, A 
to C. 
 
Section A contained the general characteristics of TB patients such as age, sex, 
residence, type of TB, their treatment phase, treatment category and treatment 
supporter.  
 
Section B contained 65 5-point Likert scales ranging from strongly disagree to strongly 
agree items based on adopted WHO people centred health care framework which 
evaluate the level of patient centeredness of the strategy. These items were categorised 
into four dimensions: health care delivery system, HCO, HCPs and patient, family and 
community. The overall section B and each dimension Cronbach’s alpha were 
measured during pilot and actual data analysis. Under each dimension category there 
were sub-dimensions and items.  
 
Section C had 23 5-point Likert scales ranging from strongly satisfied to strongly 
dissatisfy. Items that measured the participant’s levels of satisfaction with DOTS 
strategy developed based on Donabedian quality health care model. These items were 
divided into three sub-sections; structure, process and outcome. The structure and 
process sub-sections contained 10 measuring items each while outcome section 
contained 3 measuring items. The sections’ Cronbach’s alpha were above 0.7 (Field 
2009:675) during pilot and actual data analysis as described in the table 4.3 below. In 
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addition, the correlation of each items in the same dimension was assessed as a result 
there was no measuring items that show perfect correlation, r= 1 (Hambleton & Zaal 
2013:123). 
 
A stand-alone single item that measures the overall satisfaction of TB patients with 
DOTS included in section C. The item had 10-point scale ranges from 0 to 10 for 
minimum and maximum satisfaction with DOTS strategy they received, respectively. 
 
Table 4.3 Cronbach’s alpha value of the questionarrie  
Section  No of 
Items  
Cronbach’s 
alpha value of 
pilot data 
Cronbach’s 
alpha value of 
actual data  
Centeredness     
Patient, family and community dimension  21 0.82 0.84 
HCP dimension   22 0.85 0.87 
HCO dimension 9 0.76 0.76 
Health care system dimension  13 0.88 0.88 
Overall total centeredness  65 0.93 0.93 
Satisfaction section    
Structure  10 0.78 0.78 
Process  10 0.78 0.78 
Outcome  3 0.85 0.85 
Total Satisfaction (structure, process 
and outcome sections) 
23 0.88 0.85 
 
 
4.4.4.7 Data collection process  
 
The quantitative data of the study were collected by trained data collectors. The data 
collectors and supervisors involved in the study were trained on ethical aspects of data 
collection, inclusion and exclusion criteria of the study participant and questionnaire by 
the researcher for a day.  
 
After the training, the data collectors and supervisors signed an agreement with the 
researcher. In the agreement the roles and responsibilities of data collectors, 
supervisors and the researcher, remuneration and termination of the agreement was 
included. Then the data collectors collected pilot data at two 2 facilities which were not 
selected in the main data collection site. 
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Based on the pilot test outcome the questionnaire was amended. Both the data 
collectors and supervisors were updated about the amendments before the actual data 
collection was carried out.  
 
The updated data collectors were deployed to randomly selected heath institutions with 
questionnaires, ethical clearance certificate and permission letter.They were also 
informed that if they face anything that could affect the data collection process, to 
communicate the researcher as soon as possible. As they reached at assigned health 
institutions they presented the study’s ethical clearance and permission letter to the 
facility head or representative and created good rapport with HCPs.  
 
The data collectors contacted TB patients who were on follow-up of TB treatment 
randomly to do an exit interview after he or she received TB treatment service. At the 
beginning of the contact warm greetings were provided then the study information sheet 
was read. If he or she agreed to participate, written consent was obtained and interview 
was carried out. However, those who were not agreed to participate captured as non- 
respondent.  
 
The overall data collection process was supervised and managed by supervisors and 
the researcher. The researcher prepared supervision time table with two supervisors. 
Informed and incidental visit and observation and telephone calls were used during 
supervision. Corrective actions were taken for observed deviation from planed, 
orientated and agreed activities with data collectors.   
 
Every day at 5 pm the completed questionnaires were received from the data collectors 
by the supervisors and the researcher. The researcher and supervisors checked the 
completeness, consistency of collected data and gave feedback. Finally, filled and 
signed questionnaires were received by the researcher.  
 
4.4.4.8 Data management and analysis 
 
Data management and analysis is managing and making sense of the collected data 
and testing the evidence’s consistency across different sources with deliberate effort to 
strengthen the findings (Yin 2011:21).  
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4.4.4.8.1 Data management 
 
The researcher coded all the alternative responses of the questionnaire to numeric on 
paper based blank questionnaire. For instance strongly agree =5, agree=4, neutral =3 
disagree=2 and strongly disagree =1 for positively worded questions and Yes= 0, No=1, 
for Yes or no question and Type of TB 1=smear positive PTB, 2= smear negative PTB, 
3= EPTB, and 4=MDR-TB. Then all the questions and coded response were entered 
into SPSS version 21 to create data entry template in SPSS. The data entry template 
had all the variables’ name, label, measurement scale and value as per SPSS software 
requirement. The copy of created data entry template was given to two experienced 
Data Clerks after providing orientation. The created data entry had password to open 
and lock during data entry.  
 
After the completed questionnaires had been collected, the researcher and the 
supervisors checked for completeness, consistency and legibility before providing to the 
Data Clerks to data entry. The checked filled questionnaires were handed over to two 
Data Clerks to enter into created data entry template. The Data Clerks entered the data 
into different computers at the researcher office. While they log in and enter the data 
into the data entry template, the researcher was following closely. All entered data into 
SPSS software were transferred to the researcher computer with password. The 
following measures were considered in order to check accuracy and consistency of 
electronic data. 
 
1. Each set of variables were assessed for missed, out of range and duplicate 
values separately. 
2. Frequency tables for categorical variables, mean, maximum, minimum and inter-
quartile ranges summary statistics were produced for continues variables where 
appropriate. 
3. Graphical presentation of variables such as box plot and scatter plot were run. 
Box plots assisted to assess the outliers and the latter to see cases that did not 
follow the general pattern of the graphical display. 
 
All the observed discrepancies were fixed against the hard copy of the questionnaires. 
In order to keep the confidentiality of data, the collected hard copy, including taken 
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notes while interviewing, were stored at researcher office in lockable board. The 
electronic data were retained in the researcher’s computer with passwords.  
 
4.4.4.8.2 Data analysis 
 
Electronic data were analysed using SPSS version 21 for Windows. The general 
properties of the variables were described in frequency distribution, percentage, central 
tendency, (mean, mode, median) and dispersion such as standard deviation, range and 
confidence intervals. 
 
 Determination of patient centeredness 
 
Each item listed to measure patient centeredness valued a score ranged from 1 to 5; 
from strongly disagree to strongly agree, respectively for positively worded items and 5 
to 1 for negatively worded items. Each score of the respondents on each items in the 
dimension were summed and the mean value was calculated. Then the calculated 
mean score of the respondents adjusted into a 0-to-100 scale by utilising a Likert’s 
transformation formula (Liu, Wang & Lu 2010:2):  
 
Adjusted score = 100* standard score-1 
5-1 
 
Where; Standard score was average score resulted from DOTS strategy patient 
centeredness measuring items.  
 
The respondents who scored above the mean of adjusted score were considered as 
received PCC with TB- DOTS strategy. 
 
 Determination of TB patient satisfaction 
 
TB patient’s satisfaction level measuring items listed in section D of the questionnaire 
had a score ranged from 1 to 5 from very dissatisfied to very satisfied, respectively for 
positively worded questions and 5 to 1 for negatively worded questions.  
 
The mean score of the responses was calculated for each respondent; the respondent 
who got the mean score of 2 and less were classed as unsatisfied respondent while the 
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respondent who got the mean score of 4 and above regarded as satisfied respondent. 
For the respondent who scored between greater than 2 and less than 4, the median 
was calculated; then the respondent who scored less than the median were classed as 
unsatisfied and equal and above the median classed as satisfied (Bahrampour & Zolala 
2005:907).  
 
According to Dansereau et al (2015:3) the overall satisfaction measuring scale included 
in section C held the score range from 0 to 10. The lowest satisfaction score was zero 
and the maximum satisfaction score was 10. The overall satisfaction score of this scale 
was compared with the score resulted from Donabedian quality health care model 
based satisfaction level measuring items score about their correlation by rho, (r) 
correlation coefficient.  
 
 Predictors of centredness and satisfaction  
 
To determine the degree of association between variables different statistics were used. 
Chi-square was used when both outcome and independent variables were categorical 
or nominal variable measurement by cross-tabulation. Interval or ratio measured 
variables were assessed by the Pearson statistics and scatter plots for the presence of 
association between them. For continuous independent variable and categorical 
dependent variable eta (η) statistics was used to see their relationship (Nardi 2014:159).  
 
Stepwise or statistical multiple regressions was used to identify the subset of measured 
independent variables which has the strongest relationship to a dependent variable 
such as centeredness of TB patients. All the measure of association and comparison 
were assessed their significance at least at 95% confidence interval or p 0.05.  
 
 Explaining variables extraction  
 
Exploratory factor analysis was conducted to determine continuous latent variables that 
are needed to explain the PCC model. Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy and Chi-square were performed.  
  
72 
 
4.4.2 Phase II, qualitative approach  
 
In this section, population, sampling, sample size and data collection methods 
employed in the phase two study are illustrated.   
 
4.4.2.1 Population  
 
In phase II, two group of study population were included: TB patients who defaulted 
from the TB treatment follow-up and TB experts, who lead, support and direct the TB 
prevention and  control activities in Ethiopia. 
 
4.4.2.2 Sampling   
 
TB registration books at each health facility were used as a the sampling frame for 
selecting defaulted TB patients. With this, defaulted TB patients were randomly selected 
and their telephone addresses were captured for an interview. While TB experts were 
porposively selected from subcity and regional health offices.   
 
4.4.2.3 Sample size  
 
Phase II, in which qualitative approach was used, there was no pre-defined formula to 
quantify the desired number of study participants in qualitative approach, however, 
larger number of participation provides better assurance in a study’s findings (Yin 
2011:89). The recruiting of study participants were continued until the data were 
saturated, when additional study subject or interview did not yield any marginal change 
in the core concept of data (Bhattacherjee 2012:115). In this study, at 25 defaulted TB 
patients participation for telephonic interview and 23 TB experts for FGDs the 
researcher believed as the data saturation reached.  
 
4.4.2.4  Data collection tools 
 
The qualitative data collection tools used in phase II study was FGD guide (Annex G) 
and interview guide for TB experts (Annex E) and defaulted TB patients, respectively. 
Open ended probing questions were used in the FGD and interview to probe the 
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discussions of the participants. In turn it helped to fully achieve the stated objectives of 
the study.  
 
Although telephonic interview is not much suitable to capture non-verbal expression of 
the respondents, it minimize sampling bias that may arise from inclusion of only TB 
patients who were on follow up and TB experts that were easily accessible. With this 
regard using phone interviews can be a good substitute for the face-to-face interviews 
(Kenned, 2009). Hence, the defaulted TB patients’ response was collected by telephone 
due to the difficulty of accessing them physically. 
 
4.4.2.4.1  In-depth interview with defaulted TB patients 
 
The randomly selected defaulted TB patients from the list of defaulted TB patients were 
contacted by the researcher through telephone. The telephone addresses were 
accessed from TB register at randomly selected health facilities, where the TB patients 
were on follow-up. Once the defaulted TB patients’ telephone address collected, the 
telephone call was carried out randomly by the researcher.  
 
Before continuing with interview, from where the researcher accessed the telephone 
address, the purpose of the telephone call, the study’s aim, ethical clearance and risk 
and benefit of participation in the interview described and agreement requested. The 
telephonic interview was continued with whom gave consent using pre-defined interview 
guide. After they agreed, convenience of the place and time were assured to minimise 
the disturbance of their social and work responsibilities that it may incur. When the 
place was convenient the interview continued, but not, other time was arranged in 
mutual agreement. Whereas with those who did not volunteered to be interviewed, the 
researcher thanked and discontinued the discussion. 
 
In the interview, the lists of probing questions were used to guide the interview. The   
notes were taken by the researcher. The interviews took 25 to 35 minutes. Interviews 
were carried out until the researcher beliefs the data were saturated, additional study 
interview did not yield any marginal change in the core concept of data with 25 
defaulted TB patients (Bhattacherjee 2012:115). 
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4.4.2.4.2 FGDs with TB experts 
 
Twenty-three purposively selected TB experts participated in the FGDs. The 
participants in the 1st and 2nd discussions were 8 while in the third FGD 7 discussants 
participated. The FGDs were conducted at different times depending on the 
convenience of the participants.  
 
The discussion was initiated by the researcher through a five-minute introduction of the 
topic, objectives and ethical aspects of the study. In addition, permission was sought 
from the participants to record the discussion as long as it was difficult to take all 
interaction in note alone.  The main ground rule was that discussants were urged to 
focus on the discussion. As a means of stimulating the discussions, the discussants 
introduced themselves and the researcher used probing questions (attached in Annex 
G).  
 
The discussions were facilitated by the researcher assistant by means of raising leading 
questions about the topic of interest based on pre prepared interview guide. The 
discussions were recorded and also notes were taken while conducting the discussion. 
The discussions took 50 minutes to 65 minutes. At the end of the discussion all the 
participants were asked to write their e-mail address onto circulating paper in order to 
share taken notes and transcription. Taken notes and transcriptions were shared to the 
participants with the description to comment if there were any deviation from the 
discussions and none of the participants had a comment. 
 
4.4.2.5 Data management and analysis 
 
According to Marshall, Gretchen and Rossman (2011:208), the qualitative data analysis 
starts at the beginning of data collection and continues throughout the research report 
writing. Qualitative data analysis, though do not follow strict sequence, it consisted of 
the following five steps (Yin 2011:178-179).  
 
1. Compiling and sorting: all taken notes and records while interviewing were 
transcribed into English Word documents verbatim; the documents were read for 
relationships and patterns to identify similarities and differences. The word 
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document was compiled based on the date and from whom, either it is from 
defaulter TB patients or TB experts. 
2. Disassembling: all transcribed notes were broken down into smaller fragments 
(words and phrases). 
3. Reassembling: based on the code, each coded fragment from the data were 
assembled and categorised. Categories were systematically developed and 
linked with subcategories; the subcategories were integrated each other and put 
in columns and rows with arrays. 
4. Narration: the reassembled data were put into tables were described and 
explained thematically.  
5. Interpret and concluding: the narration extracted from reassembled data were 
interpreted and concluded based on the objective of the study. 
 
4.4.3 Triangulation of the findings  
 
According to Yin (2011:313), triangulation is a logical technique to corroborate the 
findings which are extracted from two or more different sources. The corroborating can 
be at design, data collection as well as during or later analysis. This research extracted 
information from questionnaire of TB patients, in-depth interview of defaulted TB 
patients and TB experts. After each sort of data set separately analysed, the findings 
were triangulated at interpretation level to complement the weakness of one source of 
data over the other (Yin 2011:79). As the nature of this study, evaluation study of 
DOTS, triangulating the findings from different sources helps to check social validity, 
integrity, and effectiveness of the intervention (Melnyk & Morrison-Beedy 2012:31). 
 
4.4.4 Ethical issues related to sampling 
 
Research ethics is the feature of the research between right and wrong, but what is 
unethical may not necessarily be illegal. Research ethical standards and norms may 
vary from one society to another (Bhattacherjee 2012:137). This study has met ethical 
standards required by Institutional Research and Higher Degrees committee of UNISA 
and AACAHB. As a result ethical clearance certificate (Annex B) and permission letter 
(Annex C) were received from UNISA and AACAHB, respectively, to conduct the 
research. Moreover, AACAHB wrote a letter to the sub-city health offices for their 
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cooperation; and sub-city health offices wrote a letter to their respective health 
institutions. 
 
4.4.5 Ethical considerations related to data collection  
 
According to Bhattacherjee (2012:139), voluntary participation, harmlessness, 
anonymity, confidentiality and disclosure of the research purpose are pointed out as 
ethical principles related to scientific research. In order to keep research ethical 
principles the data collectors explained the purpose, risk and benefit, confidentiality in 
Amharic based on prepared information sheet and shown approval of the study. The 
data collectors obtained consent from the participant to take part in the study. None of 
the study participants’ names were included in the report. The collected data were never 
being exposed to anybody except the study team. 
 
4.5 VALIDITY AND TRUSTWORTHINESS  
 
Validity is the ability of the tool to measure exactly which was intended to measure. The 
forms of validity can be regarded as internal and external validity (Bhattacherjee 
2012:58). 
 
4.5.1 Internal validity  
 
Internal validity is eliminating confounding variables within the study itself; that is 
observed change in an outcome variable is certainly resulted from a corresponding 
change of hypothesised independent variable and not from extraneous cause to the 
research context (Schmidt & Brown 2012:480-482). Internal validity components which 
maximise the tools’ capacity to extract and measure the intended outcome variables are 
content, criterion-related and construct validities (Kohtari 2004:74). 
 
4.5.1.1 Content validity  
 
Content validity is the degree of the tools to cover the whole facet of constructs under 
the study (Bhattacherjee 2012:59). The study tools were developed by the researcher. 
In order to ensure tools’ content validity, the items were developed based on research’s 
title, design, objectives and the concepts of the selected frameworks, adopted WHO 
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people centred health care framework and Donabedian health care quality model. 
Patient centeredness measurement items followed adopted WHO’s people-centred 
health care framework, beyond patient centeredness. Thus it increased the possible 
dimensions to measure level of patient centeredness to the patients perspectives. 
Another model used in this study was Donabedian health care quality model to guide 
the level of adherence and satisfaction of the TB patients with DOTS strategy, 
respectively. The items were reviewed by a PhD student supervisor of UNISA.   
 
4.5.1.2 Criterion-related validity  
 
Criterion-related validity focuses on the ability of the research method to forecast the 
outcome or estimate the existence of current condition. This was explained by reliability, 
freedom from bias, availability of the information and relevance as well (Kothari 
2004:74). 
 
4.5.1.2.1 Reliability 
 
Reliability is the degree to which the tool is dependable and consistent during repeated 
measurement (Bhattacherjee 2012:56). The reliability of this study was enhanced by 
different measures. Prior to data collection, the structured interview questionnaire were 
piloted and revised based on identified deficiency. The data collectors were nurses who 
have proximity with TB treatment strategy. The data collectors were trained on how to 
obtain informed consent, conduct structured interviews and record the information 
accurately on the questionnaire. The overall activities of data extraction were monitored 
by the researcher and there was strict supervision during data collection. The following 
measures were carried out: 
 
1. Filled questionnaires were examined daily by the researcher for completeness 
during data collection.  
2. The database template was created by the researcher then the data clerks were 
oriented. 
3. Double data entry was done by experienced Data Clerks into SPSS software. 
 
The electronic data were checked for consistency during analysis. Internal reliability of 
the items in the questionnaire was ensured by analysing Cronbach’s alpha coefficients 
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value by SPSS software. The Cronbach’s alpha value greater than 0.7 for the different 
scales of data collection tool was considered as acceptable since the tools are 
researcher designed (Field 2009:675).  
 
4.5.1.2.2 Availability of information and freedom of bias 
 
The quantitative data were accessed through interviewer-administered pretested 
questionnaire which enables to assess the TB patients’ satisfaction and patient 
centeredness of DOTS in randomly selected health facilities. Then the determined 
sample size was allocated proportional to their number of TB patients on treatment at 
the time of data collection. Also all study participants, TB patient on follow-up and 
defaulted TB patients were selected by lottery method to ensure equal chance of being 
selected. 
 
The data required to answer the study objectives were availed through questionnaires, 
and interview guides. The respondents were well experienced about DOTS strategy 
since they were utilising it or deviated from follow-up due different reasons. Hence 
service provision related information can be easily availed at both perspectives, the 
deviant and current service users. TB experts provided information with the 
management, leadership and programme perspectives of the strategy. 
 
4.5.1.3 Construct validity 
 
Construct validity is the most complex and abstract form of validity, which confirms the 
extent of predicted correlations with other theoretical propositions. The construct 
validity, despite its abstractness, looks at how well a given measurement scale is 
determining the theoretical construct required to be measured. In quantitative approach 
either correlation or exploratory factor analysis can be done to assess construct validity 
(Bhattacherjee 2012:37). This research ensured the construct validity by carrying out 
correlation or exploratory factor analysis where appropriate in the pilot study for each 
section of the questionnaires. The items that did not meet the expected norms of factor 
loading criteria were amended or dropped from the questionnaire (Bhattacherjee 
2012:58-60).  
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4.5.2 External validity  
 
External validity is mainly concerned with the generalisability of the research findings to 
other populations and settings. The external validity of different designs varies since its 
perspectives, randomness and framework varies (Bhattacherjee 2012:36). This 
research have enhanced external validity due to its multiple perspectives DOTS 
treatment strategy users and leaders and the service organisation itself. Moreover, this 
study measurered many variables based on a standardised 5-point Likert scale in 
multiple frameworks from randomly selected study participants. Sample size calculation 
also considered the design effect correction values to increase the representativeness 
of the study participants to the population. 
 
4.5.3 Trustworthiness  
 
This research provided emphasis on credibility, validity, reliability of findings and their 
transferability to similar and other contexts as described in Chapter 1. According to Yin 
(2011:19-21), trustworthiness of the qualitative research can be achieved through 
transparency, prolonged engagement and Methodic-ness of the research.  
 
Transparency of this study was achieved through clear communication from inception to 
final research project with UNISA PhD student supervisor. The proposal was submitted 
to UNISA and AACAHB hence approved ethically by institutional research and Higher 
Degrees Committee of UNISA and permission given from AACAHB ethics review 
committee. Moreover, the research objectives and right to participate were described 
clearly to the study participants with its risk, so as to describe their real feeling. 
 
The study had prolonged engagement during data collection, from September 2015 to 
November 2015. Only a few number of respondents’ information were collected per day 
to reduce single day’s episodic feeling of the patient. The study participant ranges who 
have taken their TB treatment at least for fifteen days hence this could reflect the study 
participants as have prolonged exposure with the DOTS.  
 
In addition, the study used sound methodology; field-based study that integrated 
triangulation of data collected from multiple sources. Multiple sources are TB patient 
who are following TB treatment, deviant from the treatment (defaulted) and TB experts 
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who manage and lead the implementation of the strategy. Further, the study sites were 
owned by government, private for profit, and private for not profit thus exhibited varied 
TB caseloads and different management.  
 
4.6 CONCLUSION 
 
This chapter described the research approach, design and method, population, 
sampling technique, sample size and ethical issues related to sampling and study 
participants. This study deployed questionnaire, interview guides of telephone interview 
and FGDs to collect data. This chapter also discussed how the data management and 
analysis was carried out, the internal and external validity, and trustworthiness of the 
study kept. Further, this chapter explained various measures taken to enhance the 
study’s validity, reliability trustworthiness and to keep the research ethical principles. 
The findings of this study is presented and discussed in later chapter. 
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CHAPTER 5 
 
DATA PRESENTATION AND ANALYSIS 
 
5.1 INTRODUCTION  
 
The previous chapter, Chapter 4, described the research approach, methods of data 
collection and analyses to achieve the stated objectives and rigor of the study. This 
chapter presents the data analysis outcome of quantitative and qualitative findings in 
the form of text, tables and graphs in two sections.  
 
Section 1 describes quantitative data analysis and presentation about DOTS strategy 
patient centeredness’, level of satisfaction of TB patients and associated factors with 
patient centeredness and satisfaction level. 
 
Section two describes qualitative data analysis and presentation about driving factors to 
default from TB treatment from defaulted TB patients perspective and TB experts’ 
perception about DOTS strategy patient centeredness’ and satisfaction.  
 
5.2 SECTION 1: QUANTITATIVE DATA ANALYSIS AND PRESENTATION  
 
In Section 1 quantitative data collection, handling, and analysis are described. The 
descriptive and inferential analysis outcomes are also presented.   
 
5.2.1.1 Data collection and handling  
 
The interviewer-administered questionnaire comprising of close-ended questions were 
used to collect data from respondents. The questionnaire had three parts: part one 
consist of socio-demographic characteristics of the respondents and DOTS strategy 
pertinent questions extracted from different literatures. Part two and part three consist of 
5-point Likert scale items to determine the DOTS strategy patient centeredness and TB 
patients’ satisfaction level, respectively.  
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The data were collected by trained data collectors in hard copy and then double entered 
into SPSS. The consistency, accuracy and missed values were monitored by the 
researcher both at the time of data collection and data entry. Furthermore, 5% of digital 
output responses cross checked and verified against the hard copy of the 
questionnaires.  
 
5.2.1.2 Data analysis  
 
A total of 605 TB patients were interviewed and the compliance rate was 601(99.3%). 
Three hundred ninety eight (66%) respondents were on intensive phase and 203 (34%) 
were on continuation phase of the TB treatment.  
 
The analysis was done based on the following subsection; socio-demographic and 
DOTS-related variables, patient centeredness’ and associated factors, and satisfaction 
level and associated factors. 
 
Both the descriptive statistics such as frequency, percentage, mean, standard deviation 
and inferential statistics such as X2, r, p-values,and odds ratios were carried out by the 
SPSS software version 21. In addition, Microsoft Excel 2007 was used particularly to 
generate graphs.  
 
5.2.2 Socio-demographic and general characteristics’ of the respondents  
 
Description of sociodemographic characteristics of the respondents and the cross 
tabulation of gender and type of TB, Occupation, family-income and type of TB, type of 
TB and treatment category, type of TB and presence of TB symptoms,  and place of 
residence and type of TB are presented below.  
 
5.2.2.1 Socio-demographic characteristics  
 
Gender, age, marital status, education and religious affiliations of the respondents 
presented in Table 5.1. The majority, 494 (82%) of the respondents were between 
18−44 years of age and 336 (56%) of the respondents were male.  
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Table 5.1: Demographic characteristics of the respondents (N=601) 
Items  F % Cumulative % 
Gender  
Male  336 56 56 
Female  265 44 100 
Age in years  
18-24 127 21.1 21.1 
25-34 219 36.4 57.5 
35-44 148 24.6 82.1 
45-54 58 9.7 91.8 
55-64 31 5.2 97 
>65 18 3.0 100 
Marital status  
Married  255 42.4 42.4 
Single (never married) 278 46.3 88.7 
Separated 12 2.0 90.7 
Divorced 20 3.3 94.0 
Widowed 28 4.7 98.7 
Cohabiting  8 1.3 100.0 
Educational level 
Diploma and above 143 23.8 23.8 
Secondary school (9-12) 196 32.6 56.4 
Primary school (5-8) 145 24.1 80.5 
Primary school (1-4) 47 7.8 88.4 
No formal education 70 11.6 100.0 
Religious affiliation 
Orthodox  401 66.8 66.9 
Protestant    74 12.4 79.2 
Catholic    8 1.3 80.5 
Muslim   117 19.3 99.8 
No religion   1 0.2 100.0 
 
*Do not have formal house of residence both in rural and urban; f: frequency; %: percentage   
 
5.2.2.2 Gender and type of TB 
 
Among 336 male respondents, 159 (47%) were smear positive pulmonary TB and 13 
(3.9%) were MDR-TB patients. While among 265 (44%) female respondents, 104 (39%) 
had smear (+) pulmonary TB and 19 (7.2%) had MDR-TB (Table 5.2).  
 
  
84 
Table 5.2: Gender and type of TB (N=601) 
Gender 
Type of TB 
Total Smear 
Positive PTB 
Smear 
Negative PTB 
Extra 
pulmonary TB 
MDR-TB 
Female 
f 104 65 77 19 265 
% 39.2 24.5 29.1 7.2 100 
Male 
f 159 82 82 13 336 
% 47 24.4 24.4 3.9 100 
Total 
f 263 147 159 32 601 
% 43.8 24.5 26.5 5.3 100 
 
5.2.2.3  Treatment category and gender  
 
Treatment category of respondents were 501 (83%) new in both genders and treatment 
after failure were 2 (0.8%) and 10 (3%) female and male respondents, respectively. The 
details are presented in Table 5.3. 
 
Table 5.3: Gender and treatment category (N=601) 
Gender 
Treatment category TB patients 
Total 
New Relapse 
Treatment 
after 
failure 
Return 
after 
default 
Transfer-
in 
Other 
Female 
f 221 33 2 1 5 3 265 
% 83.4 12.5 0.8 0.4 1.9 1.1 100 
Male 
f 280 35 10 3 8 0 336 
% 83.3 10.4 3.0 0.9 2.4 0.0 100 
Total  
f 501 68 12 4 13 3 601 
% 83.4 11.3 2.0 0.7 2.2 0.5 100 
 
5.2.2.4 Occupation, family-income and Type of TB 
 
Among 601 respondents, 104 (17%) were permanently employed, 219 (36%) were self-
employed, 86 (14%) were temporarily employed, 83 (14%) were unemployed and 23 
(3.8%) were on pension. The rest 74 (12.2%) and 12 (2%) were housewives and 
students, respectively. 
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The average monthly family-income of the respondents was $115 (SD= $97), while the 
median monthly income was $95 (1st Quartiles $48 and 3rd quartile $147). From the 
total of 237 smear positive pulmonary TB patients, 144 (61%) of smear positive TB 
patients’ average monthly family-income was below $95 (Table 5.4). 
 
Table 5.4: Average monthly family-income and type of TB (N=546) 
Average 
monthly family-
income in USD 
 Type of TB 
Total Smear 
Positive PTB 
Smear 
Negative PTB 
Extra PTB MDR-TB 
9.40-47.00 
f 78 37 55 22 82 
% 42.9 20.3 30.2 6.6 100 
47.1-95.00 
f 66 35 39 7 147 
% 44.9 23.8 26.5 4.8 100 
95.01-143.0 
f 33 25 19 4 81 
% 40.7 30.9 23.5 4.9 100 
143.1-957.0 
f 60 32 38 6 136 
% 44.1 23.5 27.9 4.4 100 
Total  
f 237 129 151 29 546 
% 43.4 23.6 27.7 5.3 100 
$: United state dollar; Figures are computed at Ethiopia average National Bank exchange rate of Birr 
20.8979 to $1 in october 2015. PTB: Pulmenary TB 
 
5.2.2.5 Type of TB and treatment category 
 
Among 601 respondents, 501 (83.4%) were new TB patients, 68 (11.3%) had relapsed, 
12 (2.0%) were on treatment after failure, 4 (0.7%) were returned after default, 13 
(2.2%) were transfer-in and 3 (0.5%) were in other treatment category. Thirty-three 
percent of TB patients who were on treatment after failure had MDR-TB whereas; only 8 
(1.6%) of new TB patients had MDR-TB Table 5.5). 
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Table 5.5: Type of TB and treatment category (N=601) 
Type of 
TB 
f / % 
Treatment category 
Total 
New Relapse 
Treatment 
after 
failure 
Return 
after 
default 
Transfer-
in 
Other 
Smear 
positive 
pulmonary 
TB 
Count 233 25 3 0 0 2 263 
% within Type of 
TB  
88.6 9.5 1.1 .0 0.0 0.8 100 
% within 
Treatment 
Category 
46.5 36.8 25.0 0.0 0.0 66.7 43.8 
% of Total 38.8 4.2 0.5 0.0 0.0 0.3 43.8 
Smear 
Negative 
pulmonary 
TB 
Count 126 13 3 2 3 0 147 
% within Type of 
TB  
85.7 8.8 2.0 1.4 2.0 0.0 100 
% within 
Treatment 
Category 
25.1 19.1 25.0 50 23.1 0.0 24.5 
% of Total 21.0 2.2 0.5 0.3 0.5 0.0 24.5 
Extra 
pulmonary 
TB 
Count 134 14 2 1 7 1 159 
% within Type of 
TB  
84.3 8.8 1.3 0.6 4.4 0.6 100 
% within 
Treatment 
Category 
26.7 20.6 16.7 25 53.8 33.3 26.5 
% of Total 22.3 2.3 0.3 0.2 1.2 0.2 26.5 
MDR-TB 
Count 8 16 4 1 3 0 32 
% within Type of 
TB  
25.0 50.0 12.5 3.1 9.4 0.0 100 
% within 
Treatment 
Category 
1.6 23.5 33.3 25.0 23.1 0.0 5.3 
% of Total 1.3 2.7 0.7 0.2 0.5 0.0 5.3 
Total Count 501 68 12 4 13 3 601 
% within Type of TB  83.4 11.3 2.0 0.7 2.2 0.5 100 
% of Total 83.4 11.3 2.0 0.7 2.2 0.5 100 
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5.2.2.6 Type of TB and presence of TB symptoms 
 
Among 601 respondents, 414 (68.4%) did not have any symptoms of TB illness at the 
time of responding. There was no significance difference between type of TB and 
presence of TB symptoms (p=0.6) (Table 5.6). 
 
Table 5.6: Type of TB and presence of TB symptoms (N=601) 
Type of TB f / % 
Presence of TB symptoms 
Total 
Yes No 
Smear positive pulmonary   
Count 81 182 263 
% within Type of TB  30.8 69.2 100 
% within presence of 
TB symptoms 
43.1 44.1 43.8 
% of Total 13.5 30.3 43.8 
Smear pegative pulmonary  
Count 47 100 147 
% within Type of TB  32.0 68.0 100 
% within presence of 
TB symptoms  
25.0 24.2 24.5 
% of Total 7.8 16.6 24.5 
Extra pulmonary 
Count 47 112 159 
% within Type of TB  29.6 70.4 100 
% within presence of 
TB symptoms 
25.0 27.1 26.5 
% of Total 7.8 18.6 26.5 
MDR-TB 
Count 13 19 32 
% within Type of TB  40.6 59.4 100 
% within presence of 
TB symptoms 
6.9 4.6 5.3 
% of Total 2.2 3.2 5.3 
Total 
Count 188 413 601 
% within Type of TB  31.3 68.7 100 
% within presence of 
TB symptoms 
100 100 100 
% of Total 31.3 68.7 100 
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5.2.2.7 Place of residence and type of TB 
 
The majority 511 (85%) of the respondents were urban  residents, of these 228 (46.6%) 
were smear (+) PTB patients. The proportion of type of TB among residence of TB 
patients shows a significant difference (p=0.03). The detail presented in Table 5.7. 
 
Table 5.7: Place of residence and type of TB of the respondents (N=601) 
Residence f / % 
Type of TB 
Total Smear 
Positive PTB 
Smear 
Negative PTB 
Extra 
pulmonary TB 
MDR-TB 
Urban 
f 228 126 132 25 511 
% 44.6 24.7 25.8 4.9 100 
Rural 
f 32 17 16 4 69 
% 46.4 24.6 23.2 5.8 100 
Homeless* 
f 3 4 11 3 21 
% 14.3 19 52.4 14.3 100 
Total 
f 263 147 159 32 601 
% 43.8 24.5 26.5 5.3 100 
 
* TB patients do not have formal house at either urban or rural 
 
5.2.3 Experience, perceived communication and expectations 
 
Among 601 respondents, only 177 (29.5%) visited the HCO before their current TB 
illness, for which they were being treated. The respondents’, who ever visited, median 
visit frequency were 2 times with the maximum of 5 times. Fifty-eight (32%) respondents 
visited one time, 36 (20%) respondents visited two times, 19 (10%) respondents visited 
three times, 4 (2%) respondents visited four times and 60 (34%) respondents visited 
five times before the TB illness for which they were treated.  
 
From all 601 respondents, 544 (90%) respondents had good communication with HCPs 
while they were taking their TB treatment.  
 
Four hundred and twelve (69%) of respondents did not expect the TB treatment 
duration to be as they were taking, to and from home to health institution to be observed 
  
89 
while they take their TB drugs during intensive phase of their treatment and refill every 
week during their continuation phase of the treatment.  
 
Cross tabulation of perceived good communication with HCPs and experience and 
expectation are presented in Table 5.8. Perceived good communication and 
experiences show that a significant association (p=0.04) whereas, expectation did not 
show significant association with perceived good communication (p=0.15). 
 
Table 5.8: Cross-tabulation of perceived communication, experience and 
expectation (N=601) 
Variables Response 
 Perceived good 
communication with 
HCPs 
Total 
Yes No 
Experience (ever used at interviewed health 
organisation)  
Yes 
F 154 23 177 
% 87.0 13.0 100 
No 
F 390 34 424 
% 92.0 8.0 100 
Expectation (about treatment duration and 
frequency of back and forth home-to-health 
institution) 
Yes 
F 175 14 189 
% 92.6 7.4 100 
No 
F 369 43 412 
% 89.5 10.5 100 
HCPs: Health care providers 
 
5.2.4 Perceived patient centeredness of DOTS strategy 
 
DOTS strategy patient centeredness was determined based on WHO people centred 
health care framework. The framework consists of four dimensions. The dimensions are 
patient, family, and community concern dimension, HCPs dimension, HCOs dimension 
and health care delivery system dimension (WHO 2007b:7). The overall questionnaire 
Cronbach's Alpha was 0.935. As the questionnaire is a purposefully self-designed, a 
Cronbach alpha of 0.7 and above was regarded as being acceptable (Field A. 
2009:675; Burns & Grove 2005:374). 
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5.2.4.1 Patient, family and community concern dimension 
 
The patient, family and community concern dimension mean score was 3.72 (SD=0.59). 
This dimension in turn divided into six sub-dimensions. The sub-dimensions were 
information provision, keeping preferences, recognition, improving capacity for self-care 
management, treatment supporter and family and friends involvements. The mean 
score of the sub-dimensions are presented in Figure 5.1. The maximum mean score 
was 3.67 (SD=0.85) for information provision sub-dimension and the lowest mean score 
was keeping preference sub-dimension 2.11 (SD=0.58).  
 
 
Figure 5.1:  Mean score of patient, family and community 
dimensions of PCC (N=601) 
 
The total items included in the patient, family and community dimension were 20 items. 
Each sub-dimension contains 2-4 measuring items. The frequency, percentage and 
mean score of items are illustrated in Table 5.9. Among the 20 measuring items in the 
patient family and community concern dimension, the lowest mean score 1.17 
(SD=0.37) was keeping choice of preference where to take the TB treatment either at 
home, work place or in the community. Whereas, the highest mean score 3.84 
(SD=1.07) was knowledge of treatment supporter about way of TB transmission, 
prevention and treatment of TB.  
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Table 5.9: Patient, family and community concern dimension items mean scores 
(N=601) 
Items  
Strongly 
disagree 
f (%) 
Disagree  
 
f (%) 
Neutral 
 
f (%) 
Agree 
 
f (%) 
Strongly 
agree  
f (%) 
Mean 
(SD) 
Information provision about: 
ransmission, prevention 
and treatment  
40 (6.7) 51 (8.5) 17 (2.8) 415 (69.1) 78 (13.0) 3.73 (1.01) 
importance of treatment 
supporter 
35 (5.8) 53  (8.8) 32 (5.3) 394 (65.6) 87 (14.5) 3.74 (1.00) 
prognosis of health 
condition 
44 (7.3) 49 (8.2) 49 (8.2) 386 (64.2) 82 (13.6) 3.70 (1.01) 
wrong practice about TB 55 (9.2) 75 (12.5) 49 (8.2) 349 (58.1) 73 (12.1) 3.51 (1.10) 
Keeping preference of: 
choices where to take the 
treatment 
498 (82.9) 103 (17.1) 0 (0) 0 (0) 0 (0) 1.17 (0.37) 
drug collection time 195 (32.4) 227 (37.8) 43 (7.2) 136 (22.6) 0 (0) 2.19 (1.12) 
treatment supporter 99 (16.5) 131 (21.8) 107 (17.8) 221 (36.8) 43 (7.2) 2.96 (1.23) 
Recognition:  
taking part in treatment 
plan   
107 (17.8) 162 (27.0) 92 (15.3) 215 (35.8) 25 (4.2) 2.81 (1.21) 
taking  consent during 
decisions   
105 (17.5) 131 (21.8) 74 (12.3) 255 (42.4) 36 (6.0) 2.97 (1.25) 
role acknowledgment  108 (18.0) 129 (21.5) 70 (11.6) 265 (44.1) 29 (4.8) 2.96 (1.25) 
Improving capacity for self-management and self-care with: 
health education 51 (8.5) 61 (10.1) 42 (7.0) 380 (63.2) 67 (11.1) 3.58 (1.08) 
counselling  38 (6.3) 53 (8.8) 27 (4.5) 417 (69.4) 66 (11.0) 3.69 (0.99) 
written, pictorial and 
audiovisual material  
98 (16.3) 69 (11.5) 42 (7.0) 315 (52.4) 77 (12.8) 3.33 (1.30) 
TB treatment supporter: 
know the transmission 
route, prevention and 
treatment of TB 
40 (6.7) 40 (6.7) 20 (3.3) 374 (62.2) 126 (21.0) 3.84 (1.04) 
observe while taking drugs  33 (5.5) 70 (11.6) 43 (7.2) 364 (60.6) 91 (15.1) 3.68 (1.04) 
regularly communicate and 
discuses  
 
43 (7.2) 102 (17.0) 48 (8.0) 341 (56.7) 67 (11.1) 3.64 (1.11) 
Family and friends involvement in TB care: 
families encouraged and 
allowed to participate   
47 (7.8) 54 (9.0) 42 (7.0) 379 (63.1) 79 (13.1) 3.64 (1.06) 
friends encouraged and 
allowed to participate  
60 (10.0) 87 (14.5) 73 (12.1) 313 (52.1) 68 (11.3) 3.40 (1.16) 
discussions of pros and 
cons about tb with friends  
58 (9.7) 118 (19.6) 48 (8.0) 293 (48.8) 84 (14.0) 3.77 (1.22) 
discussion of pros and 
cons about tb with families  
45 (7.5) 49 (8.2) 54 (9.0) 358 (59.6) 95 (15.8) 3.68 (1.07) 
Total Mean Score       3.27 (0.59) 
 
SD: standard deviation; f: frequency; %: percentage  
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5.2.4.2 Health care providers (HCPs) 
 
The second dimension category of the framework, HCPs dimension, overall mean score 
was 3.79 (SD=0.49). Characteristics of HCPs, consideration of the patient as unique 
person, communication with the patient, physical, emotional and psychosocial support 
to TB patients of HCPs were sub-dimensions of HCPs dimension. The sub-dimension’s 
mean scores are presented in Figure 5.2. 
 
 
Figure 5.2: Sub-divisions mean score dimensions of HCPs (N=601) 
 
The six sub-dimensions in HCPs dimension consist of 24 items. In each sub-dimension 
2-6 measuring items were included. The lowest mean score among 24 items in the 
HCPs dimension was concern of HCPs about the financial issue of the TB patients, 2.68 
(SD=1.24). The detail mean score, frequency and percentage of each item are depicted 
in Table 5.10.  
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Table 5.10: Health care provider perspective items mean scores (N=601) 
Items  
Strongly 
disagree 
f (%) 
Disagree 
 
f (%) 
Neutral 
 
f (%) 
Agree 
 
f( %) 
Strongly 
agree 
f (%) 
Mean (SD) 
HCPs characteristics: 
honesty, respectfulness, 
compassionate and 
tolerance   
18 (3.0) 14 (2.3) 16 (2.7) 415 (69.1) 138 (23.0) 4.06 (0.78) 
self-reflective  15 (2.5) 27 (4.5) 44 (7.3) 376 (62.6) 139 (23.1) 3.99 (0.84) 
accountability  17 (2.8) 12 (2.0) 26 (4.3) 403 (67.1) 143 (23.8) 4.06 (0.78 
commitment  18 (3.0) 10 (1.7) 24 (4.0) 404 (67.2) 145 (24.1) 4.07 (0.78) 
each other’s involvement 
awareness  
19 (3.2) 17 (2.8) 70 (11.6) 391 (65.1) 104 (17.3) 3.90 (0.82) 
provision of  value, share 
information and 
responsibilities(each 
others) 
20 (3.3) 24 (4.0) 82 (13.6) 360 (59.9) 115 (19.1) 3.87 (0.87) 
Considering a patient as a unique person: 
respect idea, culture and 
religion    
11 (1.8) 18 (3.0) 23 (3.8) 411 (68.4) 137 (22.8) 4.07 (0.73) 
recognise and provides  
values  
15 (2.5) 35 (5.8) 56 (9.3) 390 (64.9) 105 (17.5) 3.89 (0.84) 
understand feelings 15 (2.5) 25 (4.2) 31 (5.2) 401 (66.7) 128 (21.3) 4.00 (0.81) 
HCPs and patient communication:      
on prioritising patient’s 
problem  
13 (2.2) 20 (3.3) 20 (3.3) 443 (73.7) 105 (17.5) 4.01 (0.73) 
free discussions  15 (2.5) 40 (6.7) 30 (5.0) 416 (69.2) 100 (16.6) 3.9 (0.83) 
based on careful listening 
and understanding 
15 (2.5) 33 (5.5) 30 (5.0) 459 (76.4) 64 (10.6) 3.87 (0.76) 
built on  mutual 
relationship  
12 (2.0) 40 (6.7) 62 (10.3) 419 (69.7) 68 (11.3) 3.81 (0.79) 
clear and summarised    31 (5.2) 41 (6.8) 54 (9.0) 405 (67.4) 70 (11.6) 3.73 (0.93) 
regular and properly about 
medical condition 
27 (4.5) 59 (9.8) 63 (10.5) 373 (62.1) 79 (13.1) 2.69 (0.97) 
Physical support:  
keeping physical comfort  23 (3.8) 40 (6.7) 61 (10.1) 397 (66.1) 80 (13.3) 3.78 (0.89) 
provision of  assistance 
while feeling tire   
23 (3.8) 39 (6.5) 55 (9.2) 398 (66.2) 86 (144.3) 3.80 (0.89) 
emotional support to cope 
with: 
      
TB disease  28 (4.7) 18 (3.0) 18 (3) 432 (71.9) 105 (17.5) 3.94 (0.86) 
relationships and mood 
changes 
18 (3.0) 26 (4.3) 29 (4.8) 422 (70.2) 106 (17.6) 3.95 (0.81) 
problems related to 
employment 
59 (9.8) 81 (13.7) 95 (15.8) 283 (47.1) 83 (13.8) 3.41 (1.17) 
Biopsychosocial perspective: 
HCPs were concerned to discus about: 
life history and 
development  
103 (17.1) 192 (31.9) 97 (17.1) 176 (29,3) 32 (5.3) 2.73 (1.20) 
family and social 
interactions  
112 (18.6) 166 (27.6) 90 (15) 200 (33.3) 33 (5.5) 2.79 (1.23) 
financial issues 126 (21) 179 (29.8) 87 (14.5) 178 (29.6) 31 (5.2) 2.68 (1.24) 
psychological status 91 (15.1) 94 (15.6) 57 (9.5) 313 (52.1) 46 (7.7) 3.21 (1.24) 
Total mean score       3.72 (.49) 
SD: standard deviation; f: frequency; %: percentage  
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5.2.4.3 Health care organisation (HCO)  
 
The third dimension of the framework, HCO dimension, comprises eight measuring 
items categorised into two sub-dimensions. The first sub-dimension of HCOs was 
ensuring access, effective and efficient coordination of care; the second sub-dimension 
was strengthening multi-disciplinary care teams. The mean score of ensuring access, 
effective and efficient coordination of care sub dimension was 3.65 (SD=0.69), and 
establishing and strengthening multidisciplinary care teams sub-dimension was 1.75 
(SD=0.53). The frequency, percentage and mean score of each item are described in 
Table 5.11. 
 
Table 5.11: HCOs concerned measuring items mean score (N=601) 
HCO  
Strongly 
disagree 
f (%) 
Disagree 
 
f (%) 
Neutral 
 
f (%) 
Agree 
 
F (%) 
Strongly 
agree 
f (%) 
Mean (SD) 
Ensuring access, effective and efficient coordination of care: 
travelled longer 
distance to access 
health  facility 
86 (14.3) 132 (22) 32 (5.3) 276 (45.9) 75 (12.5) 3.20 (1.2) 
presence of 
reminder(how to cover 
mouth while coughing, 
hand and mouth care) 
57 (9.5) 32 (5.3) 30 (5) 360 (59.9) 122 (20.3) 3.76 (1.2) 
designed to keep 
comfort and safety    
14 (2.3) 22 (3.7) 39 (6.5) 420 (69.9) 106 (17.6) 3.96 (0.77) 
provision of health 
education at waiting 
rooms and premise 
42 (7.0) 54 (9.0) 46 (7.7) 376 (62.6) 83 (13.8) 3.67 (1.04) 
Establishing and strengthening multidisciplinary care teams: 
Availability of patient support service: 
availing transport  566 (94.2) 11 (1.8) 2 (1.3) 19 (3.2) 3 (0.5) 1.13 (0.61) 
food support  460 (76.5) 113 (18.8) 1 (0.2) 5 (0.8) 22 (3.7) 1.36 (0.85) 
spiritual support 102 (17) 59 (9.8) 36 (6.0) 351 (58.4) 52 (8.7) 1.04 (0.27) 
social support  547 (91) 16 (2.7) 22 (3.7) 14 (2.3) 2 (0.3) 3.32 (1.27) 
Total mean score       2.70(0.42) 
 
SD: standard deviation; f: frequency; %: percentage  
 
5.2.4.4 DOTS care delivery system 
 
The fourth dimension of the framework, DOTS service delivery system, encompasses 
13 measuring items categorised into 3 sub-dimensions. Teamwork and team building, 
health care monitoring and addressing patient and community concerns about health 
care quality, and assisting people who have experienced adverse events in the health 
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care system are the sub-dimensions of TB care delivery system dimension. The total 
mean score of the measuring items was 3.62 (SD=0.52). The highest mean score 
among 13 measuring items was 3.96 (SD=0.92) TB care service integration with 
HIV/ART services item. The measuring items frequency, percentage and mean scores 
are described in the Table 5.12.  
 
Table 5.12: TB care delivery health system concerns measuring items (N=601) 
Items  Strongly 
disagree 
f (%) 
Disagree 
 
f (%) 
Neutral 
 
f (%) 
Agree 
 
f( %) 
Strongly 
agree 
f (%) 
Mean (SD) 
Monitoring and addressing patient and community concerns about DOTS care quality: 
TB care delivery system:  
transition from diagnosis to 
treatment 
31 (5.2) 57 (9.5) 95 (15.8) 329 (54.7) 89 (14.8) 3.64 (1.01) 
appointment arrangement for 
follow-up 
22 (3.7) 26 (4.3) 36 (6.0) 401 (66.7) 115 (19.1) 3.93 (0.86) 
TB care integration with 
HIV/ART 
27 (4.5) 23 (3.8) 34 (5.7) 376 (62.6) 141 (23.5) 3.96 (0.92 
HCPs  mutual agreements 
about the care given to you 
22 (3.7) 25 (4.2) 67 (11.1) 387 (64.4) 100 (16.6) 3.86 (0.86) 
The presence of the name 
and contact details of the 
person in charge of TB care 
68 (11.3) 65 (10.8) 49 (8.2) 303 (50.4) 116 (19.3) 3.55 (1.23) 
Confidentiality of clinical 
information  
19 (3.2) 19 (3.2) 48 (8.0) 341 (56.7) 174 (29) 3.60 (1.04) 
Teamwork and teambuilding 
The TB care service delivery system has: 
good inter-facility referral 
system 
41 (6.8) 43 (7.2) 88 (14.6) 366 (60.9) 63 (10.5) 3.60 (1.00) 
good intra-facility referral 
system  
35 (5.8) 53 (8.8) 89 (14.8) 376 (62.6) 48 (8.0) 3.58 (0.96) 
good collaboration among 
registration, laboratory, 
treatment and discharge 
services 
32 (5.3) 44 (7.3) 86 (14.3 380 (63.2) 59 (9.8) 3.64 (0.94) 
Assisting people who experienced adverse events in the health system  
assistance while you faced 
difficult situations in the TB 
care provision 
36 (6) 74 (12.3) 97 (16.1) 342 (56.9) 51 (8.5) 3.49 (1.01) 
compensation system for 
difficult situation, where 
appropriate  
55 (9.2) 94 (15.6) 
122 
(20.3) 
282 (46.9) 47 (7.7) 3.28 (1.1) 
fixed contact persons is 
assigned for questions, 
problems and complaints  
90 (15) 118 (19.6) 83 (13.8) 279 (46.4) 31 (5.2) 3.07 (1.2) 
reassurance for 
inconveniences  
41 (6.8) 56 (9.3) 76 (12.6) 372 (61.9) 56 (9.3) 3.57 (1.01) 
Total mean score      3.63 (0.52) 
SD: standard deviation; f: frequency; %: percentage  
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The total items used to measure the patient centredness of DOTS strategy in four 
dimensions were 65. The overall mean score of the 65 measuring items in the 
framework was 3.44 (SD=0.44) (Figure 5.3).  
 
 
Figure 5.3:  Mean score of PCC dimensions(N=601) 
 
To determine the overall patient centeredness of DOTS strategy, the mean score of 
each respondent were adjusted into a 0-to-100 scale by utilising a Likert’s 
transformation formula as described in section 4.4.4.8.2 (Liu, Wang & Lu: 2010:2). 
 
The mean adjusted score was 61 (SD=11). The adjusted mean score was used as a cut 
point to categorise either TB patients received PCC with DOTS strategy or not. The 
respondents, who score below the mean score of 61 regarded as did not receive PCC 
whereas, equal or above mean score of 61 considered as they received PCC with 
DOTS. About 40% of the respondents perceived as they did not receive PCC with 
DOTS. 
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5.2.4.5 Perceived PCC and gender 
 
From 601 respondents, 358 (60%) were perceived as they received PCC with DOTS 
strategy. Of which 174 (49%) were female and 181 (51%) were male. Among 265 
female respondents, 91 (34.3%) of female did not perceive as they received PC-TB 
care while among 336 male respondents, 148 (45%) respondents were perceived as 
they did not receive PCC as illustrated in Figure 5.4. Male and female respondents 
perception about received PCC was significantly different (p=0.009).  
 
 
Figure 5.4:  Perceived PCC by gender (N=601) 
 
5.2.4.6 Perceived PCC and Type of TB 
 
From 242 respondents who did not perceive as they received PCC 16 were MDR TB 
patients (50% of MDR-TB patients), 114 were smear positive PTB (47% of smear 
positive pulmonary TB patients), 57 smear negative PTB (38% of smear negative 
pulmonary TB patients) and 55 were EPTB (35% of extra pulmonary TB patients). 
There was no significant association between PCC received with type of TB in DOTS 
strategy (p=0.177). 
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5.2.4.7 Perceived PCC and treatment category of respondents 
 
Among 496 new TB patients, 304 (61%) were received PCC with DOTS strategy. 
Whereas, among 12 respondents who were on treatment after treatment failure, only 3 
(25 %) perceived as the received PCC (Figure 5.5). Perceived PCC with DOTS and 
treatment category of the respondents had significant association (p=0.019).   
 
 
Figure 5.5:  Perceived PCC and registration category 
 
5.2.4.8 Perceived PCC and educational level  
 
Among all 242 (40%) of respondents who did not feel as they receive PCC with DOTS 
strategy, 46 (33% of diploma and above, 70 (37% of secondary school), 66 (46% of 
primary school (5-8), 27 (57%) of primary school (1-4) and 30 (44% of had no formal 
education). The highest educational level achieved did not perceive as they received 
PCC of DOTS service. The highest educational level attained respondents and 
perceived PCC with DOTS strategy had no significant association (p=0.10).  
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5.2.4.9 Perceived PCC and average family monthly income of the respondent 
 
The proportion of average monthly income of the family against received PCC of 
respondent is described in Table 5.13. Perceived PCC and average monthly income of 
the patient show that weak positive correlation, Spearman's rho(r) correlation coefficient 
was 0.013, where r=1 is perfect positive correlation. 
 
Table 5.13: Perceived PCC and average family monthly income (N=546) 
Income category in 
USD 
Perceived PCC 
n (%) 
Not perceived PCC  
n (%) 
Total 
n (%) 
9.40–47.00 105 (57.7) 77 (42.3) 182 (100) 
47.1–95.00 85 (57.8) 62 (42.2) 147 (100) 
95.01–143.0 54 (66.7) 27 (33.3) 81 (100) 
143.1–957.0 79 (58.1) 57 (41.9) 136 (100) 
Total 323 (60%) 223 (40%) 546 (100) 
 
5.2.4.10 Perceived PCC, communication, experience and presence of symptoms 
 
Cross-tabulation of the perceived PCC with perceived communication, experience and 
presence of TB symptoms is depicted in Table 5.14. There was a significant association 
between PCC of DOTS received and perceived good communication with HCPs 
(p<0.001), experience on utilisation of health care service (p=0.011) and presence of 
symptoms at the time of interview (p=0.016). 
 
Table 5.14: Cross-tabulation of PCC, perceived communication, experience and 
presence of TB symptoms (N=601) 
Items Response 
Perceived PCC 
received 
Total 
Yes 
n (%) 
No 
n (%) 
n (%) 
Perceived good communication with HCPs  
Yes 331 (60.8) 213 (39.2) 544 (100) 
No 38 (66.7) 19 (33.3) 57 (100) 
Experience(ever used) 
Yes 89 (50.3 88 (47.7) 177 (100) 
No 261 (61.6) 163 (38.4 424 (100) 
Presence of symptoms at the time of 
interview  
Yes 96 (51.1) 92 (48.9) 188 (100) 
No 254 (61.5) 159 (38.5) 413 (100) 
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5.2.5 Factors associated with PCC of DOTS 
 
In this section analyses of factors associated with perceived PCC received of TB patient 
with DOTS strategy is presented. The analysis aims to identify the presence and 
strength of the association between dependent and independent predictors. The 
dependent variable, PCC received with DOTS strategy was categorised based on 
adjusted mean score; below the mean score of 61 regarded as they had not received 
PCC with TB-DOT strategy while equal and above regarded as they had received PCC. 
 
The categorical variables and DOTS patient centeredness related factors were 
assessed for the presence of association based on direct response of the respondents. 
Whereas continues variable, the average monthly family income, dichotomised into two 
based on the mean family-income value, $115. Those respondents who had above the 
$115 were considered as “less-poor” whereas respondents who had below and equal to 
$115 of average monthly income regarded as “poor”. 
 
The association between dependent and independent variables were assessed by 
logistic regression. To determine the association X2, p-values, crude and adjusted Odds 
Ratios with 95% confidence intervals were calculated.  
 
Gender, age, educational level, occupation, experience, presence of symptoms, 
treatment supporter and perceived good communication had significant association with 
perceived PCC with DOTS strategy before adjusting the confounder. However, after 
adjusting the confounders in multiple logistic regression with the model fitness, Hosmer 
and Lemeshow test X2=12.939, df=8 and p=0.114; gender, communication and type of 
treatment supporter had association with perceived PCC DOTS strategy. In the 
analysis, male gender respondents were 55% less likely to receive PCC with DOTS 
strategy (AOR= 0.45; 95%CI (0.3, 0.7)) compared to female respondents. On the other 
side, respondents who had good communication with HCPs were more likely to receive 
PCC with DOTS strategy (AOR= 3.2; 95% CI (1.6, 6.1)) compared to those who did not 
have good communication with HCPs.   
 
Respondents who had HCP treatment supporters were more likely to perceive PCC 
received with DOTS strategy than those who had family member treatment supporter 
(AOR=3.4; 95% CI (2.1-5.48)). The detail logistic regression analysis is presented in 
Table 5.15.  
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Table 5.15: Logistic regression analysis of variables with perceive PCC DOTS 
strategy 
Variables  
Perceived 
PCC COR (95 % CI) 
P-
value 
AOR (95 % CI) 
P-
value 
Yes No 
Gender  
Male 181 148 0.64 (0.46, 0.89) 0.009 0.45 (0.3, 0.7) 000 
Female 174 91 1.00  1.00  
Age  
18-24 64 63 1.00  1.00  
25-34 125 89 1.38 (0.89, 1.43) 0.15 1.1 (0.65, 1.8) 0.68 
35-44 103 4 2.4 (1.4, 3.8) 0.001* 1.8 (1.1, 3.9) 0.01 
45-54 39 19 2.0 (1.0, 3.8) 0.034 2.4 (1.1, 5.1) 0.06 
55-64 15 16 0.9 (0.4, 2.0) 0.84 0.9 (0.3, 2.2) 0.52 
>/= 65 9 9 0.98 (0.4, 3.6) 0.97 1.0 (0.3, 3.1) 0.42 
Educational 
level 
Diploma and above 46 95 1.5 (0.9, 2.9) 0.12 1.6 (0.75, 3.5) 0.20 
Secondary school(9-
12) 
70 122 1.3 (0.77, 2.3) 0.30 1.4 (0.73, 2.8) 0.41 
Primary school (5-8) 66 79 .92 (0.5, 1.6) 0.77 0.9 (0.5, 1.9) 0.75 
Primary school (1-4) 27 20 0.57 (0.2, 1.2) 0.14 0.7 (0.3, 1.7) 0.68 
No formal education 30 39 1.00  1.00  
Occupation  
permanent employee 68 33 1.00  1.00  
Self employee 148 68 1.1 (0.6, 1.7) 0.83 1.0 (0.6, 1.8) 0.25 
Temporary employee 39 46 0.4 (0.2, 0.7) 0.003 0.4 (0.2, 0.8) 0.25 
House wife 40 34 0.5 (0.3, 1.0) 0.075 0.4 (0.17, 0.8) 0.20 
Unemployed 43 40 0.5 (0.2, 0.94) 0.03 0.58 (0.3, 1.1) 0.95 
Pensioner  12 11 0.53 (0.21, 1.33) 0.17 0.7 (0.2, 2.0) 0.96 
Student 5 7 0.35 (0.1, 1.1) 0.089 0.4 (0.09, 1.5) 0.86 
Average 
monthly ncome  
Poor  186 141 1.5 (1.07, 2.2) 0.01 1.35 (0.9, 2.0) 0.16 
Less poor  142 70 1.00  1.00  
Experience   
Yes 92 84 0.65 (0.45, 0.92) 0.016 0.76 (0.5, 1.1) 0.18 
No 263 155 1.00  1.00  
Good 
communicate-
on with HCPs  
Yes 338 199 4 (2.2, 7.20) 000 3.2 (1.6, 6.1) 000 
No 17 40 1.00  1.00  
Treatment 
supporter  
HCP 294 87 2.7 (1.8, 4.0) 000 3.4 (2.1, 5.48) 000 
Family 61 152 1.00    
Presence of TB 
symptoms  
Yes 96 90 0.61 (0.43, 0.87) 0.006 0.69 (0.45, 1.0) 0.07 
No 259 149 1.00    
HCP: Health care providers; 1.00: reference category; COR: Crude Odds Ratio; AOR: Adjusted Odds 
Ratio; CI: confidence interval:*Fisher exact test  
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5.2.6 Exploratory factor analysis 
 
Exploratory factor analysis was conducted to determine continuous latent variables that 
are needed to explain the PCC framework. Kaiser-Meyer-Olkin (KMO) measure of 
sampling adequacy and Chi-square were performed and results are presented in Table 
5.16.  
 
Table 5.16: KMO and Bartlett's test for PCC DOTS measuring items per 
dimensions  
Patient, family and community concern 
dimension 
HCO dimension 
Kaiser-Meyer-Olkin measure of sampling 
adequacy 
0.864 
Kaiser-Meyer-Olkin measure of 
sampling adequacy 
0.605 
Bartlett's test of 
Sphericity 
Approx Chi-Square 5244 Bartlett's test 
of sphericity 
Approx Chi-Square 708 
Degree of freedom  190 Degree of freedom  28 
Significance .000 Significance .000 
HCPs dimension  DOTS care delivery system dimension  
Kaiser-Meyer-Olkin measure of sampling 
adequacy 
0.874 
Kaiser-Meyer-Olkin measure of 
sampling adequacy 
0.816 
Bartlett's test of 
sphericity 
Approx Chi-Square 6919 
Bartlett's test 
of sphericity 
Approx Chi-Square 2452 
Degree of freedom  276 Degree of freedom  78 
Significance .000 Significance .000 
 
HCO: Health Care Organisation; HCP: Health care providers 
 
Sixty-seven percent of the total variability of PCC framework was explained by 17 
measuring items, which scored above one eigenvalue, among the total of 65 measuring 
items in the framework. The components eigenvalues and total variability explained in 
the table attached in the Annex A.  
 
Among the 20 variables included in patient, family and community dimension, 63% of 
the total variability was explained by five items, and for the 23 measuring items in the 
HCPs dimension, 66% of the variance was explained by six measuring items. Among 8 
measuring items in HCO dimension, 59% variability was explained by three measuring 
items. Among 13 items in DOTS care delivery system dimension, 57% of the total 
variability was explained by three items.   
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Table 5.17: Items extracted from principal component analysis by dimension 
Dimensions Explaining measuring items 
Total 
variability 
explained the 
dimension 
Patient, family and 
community concern 
Information provision 
63% 
Consent and taking part in treatment plan 
Treatment supporter communication, 
Encouragement of friends to involve in TB 
care 
provision of place of choice where to follow 
the treatment 
HCPs 
Communication of HCPs and patient, ,  
66% 
Concerned discussion about family and social 
issue 
Discussion on employment and financial 
status 
Recognition 
Value provision  
Emotional and physical support 
HCOs 
Availability of transport,  
59% Comfortable ness of the premises 
Food support 
TB care delivery system 
Referral system,  
57% 
Service integration  
Compensation system for faced difficult 
situation 
 
5.2.7 TB patients’ level of satisfaction  
 
The TB patient’s satisfaction level with DOTS strategy was determined by two 
approaches; 10-point scale single item and Donabedian quality health care model. 
 
The first approach, a 10-point scale single item that measures the overall satisfaction 
level ranges from 0 to 10 for minimum and maximum satisfaction with DOTS strategy 
they received, respectively. Based on this single overall satisfaction measuring item, the 
mean TB patients satisfaction with DOTS strategy was 8.4 (SD=1.57) (Figure 5.6). 
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Figure 5.6:  Satisfaction level of the respondents by single overall measuring item 
 
The second approach was by using Donabidian quality health care model. The model 
contains structure, process and outcome dimensions. Based on these dimensions a 
questionnaire was developed with extensive literature review with consideration of 
DOTS strategy treatment guidelines. The questionnaire contains 23 5-point Likert scale 
items; 10 items focused on structure, 10 items focused on process and 3 items for 
outcome of DOTS treatment strategy. The questionnaire’s overall reliability test was 
done during pilot study and after actual data collected. Cronbach’s alpha of 0.88 and 
0.85 were calculated pilot study data and actual data collected, respectively, Cronbach’s 
alpha of 0.7 and above is regarded as acceptable (Burns & Grove 2005:374). 
 
The total mean score of TB patients’ satisfaction measuring items was 3.78 (SD=0.5), 
maximum and minimum scores were 5 and 1, respectively. The level of satisfaction of 
the respondents on each measuring items with mean scores are presented in Table 
5.18. 
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Table 5.18: Level of satisfaction and mean scores of satisfaction measuring 
items 
Measuring items  
Very 
dissatis 
fied 
f (%) 
Dissatisfied 
 
 
f (%) 
Neutral 
 
 
f (%) 
Satisfied 
 
 
f (%) 
Very  
Satisfied 
 
f (%) 
Mean (SD) 
Structure; you are satisfied with: 
availability of necessary 
drugs, laboratory reagents   
31 (5.2) 51 (8.5) 87 (14.5) 312 (51.9) 120 (20) 3.73 (1.03) 
access of the HCPs   15 (2.5) 44 (7.3) 32 (5.3) 365 (60.7) 145 (24.1) 3.96 (0.90) 
easy access to re fill drugs 27 (4.5) 38 (6.3) 37 (6.2) 368 (61.2) 131 (21.8) 3.89 (0.96) 
friendliness of the 
environment 
100 (16.6) 107 (17.8) 75 (12.8) 252 (41.9) 67 (11.1) 3.13 (1.30) 
the waiting, registration and 
treatment room  
30 (5) 49 (8.2) 52 (8.7) 357 (59.4) 112 (18.6) 3.78 (1.00) 
safeness of the facility  20 (3.3) 36 (6) 37 (6.2) 364 (60.6) 144 (24) 3.95 (0.91) 
availability of  signage/ 
directions  
49 (8.2) 47 (7.8) 36 (6) 337 (56.1) 132 (22) 3.75 (1.12) 
cleanness, goodness and 
working order  of the latrine   
45 (7.5) 65 (10.8) 87 (14.5) 289 (48.1) 115 (19.1) 3.60 (1.13) 
treatment room privacy 11 (1.8) 23 (3.8) 44 (7.3) 387 (64.4) 136 (22.6) 4.02 (0.78) 
availability of safe water to 
ingest in pills 
83 (13.8) 109 (18.1) 62 (10.3) 240 (39.9) 107 (17.8) 3.29 (1.32) 
Process; you are satisfied with:  
explanation and response of 
HCPs to questions  
17 (2.8) 23 (3.8) 25 (4.2) 375 (62.4) 160 (26.6) 4.06 (0.85) 
HCPs ability of the 
diagnosis, treatment and 
care of TB   
14 (2.3) 32 (5.3) 43 (7.2) 357 (59.4) 155 (25.8) 4.0 (1.00) 
the cost you paid for TB 
diagnosis and treatment 
34 (5.7) 47 (7.8) 55 (9.2) 316 (52.6) 149 (24.8) 3.83 (1.06) 
costs paid for transport 76 (12.6) 101 (16.8) 95 (15.8) 227 (37.8) 102 (17) 3.29 (1.28) 
carefulness and allotted 
time of HCPs to check 
clinical condition 
17 (2.8) 37 (6.2) 47 (7.8) 355 (49.1) 145 (24.1) 3.95 (0.90) 
HCPs welcoming, respect  
and courteous  
13 (2.2) 32 (5.3) 25 (4.2) 379 (63.1) 152 (25.3) 4.03 (0.84) 
HCPs considerer you are 
unwise 
45 (7.5) 87 (14.5) 73 (12.1) 302 (50.2) 94 (15.6) 3.52 (1.14) 
appointment  system  45 (7.5) 87 (14.5) 73 (12.1) 302 (50.2) 94 (15.6) 3.98 (0.83) 
waiting time for processes   108 (18) 294 (48.9) 65 (10.8) 75 (12.5) 59 (9.8) 3.52 (1.20) 
HCPs usage of  medical 
terms/jargon 
51 (8.5) 71 (11.8) 38 (6.3) 314 (52.2) 127 (21.1) 3.65 (1.18) 
Outcome; you are satisfied with your: 
TB Symptoms reduction  12 (2) 24 (4) 30 (5) 322 (53.6) 213 (35.4) 4.16 (0.85) 
physical wellbeing-ness  12 (2) 33 (5.5) 33 (5.5) 325 (54.1) 198 (32.9) 4.10 (0.87) 
psychological wellbeing-
ness  
11 (1.8) 36 (6) 20 (3.3) 330 (54.9) 204 (33.9) 4.13 (0.87) 
Total mean score       3.78 (0.5) 
 
SD: Standard deviation; HCPs: health care providers  
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TB patients’ satisfaction level based on 10 points scale  and Donabedian quality health 
care model based measuring items score shows a positive correlation (r=0.419). 
However, overall single item measurement shows that higher mean satisfaction score 
than Donabedian quality health care model based measurement (p<0.05).  
 
The researcher choose the second approach satisfaction level of the respondent, 
Donabedian quality health care model outcome, for further analysis. Therefore, to 
produce binary variables related to satisfaction, the mean score of the responses were 
calculated for each respondent; the respondent who got the mean score of 2 and less 
were classed as unsatisfied respondent while the respondent who got the mean score 
of 4 and above regarded as satisfied respondent. For the respondent who scored 
between greater than 2 and less than 4 the median was calculated; then the respondent 
who scored less than the median, 3.69 (SD=0.5) were classed as “unsatisfied” and 
equal and above the median classed as “satisfied” (Bahrampour & Zolala 2005:907).” 
(Bahrampour & Zolala 2005:907). Based on this category 67.7% of the respondents 
were satisfied with DOTS.   
 
5.2.7.1 Gender and TB patients’ satisfaction  
 
From 601 respondents, 406 (67.7%) respondents were satisfied with DOTS service they 
received. Among 406 satisfied respondents, 208 (51.2%) were male and 198 (48.8%) 
were female respondents. There was significant association between the satisfaction 
with DOTS and gender (p=0.001).  About 75% of female respondents were satisfied 
with DOTS (Figure 5.7). 
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Figure 5.7:  Proportion of satisfaction by gender (N=601) 
 
5.2.7.2 Type of TB and satisfaction  
 
Among the 601 respondents, 406 respondents were satisfied with DOTS. Of whom 170 
(64.6% of smear positive pulmonary TB) 108 (73.5% of smear negative pulmonary TB), 
105 (66.0% of extra pulmonary TB) and 23 (71.9% of MDR-TB patients) were satisfied 
with DOTS. There was no significant association among satisfaction with DOTS and 
type of TB (p=0.28).  
 
5.2.7.3 Treatment category and satisfaction 
 
Among 195 unsatisfied respondents, 155 (30.9% of new), 23 (33.8% of relapse), 9 
(75% of treatment after failure), 2 (50% of return after default) and 5 (38% of transfer-in) 
were TB patients (Figure 5.8). There was marginally insignificant association among 
treatment categories and satisfaction of the respondent with DOTS (p=0.06).  
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Figure 5.8:  Level of satisfaction with treatment category of respondents (N=601) 
5.2.7.4 Educational level and satisfaction 
 
From all satisfied respondents, 93 (15.5%) were diploma and above holders, 129 
(21.5%) were secondary school (9-12), 100 (16.6%) were primary school (5-8), 33 
(5.5%) were primary school (1-4), and 51(8.5%) had no formal education. There was no 
association between education level achieved and satisfaction with the DOTS. 
 
5.2.7.5 Age category and satisfaction 
 
Among 406 satisfied respondents, 82 (13.6%) were between 18-24 age category, 145 
(24.1%) were between 25-34 age category, 106 (17.6%) were between 35-44 age 
category, 41 (6.8%) were 45-54 age category, 23 (3.8%) were 55-64 age category and 
9 (1.5%) were above 65 years old. There was no significant association between age 
category and satisfaction with DOTS.  
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5.2.7.6 Income category and satisfaction 
 
There was significant association among income category and satisfaction with DOTS 
(p=0.02). Cross tabulation of satisfaction with income category presented in Table 5.19.  
 
Table 5.19: Cross-tabulation of average family income with satisfaction (N=546) 
Level of 
satisfaction 
f /% 
Average monthly income category in USD 
Total 
9.4–47.0 47.1–95.0 95.01–143.0 
143.1–
957.0 
Not satisfied 
Count 48 56 19 51 174 
% within Satisfaction 
level  
27.6 32.2 10.9 29.3 100 
% within Average 
monthly income   
26.4 38.1 23.5 37.5 31.9 
% of Total 8.8 10.3 3.5 9.3 31.9 
Satisfied 
Count 134 91 62 85 372 
% within Satisfaction 
level  
36.0 24.5 16.7 22.8 100 
% within Average 
monthly income   
73.6 61.9 76.5 62.5 68.1 
% of Total 24.5 16.7 11.4 15.6 68.1 
Total        Count 182 147 81 136 546 
% within Satisfaction level  33.3 26.9 14.8 24.9 100 
% of Total 33.3 26.9 14.8 24.9 100 
 
5.2.8 Logistic regression analysis 
 
Binary and multivariable logistic regressions were conducted to identify the predictors 
associated with satisfaction with DOTS strategy. In binary logistic regression model 
perceived predictor for patient satisfaction extracted from literature and variables related 
to DOTS strategy was assessed. In multivariable regression the variable which had p 
value <0.05 in binary logistic regression were considered. Goodness of the model was 
assessed by Hosmer and Lemeshow Test, X2=5.904, df =8 and p=0.658 revealed the 
model adequacy. The outcome of the regression displayed in Table 5.20. 
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Table 5.20: Logistic regression outcome of satisfaction with DOTS and 
independent variables 
Variables Category  
Satisfaction 
COR  
(95 % CI) 
P-
value 
AOR 
(95 % CI) 
P-
value Satisfied 
Not 
satisfied 
Gender 
Male  208 128 1.00  1.00  
Female  198 67 1.81 (1.2,2.6) 0.001 2.2 (1.3, 3.57) 0.001 
Residence 
Urban 340 171 1.00  1.00  
Rural 56 13 2.2 (0.9,5.2) 0.016 3.4 (1.6, 7.6) 0.003 
Homeless*  10 11 4.7 (1.6, 13.5) 0.080 1.1 (0.3,3.7) 0.78 
TB symptoms 
presence    
Yes 113 75 0.6 (0.43, 0.9) 0.009 0.6 (0.40, 0.94) 0.02 
No  293 120 1.00  1.00  
Perceived good 
Communication   
Yes 375 169 1.00  1.00  
No  31 26 1.8 (1.0,3.2) 0.02 1.6 (0.8, 3.3) 0.01 
Occupation 
Permanent 
employee  
38 36 1.00  1.00  
Self-
employee  
166 53 1.6 (0.9, 2.7) 0.051 1.5 (0.87, 2.7) 0.13 
Temporary 
employee  
47 39 0.6 (0.33, 1.1) 0.133 0.48 (0.2, 0.9) 0.03 
House wife  57 17 1.7 (0.9, 3.5) 0.096 1.0 (0.4, 2.4) 0.88 
Unemployed  48 35 0.7 (0.4, 1.3) 0.291 0.56 (0.23, 1.3) 0.20 
Pensioner 12 11 0.5 (0.2, 0.4) 0.238 0.56 (0.2, 1.6) 0.28 
Student 8 4 1.0 (0.2, 3.7) 0.930 1.3 (0.11, 15) 0.82 
Income in USD 
9.40–47.0 134 48 1 0.022 1.00  
47.01–95.0 91 56 0.6 (0.4, 0.9) 0.024 0.6 (0.3, 1.1) 0.15 
95.01–143 62 19 1.1 (0.6, 2.1) 0.616 1.3 (0.6, 2.6) 0.47 
143.01–957 85 51 0.59 (0.3, 0.9) 0.035 0.6 (0.3, 1.1) 0.15 
Treatment 
supporter 
Family  
member  
53 71 1.00  1.00  
HCPs 349 122 3.8 (2.5, 5.7) 000 4.3 (2.7, 6.8) 000 
HCPs: Health care providers; 1.00: reference category; COR: Crude Odds Ratio; AOR: Adjusted Odds 
Ratio; CI: confidence interval:* No formal living houses both in urban and rural  
 
5.2.9 Correlation of TB patient satisfaction and received PCC with DOTS 
 
The correlation of scores of patient satisfaction and perceived PCC of DOTS strategy 
was done. The correlation of perceived PCC and satisfaction level of TB patients were 
positive (r=0.58) as shows in Figure 5.9 in scatter plot diagram.   
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Figure 5.9:  Scatter plot diagram of PCC and satisfaction mean score 
measuring items 
 
5.3 SECTION 2:  QUALITATIVE DATA ANALYSIS AND PRESENTATION  
 
The qualitative component of the study was intended to achieve the following 
objectives:  
 
 Explore driving factors to default TB patients from TB treatment. 
 Explore TB experts’ and defaulted TB patients’ perception about DOTS strategy 
patient centeredness and satisfaction level.   
 
These objectives were achieved through FGDs with TB experts and telephone interview 
with defaulted TB patients.  
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This section has presented firstly, FGDs and telephonic interview process. Secondly, 
the qualitative data analysis procedure carried out to answer the objectives. Thirdly, 
present composition of the discussants of FGDs and telephonic interview. Finally, 
themes revealed by qualitative data analysis will be discussed.  
 
5.3.1 Composition of FGDs and telephonic interview participant 
 
The FGDs and telephonic interview participants’ composition in terms of age, gender, 
educational and work experiences are described below. 
 
5.3.1.1 FGD the participant composition 
 
Among purposively recruited 23 FGD participants, 15 (65%) were male. TB related work 
experiences of TB experts ranges from 2-15 years with the mean of 5.3 years (Table 
5.21). Twelve (55%) the FGDs participants had Masters degree and 11 (45%) had 
Bachelor degree. 
 
Table 5.21: Demographic details of FGD (N=23) 
Variable  Category  f (%) 
Sex  
Male  15 (65.2) 
Female 8 (34.8) 
Age in years 
20-30 8 (34.8) 
31-40 3 (13.0) 
41-50 10 (43.5) 
51-60 2 (8.6) 
TB-related work experience (in 
years) 
2-4  8 (34.8) 
5-6 5 (21.7) 
7-8 6 (26.1) 
9-15 4 (17.4) 
 
5.3.1.2  Telephonic interview participant composition 
 
Among 25 defaulted TB patients, 3 (12%) recorded addresses were wrong address, 2 
(8%) did not hang up for repeated telephone calls 1 (4%) did not volunteer to discuss 
and 19 (76%) participated in the interview.  
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Among 19 fully interviewed defaulted TB patients, 11 (58%) were male respondents. 
The mean age of the respondents was 39.4 years, range was 31 and the minimum and 
the highest age of the respondents were 26 and 57 years, respectively. 
 
5.3.2 Qualitative data analysis 
 
Qualitative data analysis was started simultaneously with the data collection. During 
data collection field notes were taken, audio digital recorder (ADR) and non-verbal and 
gestural cues were observed. All the Amharic recorded data were translated and 
transcribed verbatim by the researcher and research assistant independently for the  
discussions and telephonic interview.  
 
Based on Yin (2011:177-8), after the verbatim transcription and translation of collected 
data, the qualitative data were analysed. The researcher compiled all the collected data 
using telephonic interview, discussions and field notes. Read and re-read both Amharic 
and English transcripts and listed the emerging ideas from both. He then created codes, 
categories and sub-categories from the listed ideas. He related the categories by 
drawing lines between categories. Recoding was done when necessary. Themes were 
generated from these categories. The transcripts were also given to a public health 
specialist, who was also an expert in qualitative research methodology to independently 
create codes and categories, and identify emerging themes. A consensus meeting 
between the researcher and the public health specialist was held, where the categories 
and themes identified were compared, revised and then used as research findings for 
this study. 
 
5.3.3 Themes identified in FGDs 
Five themes were revealed in the FGD discussions The themes were:  
 Implementation of DOTS strategy 
 Challenges with DOTS strategy 
 DOTS strategy’s patient centeredness 
 Contributing factors associate with patient centeredness 
 TB patients’ satisfaction with DOTS strategy 
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5.3.3.1 Theme 1: Implementation of DOTS strategy 
 
The theme 1, implementation of DOTS strategy at government and private health 
institutions had two categories and numerous sub-categories as shows in Table 5.22.  
 
Table 5.22: Theme 1: Implementation of DOTS strategy − categories and sub-
categories 
Theme 1 Categories  Sub-categories   
Implementation of DOTS 
strategy 
Implementation at 
government and 
private health 
facilities  
 
 Supervision  
 Standardised treatment guideline usage  
 Provided by trained HCPs 
 Daily bases observation during intensive 
phase  
 Weekly base follow-up during 
continuation phases 
 Trained HCPs 
Treatment outcome  Improved TB treatment outcome 
 
5.3.3.1.1 Implementation at government health facilities 
 
The FGDs participants explained that DOTS strategy has been implemented at public 
and private health institutions. The treatment strategy is expected to have daily 
observations of TB patients at least for the first 56 days and weekly follow-up for the 
rest, continuation phase in both private and public health institutions. These have been 
supported by TB/HIV treatment guideline of Ethiopia (EFMOH 2013:36). The strategy 
implementation and treatment provision has specific implementation guideline.  
 
Moreover, the discussant emphasised that the treatment is being provided by HCPs 
trained on this specific treatment guideline. The national treatment guideline standardise 
the treatment provision for better treatment outcome and patients. The following views 
were given by FGD participants about the standardisation of the treatment: 
  
“Previously, before 15 and 16 years, as DOT started, I was in the system and I know 
it. The patient whether smear positive or negative was entitled to take streptomycin 
injection but now the drug burden to the patient reduced. We even had the 
experience of pateients throwing the pills at home before DOT.” 
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The participants also indicated that the strategy’s implementation is tied with quarterly 
supervision and report; the report shows that DOTS has brought better treatment 
outcome and has contributed to reduction of TB prevalence in the country. The 
reduction of TB incidence and prevalence in Ethiopia is also reported (EFMOH 
2014a:3).  
 
In addition, the FGD participants explained that there are activities to trace and back the 
defaulted TB patients to the treatment. The following views were forwarded by one 
participant in the discussions: 
 
“When the patients default for some time the HCPs call and trace to know the 
cause and back to the service.” 
 
5.3.3.1.2 Implementation at private health facilities  
 
The DOTS strategy has been implemented at some of non-government hospitals in 
Addis Ababa. The implementation of the strategy at private health institution is similar 
with government health facilities. The similarities are in terms of using standardise 
treatment guideline, daily bases observation during intensive phase, weekly base 
follow-up during continuation phases, supervision schedule and provision by trained 
HCPs. The FGD participants explained that the implementation of DOTS strategy at 
non- government hospitals similarity as follows: 
 
“… the treatment is being provided at health stations, hospitals and other private 
clinics. The treatment services is accompanying with supervision. And a report is 
also presented to the responsible body on a quarterly basis regarding the 
respective level.” 
 
5.3.3.1.3 Treatment outcome 
 
The FGD participants explained that the DOTS strategy has brought better treatment 
outcome than before the DOT was in place. The FGD participant explains that the 
treatment outcome improvements as follows: 
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“As the report indicates the treatment outcome of TB patients has shown 
improvement and reduction of prevalence especially with in the last five years. 
This is due to usage of standard treatment guideline across all TB treating health 
institutions and bringing the DOTS strategy in place.” 
 
Scholars also report that DOTS has brought better treatment outcome (Getahun et al 
2013:521; Biadglegne et al 2013:85; Gebrezgabiher et al 2016:1). 
 
5.3.3.2 Theme 2: Challenges with DOTS strategy 
 
In the theme 2 four categories were revealed. The categories were daily observation, 
HCPs, supply, care integration perspectives and Public private partnership (PPP). The 
detail categories and sub-categories stated in Table 5.23. 
 
Table 5.23: Theme-2: Challenges with DOTS strategy − categories and sub-
categories 
Theme 2 Categories Sub-categories  
Challenges with 
DOTS strategy  
Daily observation  Obliged TB patients to be observed daily and 
weekly 
 Transport cost 
 Unavailability of permanent address 
 Mobility of patients  
 Patients insist the HCPs to get many days’ 
pills. 
 HCP-related    Incentive inquiry  
 Staff turn over   
 Less interest to work with TB particularly with 
MDR-TB 
 risk allowance inquiry,   
Supply shortage   Short expiry date of TB drugs, reagent 
Weak PPP  Weak interest of private institutions to 
provide TB treatment 
 Inconsistency of utilising standard treatment 
guideline at private health institutions  
 Less participation in the training 
 
5.3.3.2.1 Daily observation  
 
TB patients who were on intensive phase of the treatment were supposed to be 
observed daily in the health facility while s/he take-in the pills at least for two months’ 
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time and this in turn force the TB patients to be absent from their work. This was 
reported in the discussion as it was a challenge for most of TB patients particularly for 
those who had low income. However, this part of the community is the widely TB 
affected society. In addition, daily observations expose TB patients to spend more 
money for transportation and other related costs. The following statement were 
mentioned in the discussion by the participants.  
 
“TB patients have to come on daily bases during intensive phase whereas, for 
instance the patient might be industry employees who are expected to enter to 
work early in the morning. In addition, bedridden critical TB patients have to come 
to health facility daily with transport and should pay for that.” 
 
Moreover, the daily observation’s phenomenon requires permanent address of TB 
patients and it is less flexible to TB patients’ mobility from one health institution to 
another, once they are registered at a given facility. The inflexibility of the phenomenon 
was brought up in the discussions as challenge with DOTS. For this reason, the TB 
patients insist to receive many days’ pills and obliged to give wrong address. The 
importance of TB patients having permanent address was explained by participants as:  
 
“Patients do not have permanent resident addresses and has become difficult to 
reinstate them to the treatment process every time they change their addresses.” 
 
5.3.3.2.2 Health care providers (HCPs)  
 
In the discussions, the existences of high staff turnover intra facility and out of the 
facilities were quoted as a challenge with DOTS strategy. As motioned in the 
discussions the more experienced and familiarised staffs with DOTS strategy are 
leaving and others taking their places. This creates a huge gap between implementation 
of DOTS strategy and its proposed goals.  
 
Despite HCPs’ belief to get better benefits only by working with TB control activities, 
unavailability of risk allowances and related benefit packages for TB care provider were 
raised in the discussions. This is thought to contribute to a high turnover rate at the 
section by the participants and it was explained as follows: 
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“When health care providers work for long period of time with TB patients, they 
always request incentives by comparing themselves with midwives and 
anaesthetists who has professional fee.”  
 
As a result of above mentioned reasons and fear to contract TB while working with TB 
patients, HCPs’ poor interest to work with TB patients particularly with MDR-TB patients 
were also raised. The following verbatim sentences were mentioned in the discussions:   
 
“Involuntariness of HCPs to work with MDR-TB patients; even sometimes HCPs 
do not let in the MDR-TB patients to the TB treatment room to refill the TB drugs 
they serve through window.” 
 
5.3.3.2.3 Supply 
 
Another challenge mentioned by participants was shortage of supplies. Shortage of 
supplies were mentioned as a chronic problem particularly on some drugs especially 
loose form of TB drugs for re-treatment category of TB patients and laboratory reagents. 
The participants added that even the newly applied kit system for medication has very 
short expiry date and requires a speedy request on supply whereas failing on doing so 
is associated with shortage of supply. The following sentences were forwarded by FGD 
participants to explain the supply shortages were challenge: 
 
“... for instance for long period of time Ethambutol was not available.”  
 
“The supply issue is always the desk agenda even for Pharmaceutical Fund 
Supply Agency (PFSA) and the higher officials including Mayer know.”  
 
5.3.3.2.4 Public private partnership (PPP) 
 
Despite the provision of training for the HCPs and TB drugs for-free, for private health 
institutions, weak participation of private health institutions in TB treatment programme 
was noticed. The participants considered this weak participation of private health 
institution as a challenge. The participants described less involvement of the private 
health institutions to TB programme might be due to the demand of additional room 
dedicated only to TB treatment and they are expected to deliver the treatment follow-up 
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service for free. The participants pointed out that there was less involvement of private 
health institutions as:  
 
“Despite the availability of numerous private health institutions in the city, less 
than 10% of the facility is involved in TB programme. Most private health 
institutions have limited interest to work with TB programme due to the inquiry 
of separate room dedicated for TB and obliged to deliver the TB treatment for 
free. Even those involved in TB programme are not well sticky with the TB 
treatment guideline and less interested to send participant for trainings.” 
 
5.3.3.3 Theme 3: DOTS strategy on patient centeredness 
 
Patient centeredness perspective of DOTS strategy theme had 6 categories: patient 
preferences, treatment supporter, DOTS delivery system and its integration, HCPs, and 
similarity and difference of PCC and DOTS strategy.   
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Table 5.24: Theme 3: DOTS strategy on patient centeredness − categories and 
sub-categories with FGDs 
Theme 3 Categories Sub-categories 
DOTS strategy on  patient 
centeredness 
Patient 
preferences  
 Home-based treatment provision for bed 
ridden patients with initiative of HCPs 
 Patient choose health facility where to 
take the treatment   
 Convince the patient to follow daily 
observation   
 Health extension worker  
 Private institution  
 Government institution  
 Workload imbalance  
 Time of drug collection  
Treatment 
supporter  
 Family member  
 Any one who have close relationship  
 Difficulty to report to HCPs 
 None-feasibility of treatment supporter 
card 
 Continuation phase  
 Choice  
 Counsel  
 Treatment supporter card  
 Family member 
 Wrong person  
Similarities and 
difference of PCC 
with DOTS 
strategy  
 Planning 
 Follow-up duration 
 Health condition improvement  
 Flexibility required  
 Observed by different observer  such as 
HEW 
 Patient knowledge  
 Health education  
 HCPs knowledge 
 HCPs commitment 
 Sick leave    
 Community awareness  
 Community empowerment  
 
5.3.3.3.1 Patient preferences   
 
The issue of keeping preferences of TB patients’ with DOTS strategy was raised in the 
discussions repeatedly and was declared as it is existed in “principle” only and depends 
on HCPs personal inspiration. As a principle, after diagnosed as they have TB, 
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provision of place of choices to TB patients to decide where they can follow their 
treatments with strong advice to patients to choose nearby health facility. Majority of 
defaulted TB patients’ response also affirmed the provision of choice where the 
treatment follow-up takes place. The FGD participants explained the provision of 
choices as: 
 
“Soon after a patient is diagnosed for TB, the patient is asked for a place of 
preference where to follow a treatment.” 
 
However, the FGDs participants mentioned that TB patients prefer to go to well-known 
facilities, which have already treated a lot of patients before, rather going to nearby 
health facility. Selecting famous health facilities was reported to cause work imbalance 
among district health centres. As a result, HCPs insist the TB patients not to select such 
facilities. The FGD participants explained the TB patient case load imbalance across the 
facilities and influence to choose as:  
 
“Some district health stations will bear the burden of providing the treatment 
process.” 
 
“The rest of the process, however, is more of a guided procedure.” 
 
In addition, TB treatment follow-up also can be carried by health extension worker 
although not well practiced in the region. The FGD participant explained the possibility 
of getting treatment through health extension workers as: 
 
“They are also being treated through the health extension workers.” 
 
In the discussion, starting DOTS service provision time adjustment early in the morning, 
at 1:30 am, earlier than official starting working hour was reported. This adjustment 
existed where there are HCPs that have extra motivation. The time adjustment enables 
some of TB patients to take-in their TB drugs and go to their work. Besides, with HCPs 
personal initiation, provision of TB treatment at home bases for seriously ill TB patients 
was reflected in the discussion. The verbatim explanation of extra motivated HCPs 
support to keep TB patients preferences in the discussion was as:  
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“There are professionals who on a personal initiative are delivering the treatment 
in such a way. Some others prefer to receive the treatment from home ...” 
 
However, the FGDs discussant mentioned that there were many preference requests 
and preference changes through time of TB patients. TB patients’ preference usually 
changes from what they have preferred primarily, after two weeks or so of treatment. 
The change of preference through time reported to be related with patients’ health 
condition improvement. Among mentioned preferences taking the drug at home at least 
a week doses during intensive phase. The place of choice and unkempt preferences 
were explained by the defaulted TB patients as:  
 
“Though I chose the treatment centre, I requested at least to give me a week 
doses, I told him my reason but he strongly rejected to do so. Am I not 
responsible even to take the drug? Who is benefited primarily?” 
  
Another defaulted TB patient explained that the DOTS service provision system’s 
incapability to keep choices of the TB patients as:    
 
“It surprised me when there was imposition to bring advocator at the time of 
treatment initiation; of course I took since I had no choice to get the drug.” 
 
The FGDs discussants reported that patient preferences such as taking the drugs and 
swallow without direct observation were difficult to align with DOTS principles. The 
following sentence was forwarded about keeping preferences of TB patents’ by the FGD 
participants: 
 
“Considering all patients’ preference throughout the entire process of treatment 
will jeopardise the applicability of the DOTS service.” 
 
5.3.3.3.2 Treatment supporter 
 
The FGD discussant explained that the treatment supporter can be a family member of 
TB patients or anybody who is living in close relationship with the TB patients. The 
patients usually get counselled about the importance of treatment supporter by HCPs 
and obliged to choose and bring treatment supporter before the start of treatment. 
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However, as raised in the discussions some patients get difficulties to choose and bring 
the treatment supporter and are obliged to bring a person that may not support them at 
all. The FGD participants explained about the difficulties of bringing treatment supporter 
as:  
 
“Some patients bring people that they do not know, who later fail to show up.” 
 
The treatment supporters’ roles stated in the discussions were observing the TB patient 
while taking in the drugs and reports to the HCPs about the adherence level of the 
patient. The treatment supporters are also expected to come every week with TB 
patients, for whom they are accounted for, to communicate the HCPs based on 
checklist (treatment supporter card). The roles of the treatment supporter discussed 
were in line with the recommendation of TB treatment guideline of Ethiopia (2013:124). 
However, the roles of treatment supporters’ were mentioned as it is not feasible in 
application. The following verbatim sentences were forwards by the FGD participants 
as: 
 
“At the end of the week the patients just tick all the days by themselves even 
without taking the pills. Let alone the supporters, the patients themselves 
sometimes have to go and ask for the pills from other patients as they could not 
make it to the health institution.’’ 
 
The FGD discussants also agreed that using the treatment supporter and treatment 
supporter cards may not objectively indicate whether the TB patients’ were adherent 
with TB treatments. As long as daily record of treatment supporter card requires daily 
observation of the patient, treatment supporter may rely on and trust the TB patients 
information and fill the treatment supporter card. The participants explained the 
treatment supporter roles and treatment supporter card weak contribution for adherence 
with TB treatment by the FGD participants as: 
 
“I don’t think things are working quite...the idea of treatment supporter is more of 
subjective than objective.”  
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5.3.3.3.3 PCC in DOTS  
 
The FGD participants explained that at the initiation of the treatment process, the 
patient discuses with HCPs to start the treatment follow-up as in line with the principle of 
PCC. The participants explained that the discussion includes how long the treatment 
takes, and do’s and do not’s of the treatment. Furthermore, they add that Information 
provision and counselling are integral part of the treatment initiation with DOTS. As a 
result the patient will reach to informed decision; and most TB patients agree to follow 
their treatment at health facility at which their TB was identified. If they do not need to 
follow, referral will be written for those who choose other facility. The following 
sentences were forwarded to compare DOTS with PCC as perceived by participants in 
the discussion. 
 
“Obviously the first 15 days are totally patient-centred.” 
 
“DOTS is a patient-centred strategy in general. Patients agree on all the 
preconditions of the treatment at the start and may tell you that they are from the 
regions and cannot pursue the treatment anymore. Even in such cases, the 
strategy is that the patient should be transferred to another clinic near by the 
patients’ destination.’’ 
 
The FGD participants explained that after the TB patients started the follow-up, the 
decision of most of the TB patients to follow the treatment at the health facility he/she 
selected will be changed, usually after two weeks or so. A participant explained how 
daily observation is difficult with respect to TB patients as follows: 
 
“Patients are seen to have faded up with visiting the health centres on a daily 
basis.” 
 
The discussants also mentioned that the TB patients usually request to follow their 
treatment by themselves rather than coming back on a daily basis after taking 
sometime. However, the principle of DOTS does not allow the patients to take the 
treatment at their home without direct observation during intensive phase. They added 
that DOTS lack flexibility whiles the patients’ preference changes. Hence, agreed as a 
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conclusion as DOTS is not fully patient centred. The participants explained DOTS 
patient centeredness’ verbatim as: 
  
“We cannot say it is entirely patient-centred.”  
 
5.3.3.4 Theme 4: Contributing factors to DOTS patient centeredness 
 
DOTS strategy implementation system and its integration with other health care 
services, community perspectives and HCPs perspectives were revealed categories in 
the discussion to make feasible PCC in DOTS strategy.  
 
Table 5.25: Theme 4: Contributing factors associated with DOTS patient 
centeredness − categories and sub-categories  
Theme 4 Categories Subcategories  
Contributing factors 
associated with DOTS PCC  
  
 
  
Service provision   Flexibility provision of alternative to 
where to do follow-up window follow-
up 
 Follow-up checklist 
  Patient education  
Service 
integration 
 Nutrition support 
 HIV/AIDS 
 Mental health  
 Referral  
 Counselling 
 Ambulance 
 Bedridden  
 Prisons  
 Social service  
 Sick leave 
HCPs   Communication 
 Motivation 
 Characteristic 
 In-service training for HCPs  
Community   Community awareness towards TB 
 Community education 
 
5.3.3.4.1 DOTS service provision system 
 
As reflected in the discussion, practically DOTS implementations particularly after 
diagnosed as the patients identified as have TB, is rigged, does not allow flexibility to 
change the place where you do follow-up and treatment supporter. Besides, once 
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you registered and started treatment the refill of TB drugs is through window at 
majority of health institution. However, this could hinder the relationship of HCPs and 
patients so it might be barrier to provide one to one patient counselling, education 
and fully track the prognosis of the patients. The participants explained how the 
counselling is not well practiced in the implementation of DOTS strategy aligning with 
PCC comparing with others strategy as follows:   
 
“Counselling must be an area of priority like other programmes such as the 
PMTCT. Counselling should not also be passing the information; there should be 
a way to do it in a more detailed manner.” 
 
The way of service provision on TB treatment and the negative consequences was 
explained by the participants as follows:  
 
“When you come to the TB treatment process, the patient is received through 
windows after the first registration instance.” 
 
“I remember a case from Ormoiya region, where a patient collapsed and was 
carried to the clinic due to ionised drug. Professionals did not hold close 
discussions with their patients unless the patient shows symptoms of a need for 
another treatment.” 
 
To improve these circumstances, the participants suggest that the presence of daily 
checklist that can track the way TB-treatment service is given for TB patients during 
their treatment follow-up.  
 
5.3.3.4.2 Health care service integration  
 
Both inter and intra integration of different health care services with DOTS are the 
essential parts to provide PCC in TB control programme. Intra health service integration 
of nutrition support and HIV testing services are integrated with TB treatment. However, 
in both integrations limitations were mentioned. Due to stigma for anti-retroviral 
treatment (ART) service the patients prefer to take their ART at the farthest place where 
they perceived no one know them. Disruption of nutrition supply was limitation factor to 
fully integrate for all TB patients so that nutrition support is dedicated only for MDR-TB 
patients.  
  
127 
 
Most of the discussants raised this as a major factor to default from the treatment and 
suggest that nutrition and financial aid projects to be linked with the TB treatment in 
order to reinforce PCC with DOTS even to reduce defaulting TB patents. 
 
As reported in the discussion, the existing system has no place alongside screening of 
TB patients for a diagnosis other than TB and HIV. The participants explained weak 
integration of DOTS with other services in these words:  
 
“Recently the organisation that supports that integration has pulled out. So such 
integration now is only available at those with the necessary supply.” 
 
“The TB room maintains integration with HIV cases but not with nutrition .” 
 
In addition, the participants perceived TB treatment service provision and nutrition were 
given little attention compared to HIV service. The participants had the following to say 
about the limited attention of TB treatment provision:  
 
“It is a question to me sometimes comparing the HIV and TB treatment 
processes. The latter is  not given due attention despite its long history.” 
 
Apart from this, other health care services such as psychological support and mental 
health services have to be integrated with DOTS strategy. A participant explained faced 
situation on the importance of psychological and mental health integration as:  
 
“I had an experience during defaulter tracing with a defaulted patient. It is sad  
that I have latter learned that a patient has gone through insanity. I was 
wondering if the problem of insanity would have been detected and cured if a 
psychological service had been integrated into the DOT care service.” 
 
The integration of DOTS service with Ministry of Civil Servant and Social Affairs, and 
Ministry of Justice was also mentioned as a factor to make DOTS patient-centred. 
The health care service needs to integrate with Ministry of Civil Servant and Social 
Affairs to arrange flexible time for TB patients, and apply the sick leave application 
while TB patients follow their treatment. The practice of sick leaves for TB treatment 
follow-up was explained by the participant as follows: 
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“Back in the days, there was a sick leave issued by the health centres for a 
patient for TB treatment. Now that is not the case anymore. It is of course quite 
difficult to issue a sick leave for a patient for the entire 6 months, but at least a 
sick leave during the intensive phase would help in following the DOTS strategy 
more seriously and having into consideration the patients’ preference.” 
 
The importance of integration of DOTS with Ministry of Justice was associated with 
informing the health institution whenever one TB patient prisoner relocates one 
prison sit to another site. The participants explained their experience and perception 
about loose integration as follows:  
 
“I remember once a patient went to jail after starting the TB treatment and we 
tried to contact the clinic within the prison repeatedly. We lost patience of follow-
up after that. We cannot say there is a tangible form of integration unless the 
patients are within the treatment setting.” 
 
5.3.3.4.3 Health care provider (HCP)  
 
The FGD discussants were encircling repeatedly about the HCPs characteristic, 
communication skill and motivation to make health care delivery system patient-centred 
in particular DOTS. One of the participants explained the way of the communication 
between HCPs and patients as:  
 
“HCPs need to engage in teaching patients respectfully and systematically how 
important it is to complete the treatment and taking the pills the entire time. I am 
sure patients, once aware of the impacts, are willing to complete a 2 years 
treatment process, let alone a 6 months one.” 
 
In-service training was also mentioned in the interaction to build PCC in a given health 
care system in terms of provision of knowledge about the principles and practice of PCC 
and as a motivator as well. The importance in service training was highlighted in the 
discussion repeatedly by the participants as: 
 
“Even the TB treatment process is more than our undergraduate lessons, not the 
principles and practice of PCC.” 
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“Professionals need to be aware that if they have to be engaged in creating 
PCC.” 
 
“There needs to be a work to be done to boost not only the awareness on PCC 
but the commitment to live up to that awareness among the professionals 
providing the service.” 
 
5.3.3.4.4 Community awareness   
 
The FGDs participants explained that the work that increases community awareness 
about TB has to be reinforced in order to increase the knowledge of the general 
population. When the knowledge of a given population increases, PCC feasibility at 
each service delivery point at health sectors increases. Moreover, it is one of the 
factors to make informed decision. Community awareness can be achieved through 
consistent and programmed health education in the community. The participants 
explained the importance of increasing the community awareness as follows: 
 
“First and foremost there needs to be an awareness creation work at the 
community level in provision of programmed and consistent health education 
about TB in the community.” 
 
“I would agree with the awareness work that must be done at a community level.”  
 
5.3.3.5 Theme 5: TB patients’ satisfaction with DOTS 
 
The theme of TB patients’ satisfaction with DOTS strategy as perceived by TB experts 
had three categories:  presence of satisfaction survey exclusively for TB patients with 
DOTS strategy, integrated patient satisfaction measurement and the level of satisfaction 
of TB patients with DOTS as illustrated in Table 5.26. 
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Table 5.26: Theme 5: TB patients’ satisfaction with DOTS strategy − categories 
and sub-categories 
Theme 5 Categories  Subcategories  
TB patients’ satisfaction with 
DOTS strategy 
Presence of 
satisfaction survey 
for TB patient  
 Availability of survey 
 Exit interview with TB patients  
 Indicator  
 Tool  
 Homogeneity  
 Good reception  
 Good communication   
Integrated 
satisfaction survey 
 Writing on recording book 
 Identifying tag 
 Every year  
 Suggestion box utilisation  
 Satisfaction not objectively 
measured 
 
 
5.3.3.5.1 Presence of satisfaction survey for TB patient 
 
The FGDs participants explained that there is no regular and standardise satisfaction 
survey for TB patients as a strategy to understand the level of TB patients’ satisfaction 
particularly with DOTS strategy. The participants described unavailability of TB patients’ 
satisfaction survey as follows: 
 
“There is no satisfaction evaluation scheme for the TB treatment individually.” 
 
However, at some facilities, the participants declared that there are fragmented ways of 
understanding the satisfaction level of TB patients. Opinion recording books and boxes 
presented in the health institutions and random interview of TB patients during 
supportive supervision schedules help to understand the level of TB patients’ 
satisfaction. The practice so far tried to understand the level of TB patients’ satisfaction 
at some facilities was explained in the discussion as:  
  
“We conduct supervision quarterly. We interview the patients in person on the 
treatment they have been given by the professionals in the TB room. We also 
have the public opinions gathering boxes on every department room. Those who 
can write drop their opinions there and other uses the chance during the 
interviews.” 
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However, the recording books and suggestion boxes were criticised for their lack of 
effectiveness to measure the level of satisfaction objectively since the two extremes; 
either so much dissatisfied or so exited patients write their feelings. The deficiency of 
the record book as a tool for satisfaction survey was augmented by FGD participant’s 
personal experiences as service user and it was explained as:  
 
“I remember once, I went to a clinic to have my eyes treated and I was very 
upset. I wrote away my temper but forgot to drop it in the box. These are the 
kinds of opinions we are talking about and they may not be bias free enough to 
evaluate to gauge client satisfaction.” 
 
The FGD participants agree that there is TB patients satisfaction measuring mechanism 
that apply for TB patients in Addis Ababa. In addition, the discussants suggested that 
the indicator of TB patient satisfaction survey to be scrutinised. A way of understanding 
their satisfaction level and the time interval to be yearly, biannually or quarterly at which 
the level of satisfaction should be measured.  
 
5.3.4 Themes identified in telephonic interview  
 
In the telephonic interview three themes were revealed. The themes are reason to 
default from TB treatment, DOTS centeredness with defaulted TB patients and 
defaulted TB patients satisfaction with the DOTS. 
 
5.3.4.1 Theme 1: Causes to default from TB treatment  
 
In theme 1 three categories were identified from the interview with defaulted TB 
patients. The categories were DOTS delivery system, incompatibility of diagnosis and 
patient induced as described in Table 5.27. 
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Table 5.27: Theme 1: Causes to default from TB treatment − categories and sub-
categories  
Theme 1 Categories  Subcategories  
Causes to default from anti- 
treatment  
DOTS delivery system    Incapability to daily 
follow-up 
 Less flexibility to write 
referral  
 Expose for different costs 
 Work-related  
 Change of place 
Incompatible of diagnosis   Diagnosed as have TB at 
government  
 Not TB at private health 
institution   
Patient belief    Feeling good  
 Discouraged to be cured 
 Exhaust to take for long 
 Alternative treatment 
inquiry  
 
 
5.3.4.1.1 DOTS delivery system 
 
From the interview, one of the reasons explained to default the TB treatment was the 
DOTS delivery system. As it has been stated in the FGDs and TB treatment guideline 
the patient should follow the treatment at least daily for the first 56 days. However, the 
daily follow-up exposed the TB patients for different direct and indirect costs as the 
respondents mentioned. The respondents explained the delivery system as the cause to 
default as follow:  
 
“I was supposed to go to health facility daily and wait at least for 30 minutes there 
except Saturday and Sunday and also I had to buy breakfast, water and pay for 
transport.”  
 
“I am factory employee; I should be available at 6 am since the service reach at 
this time, otherwise I had to pay 12 Ethiopian birr per trip to reach to the factory 
where I work even I may reach at 10 am or so. However, they obliged me to go 
health facility daily to take the drug.” 
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“I and my wife were supposed to take him to health centre daily to follow-up. I got 
few days’ work permission and took him but after that my wife alone could not 
take him since he was bad-tempered. Now sadly, he went crazy and on the 
road.” 
  
In addition, the DOTS delivery system is resistance to change and due to little attention 
to give referral paper to another place. Hence this was also mentioned as the cause to 
default in relation to DOTS delivery system. The respondents explained the resistance 
as: 
 
“I told him that my husband should have to will move to another place for work 
with me and to write me a referral paper. He asked me where? ... he responded 
that I need to give him exact name of the facility where I would follow but I knew 
only the area but not specific health centre’s name.” 
 
5.3.4.1.2 Incompatibility of diagnosis 
 
The existence of incompatible diagnosis result between health facilities was declared by 
the respondents. The respondents reported incompatible diagnosis results were the 
cause to default from treatment follow-up. Two respondents’ explained the 
incompatibility of the diagnosis as follows: 
 
“I went to health centre where you find my address and had been told that as I 
had Extra Pulmonary TB and stared TB treatment. After a week I went to private 
clinic and have been informed as I had no TB.” 
 
“I diagnosed as I had TB at health centre and started TB treatment after three 
days I went to another health institution and I have been informed to stop TB 
treatment, after being informed that I had no TB.” 
 
Existence of incompatibility of diagnosis was also mentioned in FGD by the discussant 
as follows:  
 
“Patients sometimes go to private clinics amidst their treatment and 
claim that they have been told their case is not TB related.” 
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5.3.4.1.3 Patient-related  
 
The sub-categories, patient-related, extracted from interview was among mentioned 
reason to default from the treatment. TB patients feeling of better health condition, 
discouragement and exhaustion to take and follow the whole course of the treatment 
duration, and alternative treatment inquiries were extracted reasons from patient related 
aspects. The respondent who felt better health condition explained as: 
  
“Now I feel good, no symptoms at all hence I did not want to take more.”  
 
Other respondents who disheartened and exhausted described as:  
 
“People talk once you have TB, it is associated with incurable disease so that is 
why I ...” 
 
“I took it consistently for four and half months; then fade up even to see the 
health centre.”  
 
“I took the treatment for a month and then went to holy water.”  
 
 
5.3.4.2 Theme 2 defaulted TB patients view of DOTS patient centeredness  
 
In this theme three categories were identified. The categories are DOTS delivery 
system, DOTS service integration and HCP perspectives.   
 
5.3.4.2.1 DOTS delivery system  
 
In DOTS service delivery system, information provision, respect and value provision 
to TB patients were reported as less emphasised components by the telephone  
interview respondents.  
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Table 5.28: Theme 2: DOTS strategy patient centeredness with the view of 
defaulted TB patients− categories and sub-categories  
Theme 2 Categories Sub-categories 
DOTS strategy on 
patient 
centeredness 
DOTS delivery 
system 
 Information 
 Respect patient 
 Value patient 
DOTS integration   Transport  
 Nutrition  
 Mental health   
HCP   Support to self-care management  
 Support to cope with mood 
change 
 Support to keep relationship 
 Psychological support  
 Communication  
 Commitment 
 Politeness   
 
 
 Information provision 
 
Information provided about TB during TB care delivery was considered very limited 
and lacked continuity and persistency. The information provision about TB at TB 
care delivery point was expressed by the respondents as:  
 
“I have been informed TB ... at the first day of the treatment, and then after, no 
one talked about it and you just swallow the drug and go.” 
 
“When I was diagnosed of TB, a lot of information about TB was given to me but I 
forget them since I was in stress thinking about the TB.”  
 
 Respect and value 
 
The defaulted TB patients report that respect and value are not provided during 
diagnosis and treatment process of DOTS service. However, they explained that they 
deserve respect and value. The value and the respect might start from simple 
recognition of the patient as a person who gives much attention about his health and 
family, and of course as have many responsibilities in other sector. The concern of the 
respect and values were reflected by the respondents as:  
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“Do not remind me! One day I had to go as early as possible and told him about 
…….. but he was treating me as I cannot tell you how.”  
Another respondent explained as: 
 
“It is hazy to speak about respect and value; sometimes give you much respect 
another day almost may throw your drug through a window.” 
 
5.3.4.2.2 DOTS delivery integration  
 
As the defaulted TB patients explained the only integrated service that is made with TB 
treatment was HIV diagnosis services. Most of the respondents mentioned that as they 
received HIV testing whereas the respondents strongly suggest that availing other 
services such as nutrition support, transport and mental health service to be integrated. 
The defaulted TB patients explained DOTS service integration and require of integration 
as follows:  
 
“My blood tested for HIV infection, while I was following the TB treatment.” 
 
“May be I would not default if I had transport availability to go daily.” 
 
“I got HIV testing service but I would love there was nutrition support for us.” 
 
5.3.4.2.3 Health care providers (HCPs)  
 
Some of the defaulted TB patients’ explained  that the HCPs were not devoted to 
provide TB care  service while  some of the respondents explained as they were so 
keen. The disagreement views of defaulted TB patients are explained as:  
 
“The HCP started writing while I was talking with, even was not willing to see my 
face and respond.” 
 
Whereas others defaulted TB patient explained that the HCPs’ compassionated 
care and support as:    
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 “He, the HCP, was so kind while I was tired; even he was the one who holds me 
up to get into the car at the first week of the treatment.” 
 
 
The defaulted TB patients explained that HCPs commitment and psychological support 
to TB patients was not consistent among themselves and across health institution. The 
respondents put the level of commitment at two extremes. The extremes are range 
from holding up the weak patient to getting into the car to turning the face while the TB 
patients request or raise an issue. These extremes were explained by a respondent as:  
 
“I remember that, the HCP gave me my drugs in the car, almost 50 metres far 
from TB room.” 
 
Nonetheless, another respondent explained other extremes of HCPs, having less 
commitment as:  
 
“The HCP was waiting for me until I really combat on to TB room window let 
alone provision of the drug to a place where I was.”  
 
Majority of the FGD participants’ agreed with the side of showing less commitment of 
HCPs to work with TB patients as it was explained in challenges related with DOTS in 
theme 2. 
 
5.3.4.3 Theme 3 Defaulted TB patients’ satisfaction with DOTS strategy 
 
In this theme four categories were revealed in telephonic interview. The categories are 
HCPs, DOTS delivery process, HCO premises and aligned services.  
 
 
 
 
 
 
 
 
  
138 
 
 
Table 5.29: Theme 3: Defaulted TB patients’ satisfaction with DOTS strategy − 
categories and sub-categories 
 
Theme 3 Categories  Subcategories  
TB patients’ satisfaction with 
DOTS strategy 
HCPs   Availability 
 Communication 
 Reception 
 Respect  
 Information provision 
DOTS delivery 
process  
 Registration 
 Treatment 
 Referral  
 Diagnosis compatibility  
 Treatment supporter  
Premises    Convenience the compound 
 Availability of chairs  
 Access of toilet  
Aligned services   Nutrition  
 Ambulance  
 
5.3.4.3.1 Health care providers (HCPs) 
 
As it was explained in theme one by the FGD participants, defaulted TB patients 
assured HCPs who were engaged on DOTS service delivery were available at their 
working hours though they were not so punctual. With this perspective majority of the 
respondents reported as they had good feeling. Few of telephone respondents had 
reservation to fully agree with HCPs availability. One of the respondents explains as 
follows: 
 
“While I was following my treatment HCPs were available usually after 8 am 
though they appointed us at 7:30 am.” 
 
However, when the patients arrived earlier than HCPs at TB treatment room they tend 
to contempt the TB patients.  
 
“If I reached earlier than the HCPs I usually sit aside of the TB room to prevent 
myself from being visible to HCPs when they come in.” 
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The HCPs reception on the first day of the treatment mentioned as it is with due 
respect, in polite way and provide required information. Whereas the days goes on 
they may throw the drugs through window. One of the respondents explained this 
mood swing on respect and information provision as follows: 
 
“I could not tell you how he received me, respect, advise... when I was diagnosed 
as I had TB but it lasts on the same day.” 
 
5.3.4.3.2 DOTS delivery process  
 
Most of the telephone respondents report that the TB diagnosis and examination was 
started on the registration date without much time desecrated. However, the 
respondents’ cause of illness was not detected in the same day; at least lasted for 
three days. The registration and process starting day was explained as: 
 
“As I went they registered me and I was seen by doctors. With this perspective I 
want to say thank you.” 
 
As it was reported by defaulted TB patients, the time elapsed to have apparent TB 
diagnosis was displeasing. One of the respondents explained the dissatisfaction due to 
elapsed time as follows: 
 
“I started my examination on August 5 2015; I did not receive the definite 
diagnosis until August 12, 2015.” 
 
Another discontented issue described by the respondents in the DOTS service delivery 
process was an obligation to treatment supporter. This issue was reported by the 
respondent as:  
 
“After you are diagnosed with TB, you should bring somebody on the behalf of 
you. Should not I be responsible for me?” 
 
Some of the “registered as defaulted TB patients” received controversial diagnosis 
result from different facilities; TB in one facility and other disease at another facility. 
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The controversy result exposed the patients unwanted cost. One of the respondents 
explained the controversy results and its financial consequences as follows: 
 
“In one health facility I was told that I had TB but after few days, in another facility 
they rejected the findings as I had TB. I did not go to third facility due to money 
shortage.” 
 
5.3.4.3.2 Premise of the health facilities 
 
The premises of the HCOs were not so much appreciated by telephone respondents. 
The respondents explained that though there were improvements in availing chair 
around TB room, no water to take in the drugs and clean toilet which enables you to 
use cosily near to treatment room. The respondent explained premise inconvenience. 
 
“I had to go to health facility after I emptied my colon at home since there were no 
convenient toilets.” 
 
5.3.4.3.3 Aligned services 
 
As reported by the respondents, at health facilities where the defaulters got TB- 
treatment service there was minimal nutrition support and absence of transport for TB 
patients even for seriously ill TB patients. The respondent explained the less 
availability of aligned services as:  
 
“I saw the ambulance which stood in the compound and I requested the HCP to tell 
the driver but the HCP replied as this is only for bleeding mother.” 
  
“I had seen that some of TB patients were receiving nutrition and asked to give me 
too but the response was you are not MDR-TB patient.” 
 
5.4 CONCLUSION  
 
This chapter presented the response of three study groups in the form of numbers, 
graphs, tables and texts to achieve the stated objectives of the study in two sections. 
Section 1 achieved the level of TB patient centeredness’ and satisfaction of TB patients’ 
with DOTS strategy and associated factors quantitatively.  
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Section two presented the explored perceptions of TB experts about DOTS strategy’s 
patient centeredness and satisfaction level of TB patients. Furthermore, section two 
presented the defaulted TB patients’ perception about DOTS strategy patient 
centeredness, satisfaction level and the driving factors to default from the TB treatment 
follow-up in qualitative analysis approaches.  
 
The next chapter, Chapter 6 will discuss the pertinent discussion, recommendation and 
conclusion of the study. 
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CHAPTER 6 
 
DISCUSSION, CONCLUSION AND RECOMMENDATIONS 
 
6.1 INTRODUCTION 
 
The previous Chapter presented the quantitative and qualitative findings of the study and 
explained how the innings are explored. This chapter explores and discusses the core 
findings of the study and presents conclusions. The later part includes the contribution, 
limitations and recommendations of the study.  
 
This study arose from the critical concern that despite the wide use and implementation 
of DOTS strategy across the world, there have been critics who argue that the strategy 
offered limited preferences to TB patients. Cognisant of this criticism, the researcher has 
conducted this study in Addis Ababa, Ethiopia and achieved the following objectives:  
 
 Determined the level of patient centeredness’ of DOTS strategy.  
 Determined the level of satisfaction of TB patients with DOTS.  
 Described factors related to TB patient centeredness and satisfaction with 
DOTS.   
 Explored TB experts’ and defaulted TB patients’ perception about DOTS 
strategy patient centeredness and satisfaction level.   
 Explored defaulted TB patients’ driving factors to default from TB treatment.  
 Proposed a descriptive model that will support DOTS strategy with regard to 
patient centeredness and satisfaction. 
 
6.2 RESEARCH APPROACH, DESIGN AND METHOD 
 
The study explored a complex phenomenon of DOTS strategy from TB patients, 
defaulted TB patients and TB experts in the region. The study used mixed method 
sequential explanatory design in two phases. 
 
Phase I followed the quantitative approach to collect primary data from TB patients. Data 
were collected using a pre-tested interviewer-administered questionnaire organised in a 
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five-point Likert scale response. The primary aim of the quantitative approach was to 
achieve the first three objectives of the study. The data were analysed using SPSS 
version 21 software.  
 
Phase II followed a qualitative approach using FGDs with TB expert and telephonic 
interviews with defaulted TB patients primarily to achieve objective four and five, 
respectively. While the sixth objective, the model proposed by using synthesis of 
qualitative and quantitative data findings and then substantiated by literature review 
 
In both quantitative and qualitative data collection procedures, important validity and 
reliability measures were taken to insure data quality and consistency. The study strictly 
followed ethical considerations to safeguard participants’ rights in accordance with 
standard ethical principles of human subjects’ research that are stated in Chapter 4 of 
the study.  
 
 
6.3 DISCUSSION OF THE RESEARCH FINDINGS  
 
Although the main interest of this study was to evaluate DOTS to the perspective of 
patient centeredness and satisfaction of TB patients, it is useful to understand the 
respondents’ general characteristics.  
 
The response rate for questionnaires was 99.3%. Among all the respondents, the male 
respondents constituted 56% (336), significantly higher than the female study 
participants (p=0.009). Similarly, the gender disproportion was reported in other studies 
and report conducted in Ethiopia (Nezenega, Gacho & Tafere 2013:3; EHNRI 2011:45; 
WHO 2014a:58). The disproportionate of gender related to different TB prevalence 
proportion between genders, high proportion of TB occur with men. The epidemiologic 
difference is related to differences in social roles, risk behaviours and activities which are 
conducive to transmission of TB, such as more social contacts and engagement in 
professions associated with a higher risk for TB for men (Nhamoyebonde & Leslie 
2014:102-103). 
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Similar with other studies conducted on TB in Ethiopia (Getahun et al 2013:524; 
Nezenega, Gacho & Tafere 2013:3) the majority, 494 (82%) of the respondents of this 
study were in productive age groups (18-44 years).   
 
The MDR-TB proportion among all TB patients reported in this study is 32 (5.3%). Of 
which 8 (1.6%) were among new TB patients, and this is similar to WHO’s (2014a:73) 
report and 24 (3.7%) were among retreatment TB patients. However, the proportion of 
MDR-TB patients in retreatment category was by far lower than WHO (2014a:73) 
estimated report for Ethiopia and globally, 12%. 
 
6.3.1 DOTS strategy implementation 
 
Otu’s (2013:229) review reflected that DOTS strategy is remaining as a cornerstone of 
TB control in developing countries and globally. Similarly, the DOTS strategy is a main 
approach to control TB at public and private health facilities in Addis Ababa, Ethiopia 
(EFMOH 2013:36). Both government and non-government health facilities provide 
standardised TB treatment service by trained HCPs on the guidelines for clinical and 
programmatic management of TB, TB/HIV and Leprosy in Ethiopia. Gebrekidan et al 
(2014:5) asserted that non-governmental health facilities usage of the stated guideline. 
Abiding and implementing this guideline standardised TB treatment provision reduced 
dissimilarity of treatment provision across the region and enables to monitor individual 
TB patients. Similarly, though with provision of flexibility, most TB treatment guideline 
supports the use of direct observation to monitor TB patient’s treatment adherence 
(Horsburgh, Barry & Lange 2015:2157).  
 
The TB patients are observed daily for the first two months of treatments and then after 
will collect their drugs weekly. However, different times studies report that the number of 
travel frequencies to be observed and collect the drugs exposes the TB patients for 
different costs and exhaustion in Ethiopia and elsewhere in Africa (Vassall, Seme 
Compernolle & Meheu 2010:608; Tadesse Demissie Berhane Kebede & Abebe 2013:6; 
Fiseha & Demissie 2015:6). 
 
Even if DOTS is criticised (Otu 2013:230), different scholars described that 
implementation of DOTS strategy has brought better treatment outcome and 
contributed for reduction of TB prevalence (Marais 2013:89; Moonan et al 2011:1; Yen 
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et al 2012:178-180; Chien, Lai, Tan, Chien, Yu & Hsueh 2013:1916; Hamusse, 
Demissie & Lindtjorn 2014b:1). Similarly, the study demonstrates that DOTS strategy 
improved treatment outcome of TB patients and contributed to reduction of TB 
prevalence compared to before it was not in place. However, Horsburgh et al 
(2015:2152) in their review raised the criticism that though direct observation is 
important to TB treatment, it is deficient to solve cause of non-adherent with TB 
treatments entirely and related with number of limitations. 
 
6.3.2 Challenges related with DOTS 
 
As evidenced by Gebrekidan et al (2014:7) and Gebreegziabher, Yimer and Bjune 
(2016:3), the study pointed out a number of challenges with DOTS strategy. Among the 
challenges inconsistent supply of laboratory reagents and drugs are major, as reported 
elsewhere in Ethiopia. In cognisant of this challenge particularly related to TB drugs 
logistics problem kit system has been started and reached to 70% of national 
geographic coverage (EFMOH 2015a:63). However, the kits also criticised for having 
short expiry date. 
 
The daily observation of TB patients while they take-in their drugs is indicated as the 
DOTS delivery system related challenge since it demands effort from TB patients. The 
efforts are the ability of TB patients to pay daily for transportation fee, undesired 
implications on their work and social lives disturbance (Fiseha & Demissie 2015:1; 
Gabriel & Mercado 2011:2178). Consequently, this may lead to non-adherent to full 
course of the treatment (Tanimura et al 2014:1770). This has been reported as a cause 
to default from the treatment elsewhere in Ethiopia (Tesfahuneygn, Medihin & Legesse 
2015:8).  
 
Alike Wynne, Richter, Banura and Kipp (2014:8) inflexibility of TB patients referral 
system, once after they started the follow-up at a given health facility, is another 
reported weakness related to TB care delivery system. 
 
As Fiseha and Demissie (2015:9) and Behzadifar, Mirzaei, Behzadifar, Keshavarzi, 
Behzadifar and Saran (2015:3) indicate, incentive inquiry and having less interest to 
work with TB particularly with MDR-TB of HCPs and trained staff turnover are 
challenges related to human resource of TB control programme.  
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The study explains that the need of treatment supporter is mandatory to start TB 
treatment. The treatment supporter could be anybody who is living in close relationship 
with the TB patients alike Soomro et al (2012:16) stated. However, the study highlight 
that bringing the right treatment supporter is difficult to some of TB patients particularly 
for TB patients who are living alone and came from outskirt of the city.  
 
A review made by Otu (2013:229) indicates that different types of treatment supporter 
or observers do not have significant difference on treatment outcome of TB patients. In 
addition, a study conducted in Botswana affirmed that TB patients who got their 
treatment by direct observation did not show better treatment outcome than those who 
took their treatment at the community health care centre (Mugisha et al 2013:93). 
 
The study identified weak PPP in the TB control activities particularly participation of 
private for profit health facilities. Despite provision training for free for HCPs who work 
in private health sector, drugs and laboratory reagents; less than 10% of non-
government health facilities is providing TB treatment. Limited number of private health 
facilities involvement in TB control activities are stated in Ethiopia (EFMOH 2015:65). 
 
6.3.3 Patient-centeredness of DOTS  
 
Although components of PCC were not boldly put in DOTS, the concept of PCC as a 
component was started at the introduction of DOTS (Grant 2013:3). In stop TB strategy 
and end TB strategy, the PCC is a required component and a core pillar for TB control, 
respectively (WHO 2013c:10).  
 
Nevertheless, the PCC focuses on considering patient’s point of view, situations in the 
PCC decision-making process goes far beyond simply setting target with the patient 
(Locatelli et al 2015:24). Empowering people with TB and communities, social support 
programmes, communication and partnership between health sectors are components 
of the stop TB strategy that reflects patient centeredness of TB care (WHO 2012:4). 
 
The study used overarched framework to determine patient centeredness of DOTS as 
pioneer work to the researcher’s knowledge level. As a result, the study shows that, 
although feeling of the respondents was not similar across dimensions, overall 
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perceived PCC was 60% among TB patients who were on follow-up of their treatment. 
However, none of the defaulted TB patients was in a position to feel as they received 
the PC-TB care. TB experts also agreed that the current TB treatment provision is not 
entirely PCC. 
 
Among PCC dimensions, the lowest mean score was reported on HCO’s particularly 
with regard to establishing and strengthening multidisciplinary care teams to TB care. 
However, evidences (Pulvirenti, McMillan & Lawn 2014:306; Carver & Jessie 2011:4) 
stated that coordinated health care services are starting position for PCC. 
Subsequently, coordinated health care service help to avail the health care service in 
reduced cost. Allied health care services such availing transport, food, spiritual and 
social support to TB patients are limited, however, the availability of these services is 
imperative for TB patients not only to avail PCC but also to provide health care services 
with affordable cost (Berhe et al 2012:7). 
 
The perceived PCC received is significantly different between gender; males are less 
likely to feel as they received PCC (AOR= 0.45, 95%CI 0.3, 0.7) while level of 
education did not show significant difference with perceived PCC. The level of 
perceived PC-TB care received did not show any significant difference among the 
patients’ type of TB, and TB patients expectation. 
 
PCC determined by quality of interaction between HCPs and patient (Epstein, Fiscella, 
Lesser & Stange 2010:1490). Pre-service and in-service training that focus on good 
communication skill provision for the HCPs can improve the ability to interact with TB 
patients (Otero et al 2015:30). In the study perceived to have good communication with 
HCPs and experience on using health care services show significant association with 
perceive alike Jayadevappa & Chhatre (2011:21) stated in their review.  
 
Communication and prioritising patients’ concerns are stated factors to increase patient 
centeredness of a given health care (Ahmad et al 2011:185; Constand et al 2014:6). 
The highest mean score reported by the TB patients with HCPs’ perspective was 
prioritising patients concern and communication of HCPs with patients. 
 
Consistently numerous evidence (Greene et al 2012:49; Sevin et al 2009:25; WHO; 
2007b:14; Scholl et al 2014:6) stated that keeping preference of patients is a key 
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component of PCC. However, although the guideline provides a choice to TB patients 
where to follow the treatment either at home, workplace or health institution (EFMOH 
2013:36), TB patients were allowed only to follow nearby health facilities against 
preference request and dynamicity of TB patients preferences. 
 
One of the components of DOTS is the requirement of treatment supporter who 
watches and witnesses whether the patient takes in the drug or not and communicate 
with HCPs to improve treatment adherence (EFMOH 2013:36). However, the study 
identified that none of treatment supporters, either family or closes friends, had a 
regular communication with HCPs about the TB patients accounted for. Despite the 
fact, all TB patients are obliged to take an individual, who is in charge of them, to health 
institution to start a treatment.  
 
The obligation and detention to take the treatment at home or in the community may 
lead to the question of “human rights” issue and may reflect a violation of right to health 
as stated in Article 12.1 of the International Covenants on economic, social and cultural 
rights. The extended right not only to timely and appropriate health care but also to the 
underlying determinants of health International (CESCR General Comment No. 14: The 
Right to the Highest Attainable Standard of Health Art. 12). However, through providing 
quality and accessible community-based DOTS, or the use of mobile-health 
technologies the role of treatment supporter might be replaced and defaulters and non-
adherent TB patients can be reduced (Slagle, Youssef, Calonge & Amor 2014:8). 
 
Similarly with report in Uganda (Kisambu, Nuwaha & Sekandi 2014:799) DOTS delivery 
system in this study is tied with inflexibility to get referral paper once after treatment 
started. However, taking into account the patients' preferences during referral is 
essential to address access barriers to treatment adherence and improved treatment 
outcome. In addition, the referral system needs to supplement with feedback from 
recipient facility to referral facility which enables to assess and trace barriers related to 
referral system (Islam Hirayama, Islam, Ishikawa & Afsana 2015:239). 
 
The community and individual patient’s level of knowledge about TB is a requirement to 
reinforce the PCC. Limited level of knowledge of individual TB patients and community 
is one of the limiting factors to enhance PCC (Tolossa, Medihin & Legesse 2014:10). 
Mosadeghrad (2014:77) explained that the requirement of patients' knowledge helps 
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the patients to involve in the care and to follow consistently with require instruction of 
the care.  
 
Counselling while taking TB care, programmed and consistent targeted education 
about TB prevention and control at the community and health facility is of paramount 
importance to improve the knowledge limitation of the community and individual TB 
patients (Tolossa, et al 2014:1; Addis et al 2013:170).  
 
Empowering the community and TB patients is a key strategy that are required to settle 
the PCC across the health care delivery as it has been stated in this study and other 
study empowerment can be achieved through community education, counselling of the 
patients and mobilisation (Pulvirenti, McMillan & Lawn 2014:8).  
 
The study shows that weak provision of information particularly after the TB treatment 
started and the value for the TB patients are intrinsic with DOTS. Consequently, this 
may hinder to follow the full course of treatment, patient involvement and informed 
decision. However, these are factors that reinforce the patient centeredness of the TB 
care (Scholl et al 2014:8). 
 
The study indicates that a way of improving patient centeredness through health 
education at the community to build the knowledge of the community is one approach. 
As a result a knowledgeable community could be the foundation to reinforce the patient 
centeredness of TB care (Tolossa et al 2014:10). Similar to another study (Mohr, 
Hughes, Snyman, Beko, Harmans, Caldwell, Duvivier, Wilkinson & Cox 2015:633), the 
study indicates that in addition to provision of clinical TB care service, the HCPs’ 
enhanced engagement onto counselling and health education while they come to drug 
refill are paramount importance to reinforce the PCC of TB care. 
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6.3.4 TB patients’ satisfaction 
 
Satisfaction measurement is a core component to design and evaluate modern health 
care services and delivery system (Dansereau et al 2015:9). It is also one of the 
measurements that evaluate quality health care service that plays a positive role in 
evaluation of health care service especially their perceptions concerning care they 
received (Onyeonoro et al 2015:26). In addition, patient satisfaction measurement 
regarding the process of care as seen through the patients’ eyes that cannot be 
replaced by other performance indicators (Schoenfelder 2012:2). Mpinga and 
Chastonay (2011:149) concluded that satisfaction measurement, beyond the quality 
indicator, is a neutral indicator of the right to health that can be easily monitored and 
capable of integrating individuals and populations in to the decision-making process in 
the health sector.  
 
Although the Ethiopian Federal Ministry of Health has given due attention and priority to 
the quality of health care service since the first health sector development plan in 1997, 
a health care quality strategy is developed recently. The Ethiopia health care quality 
strategy has included patient satisfaction as one of success indicator for the provision of 
quality service for the patients at HCO (EFMOH 2015a:23). Even during Ethiopian 
hospital performance recognition ceremony in Addis Ababa, Ethiopia, in 2016, the 
Ethiopian Federal Ministry of Health minster stressed that “the next selection of hospital 
awardees will be mainly based on survey of client satisfaction. Client satisfaction will be 
the main indicator.” In addition Ethiopia’s 2015-2020 health sector plans are focused on 
quality health care delivery and equity in health (EFMOH 2015b:71). 
 
Regular measuring and knowing satisfaction level of the patients emphasized as 
indicator in quality services provision (Onyeonoro et al 2015:29; EFMOH 2015b:17). 
However, the current study indicates that the DOTS implementation in Ethiopia is not 
tied with regular mechanism which enables to capture level of satisfaction of TB patients 
with DOTS; except the presence of few fragmented capturing tools such as opinion 
record book and suggestion box in the facilities. The use of opinion record books and 
suggestion boxes are criticized to capture the level of satisfaction of TB patients 
because they are usually used by few highly excited TB patients. Therefore, TB experts 
that participated in this study could not affirm whether the dissatisfaction of TB patients 
with DOTS existed. The study highlights the importance of the presence of regular and 
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consistent measuring mechanism to understand satisfaction level of TB patients across 
the facilities.  
 
The study reveals different level of satisfaction with DOTS among different study’s 
participant groups. Similar to studies conducted in SNNPR, Ethiopia (Nezenega, Gacho 
& Tafere 2013:1), Uttar Pradesh, in India (Gupta 2015:36), KwaZulu-Natal, in South 
Africa (Chimbindi, Barnighausen & Newell 2014:3) and in Rio de Janeiro, Brazil 
(Portela et al 2014:505) majority (67%) of TB patients that were on follow-up of their TB 
treatment were satisfied with DOTS. However, in contrary to TB patients who were on 
follow-up of TB treatment, the defaulted TB patients were totally dissatisfied with 
DOTS. Even similar with another study conducted in Ethiopia the defaulted TB patients 
pointed out that dissatisfaction was one of the reasons to default from the treatment 
(Nezenega, Gacho & Tafere 2013:2). 
 
In a study conducted in Pakistan (Ahmad et al 2011:40) age, gender and income of the 
patients shows that significant association with satisfaction level with the care they 
received, similarly the study shows that a significant association of gender and income 
with satisfaction level of Tb patients. Similar with another study female TB patients 
were 2.2 times more likely to be satisfied with the service they received than male. In 
contrary, another study shows that although female has more tendencies to be satisfied 
than male, gender was not significantly associated with satisfaction (Young, Meterko, & 
Desai 2000:325). In addition, alike with Ahmad et al (2011:40) reported, the study 
shows that residence and presence of TB symptoms were associated factors with 
feeling of satisfaction with DOTS strategy. 
 
Dissimilar to the studies (Rahmqvist & Bara 2013:89; Onyeonoro et al 2015:30), in this 
study educational level was not associated factor with satisfaction level. However, 
highly educated patients are less likely to be satisfied than who have less educational 
level due to expectation difference, patients with high expectations tend to be less 
satisfied with health care service.  
 
Similar with Ahmad et al (2011:184), attributes of patient satisfaction from the side of 
HCPs are attitude, communication skills, technical skills and responsiveness of HCPs 
to patient needs. Similarly, the study shows that HCPs related attribute to level of 
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satisfactions are on time availability, good communication, good patients reception and 
provision of information and respect to the patients. 
 
Similar with the study conducted in Khyber Pakhtunkhwa (Ahmed et al 2011:8), the 
study shows that attributes of patient satisfaction to the side of HCPs are 
communication and technical skills and responsiveness of HCPs to patient needs. In 
addition, similar with the study conducted Ethiopia (Nezenega, Gacho & Tafere 2013:7), 
the study shows that satisfaction level of TB patients are influenced by on time 
availability, good reception, provision of information and respect to the patients and 
waiting time.  
 
Alike Pefoyo and Wodchis (2013:9) suggest that the study indicates that the patients’ 
satisfaction is related with access and convenience of the HCOs premises such as 
availability of comfortable chair to get health education and clean toilets. Similar with the 
other studies (Nezenega, Gacho & Tafere 2013:6; Sagbakken, Frich, Bjune 2008:7), the 
study shows that unavailability of consistent nutrition support and absence of transport 
for TB patients especially for seriously ill TB patients  were the cause for dissatisfaction; 
even they are highlighted as causes to default from treatment.  
 
The current study reports that TB patient satisfaction level and perceived PCC received 
have positive correlation. This correlation may indicate that the presence of PCC have 
important role to enhance patient satisfaction and can play as evaluation scheme of 
health programmes, and reduce symptom severity, use of health care resources and 
health care costs (Jayadevappa & Chhatre 2011:16).  
 
6.3.5 Reason to default from TB treatment 
 
Defaulting from TB treatment may increase the risk of drug resistance, relapse and 
death and may also prolong infectiousness (Da Silva Garrido et al 2012:6). Studies 
show that the default rate in Ethiopia ranges from 1.5% to 5.1% (Getahun et al 2013: 
527; Tesfahuneygn, Medihin and Legesse 2015:9; Addis et al 2013:171). 
 
Similar with the study conducted in Nairobi, Kenya (Muture, Keraka, Kimuu, Kabiru, 
Ombeka & Oguya 201:1) and Uganda (Buregyeya et al 2014:7) the present study 
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shows that the TB patients’ reasons to default are related with DOTS delivery system, 
incompatibility of diagnosis at different health institutions and patient related.  
 
As other studies have stated the DOTS delivery system exposes TB patients to direct 
and indirect cost associated with the daily follow-up at health facilities. The direct costs 
are incurred for transport, food and water while on the road for follow-up while the 
indirect cost associated with work absenteeism (Tadesse et al 2013:6; Tesfahuneygn, 
Medihin & Legesse 2015:1). 
 
Similar with the study findings extracted from mixed study conducted in Karachi, 
Pakistan (Chida, Ansari, Hussain, Jaswal, Symes, Khan & Mohammed 2015:7) and in 
South Africa (Finlay, Lancaster, Holtz, Weyer, Miranda & Van der Walt 2012:5) cause 
to default with the patient perspectives are feeling good health after taking a treatment 
for a while, discouragement and exhaustion to take and follow the whole course of the 
treatment duration, and alternative treatment inquiries. However, strategies such as 
phone call reminder would be possible to reduce defaulters and minimise the effort 
required from TB patients instead of daily come and forth to the health facilities 
(Chaudhry, Al-Tawfiq, Ba-Essa & Robert 2015:2).  
 
Despite the use of the standard TB treatment guideline across the nation (Gebrekidan 
et al 2014:6), incompatibility of diagnosis among health institutions particularly 
government vs non-government health facilities is one of the causes to default. Even 
though evidences to substantiate the incompatibility of diagnosis among the facilities 
are limited, the TB experts share the presence of incompatibility of the diagnosis and 
explained the deference as “In the private health providers, we also have problems of 
administering the DOTS in the proper way.” 
 
As reported in Kampala, Uganda, (Elbireer, Guwatudde, Mudiope, Sekandi & Manabe 
2011:984), TB patients feeling of good health condition, discouragement and 
exhaustion to take and follow the whole course of the treatment duration are cause to 
default in the current study. 
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6.4 CONTRIBUTION OF THE STUDY 
 
The general purpose of this study was to evaluate the DOTS strategy with respect to 
patient centeredness and satisfaction, and propose a model that supports DOTS 
strategy with regard to patient centeredness. This section looks at the extent to which 
the objectives of the study have been met and the contribution of the study.  
 
Objective 1: Determine the level of patient centeredness’ of DOTS strategy   
 
This objective achieved through the overarched dimension of people centred framework 
and augmented by defaulted TB patients and TB experts. There were TB patients who 
denied getting PCC that focused on their need, value, preference, and choices while 
they receive TB care with DOTS strategy.  
 
Objective 2:  Determine the level of satisfaction of TB patients’ with DOTS 
strategy   
 
This objective achieved by the quantitative approach with two modalities:  Donabedian 
health care quality model and single overall satisfaction measuring item. Though 
majority of TB patients were satisfied with the TB care they received, there were TB 
patients who were following their TB treatments with dissatisfaction. Moreover, not all 
defaulted TB patients were satisfied. TB experts did not assert this since there was no 
survey that can indicate the level of TB patient’s satisfaction with DOTS.  
 
Objective 3: To describe factors related to TB patient centeredness and 
satisfaction with DOTS strategy   
 
From the quantitative analysis perceived good communication, gender and treatment 
supporter type were significantly associated with PCC of DOTS strategy. Moreover, 
seventeen measuring items were explored as principal determinant of the variability of 
PCC with DOTS strategy by principal component analysis. 
 
The qualitative data findings also pointed out that DOTS delivery system inflexibility, 
loose integration, HCPs’ characteristic, communication skill and motivation and the 
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community awareness levels were mentioned as factor to enhance PCC with DOTS 
strategy. 
 
Gender, place of residence, presence of TB symptoms, perceived good communication 
and the type of treatment supporters were significantly associated with level of 
satisfaction with DOTS strategy from logistic regression outcome.  
  
Objective 4: To explore TB experts’ perception about DOTS strategy patient 
centeredness and satisfaction level 
 
This objective achieved through FGDs of TB experts. DOTS strategy implemented in 
the region was not entirely patient-centred with view of TB experts. Availing aligned 
service such as transport and nutritional support, making the TB care delivery system 
flexible with preference of TB patients recommended to enhance DOTS patient 
centeredness.    
 
Even though, there was lack of TB patients’ satisfaction level measuring mechanism 
across the region, availing aligned service such as transport and nutritional support are 
required in convenient premise of HCOs.  Moreover, characteristics, timely availability, 
communication skill, good reception and respect of HCPs, and quality service have to 
be in place to increase TB patients’ satisfaction. 
 
Objective 5: To explore defaulted TB patients’ driving factors to default from TB 
treatment 
 
This objective was met by in-depth telephonic interview of defaulted TB patients and of 
course asserted by TB experts. The thematic analysis extracted that TB patients’ belief, 
DOTS delivery system related and incompatibility of diagnosis between different 
institutions were the reason to default.   
 
Objective 6: To propose a descriptive model that will support DOTS strategy with 
regard to patient centeredness and satisfaction. 
 
The researcher proposed a PC-TB care descriptive model that could support the TB-
care delivery system. The researcher proposes the model from synthesis of quantitative 
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and qualitative data findings and literatures. The proposed model contains overarched 
core players to provide TB patient-centred care. 
 
The model proposed by the researcher in support of the TB care delivery is a high point 
for Ethiopian Federal Ministry of Health and the AACAHB to improve patient 
centeredness and satisfaction level of TB patients in TB care delivery activities. Intern, 
it supports TB improvement of ant-TB treatment adherence and better TB treatment 
outcome. If the Ethiopian government is able to effect the proposed model, Ethiopia 
may then be an example and be in a good position to implement post 2015 WHO 
proposed end TB strategy to achieve stated goals toward TB. The TB care delivery 
system increase to satisfy TB patients, reduce defaulters and improve TB treatment 
outcome of TB patients. In addition, it may encourage first line HCPs to work with TB 
care delivery in HCOs and motivate the population to utilise TB care delivery.  
 
Moreover, the study contributed in showing the correlation of patient satisfaction level 
with PCC. Thus, the study’s overarched PCC framework can use to assess the level of 
DOTS patient centeredness in other settings. In turn, determining patient centeredness 
level of health care programme could pave a way to augument the patient satisfaction 
measurement as a quality indicator of other health programmes. 
 
 
6.5 LIMITATION OF THE STUDY  
 
Addis Ababa is among the eleven geographic regions in the Ethiopian government 
structure, and is an autonomous administrative region and the largest and capital city of 
Ethiopia and the population is totally considered as urban dwellers (CSA 2013). Hence, 
the majority of the respondents were urban dwellers; therefore, its generalisation might 
be compromised for rural settings. In addition, satisfaction ratings in this study do not 
replace TSRs or other treatment outcome indicators in DOTS strategy. The study 
followed “the model-building process” proposed by Bhattacherjee (2012:15) while the 
use of other model development strategies such as those proposed by Chinn and 
Kramer (2011) and Walker and Avant (2011) may alter the feature of the model’s 
constructs.  
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6.6 RECOMMENDATIONS  
 
As it is well known one of the research outcomes is to provide recommendations based 
on the findings. Therefore, in this section recommendations are provided. 
 
These are provided at different levels that the researcher thought the most relevant to 
use and implement the specific recommendations: health care policymaker and leaders 
of health programmes, researchers and HCPs. 
 
6.6.1 To health care providers  
 
 HCPs should improve their communication skills and interaction to convey the 
information to the TB patients and the patients’ family. A good relationship can 
be built by listening carefully to the patient.  
 It is important at the beginning of treatment to create a time to counsel patients 
regarding the disease, the prescribed treatment, and how the diagnosis and 
treatment may affect their lifestyle. 
 Ongoing patient education needs to be provided consistently.  
 The health care worker should discuss expectations of the treatment period, 
identify potential barriers to completing treatment, give a sense of emotional 
support, and identify if the patient needs to take his or her medicine in a “TB 
treatment facility” other than the management unit itself. 
 A plan of care need to be participatory and agreed between the HCP and the 
patient based on the patient’s individual needs and concerns. 
 Must provide a TB care service with using standard precautions for all TB 
patients without discrimination of either MDR-TB or susceptible TB patients.  
 The capacity of HCPs also needs to be enhanced with regards to provision of 
psychological support to TB patients that could support better treatment 
outcome.  
 
6.6.2 To health care policy makers and leaders of TB care services  
 
The policy makers at National, Regional, Zone and Woreda levels, health bureaus need 
to continue playing a significant role in ensuring and improving the TB patient 
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centeredness of TB care delivery at public and private health institutions. In addition, 
they have to gear or support the TB care delivery system policy to give attention for 
patients’ right to receive a service focused on their need, value, respect and 
preference. 
 
One of the ways to improve patient centeredness and satisfaction level of TB patients is 
endorsing fully or partially the proposed PC-TB care model of this study at policy level 
and then support the HCOs to implement progressively from few numbers of health 
organisations to all health organisations both at public and private health care 
organisations.  
 
Support the proposed PC-TB care model implementation through provision of 
guidance, training, supportive supervision and monitoring and evaluation of its 
effectiveness.  
 
Design an effective survey mechanism that can reflect the TB patients feeling whether 
they feel that they are receiving a care focused on their need and satisfaction with the 
TB care delivery system in the nation. So as to able amend when there is a gap in the 
TB care delivery system.  
 
The National, Regional, Zone and Woreda health bureaus need to facilitate the training 
that increases the HCPs communication skill, attitude and reinforce programmed 
community education that give emphasis on route of transmission prevention and 
treatment of TB and the importance of the communities role in improvement of health 
care services in the nation and regions as well. In addition, monitor the happening of 
ongoing patient education by HCPs at service delivery point during refill of the 
treatment is important.  
 
The health care organisation’s capacity has to be built and reinforced to provide 
integrated TB care service with nutritional support, HIV/AIDS services, psychological 
support, mental health care and social support for TB patients. Moreover, the HCOs’ 
premise comfortableness must be improved and should encourage to TB patients to sit 
and listen the health education. 
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It is essential not to overlook the importance of reliable laboratory reagents and drug 
supply lines and buffer stock management with contingency planning in case of failure 
of supply lines. 
 
The health care policy makers and leaders of TB care services also need to have 
regular supportive supervision schedule by skilled professionals in discussion with the 
supervisees. The supportive supervision should aim to hold-up observed improvements 
and identify gaps that may need intervention.     
 
6.6.3 To researchers 
 
As Cobelens et al (2012:14) pointed out there are numerous areas of TB that need 
research particularly programmatic activities of TB control. In addition, research and 
innovation is one of the pillars to end TB in combination with integrated PCC of TB 
(WHO 2015:7). Therefore, the following research agendas are forwarded:   
 
 Pilot the proposed PC-TB care model whether support TB control strategy in 
terms of the patient centeredness of TB care, TB treatment outcome, TB 
patients’ satisfaction and cost effectiveness in community trial design.  
 Assess the quality of TB care service provision across government and non-
government TB care service rendering health facilities.  
 
6.7 CONCLUSION  
 
This chapter discussed the study’s finding in comparison with other literatures, how far 
the study’s objectives have been met, contribution and limitation. Furthermore, the 
recommendations for health care policymaker, leaders of health programmes, 
researchers and HCPs are provided. 
 
The following final chapter, Chapter 7 will present the descriptive model development 
process and the proposed model that would enhance TB patient centeredness of the 
TB-care.  
 
 
  
160 
CHAPTER 7 
 
MODEL TO ENHANCE TB PATIENT CENTEREDNESS OF TB CARE 
 
7.1 INTRODUCTION  
 
One of the objectives of this study was to propose a model that supports the TB patient 
centeredness of the DOTS strategy. Therefore, this chapter describes the triangulated 
findings of the study that drive the development of the proposed model, background to 
the model which includes a rationale, aim, context and assumptions of the model. In 
addition, the Chapter contains a description of the proposed model, its weaknesses and 
strength. 
 
The methodology followed in the development of the model was “the model-building 
process” proposed by Bhattacherjee (2012:15). In this methodology, the deductive and 
inductive reasoning are proposition to draw conclusion in the model development 
process. Deductive reasoning used to draw a conclusion in initial set of the premises of 
a phenomenon based on the framework while inductive reasoning, draws a conclusion 
based on observed evidences (Bhattacherjee 2012:4). The syntheses were repeated 
back and forth of deductive and inductive reasoning of the findings.  
 
The quantitative findings that come out from TB patients who were on follow-up, who 
have live experience with DOTS, and qualitative findings from a different set of 
populations (defaulted TB patients and TB experts) were synthesised. Synthesis is a 
process of combining parts into a whole and explaining the whole. It is the final activity 
of analysis and a process by which knowledge of a part is aggregated into knowledge of 
a whole (Polit & Beck 2008:751).  
 
Deduction of factors for patient centeredness of DOTS strategy identified from 
overarched WHO people centred framework measuring items was used to extract core 
constructs. Inductively, the qualitative data findings enriched the constructs of the model 
and shape indicated prepositions and pattern of the core constructs. Further, the 
proposed model substantiated by literatures. These approaches, synthesising the 
qualitative and quantitative data findings from a different set of populations enable the 
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model to take an advantage of both qualitative and quantitative approaches and get a 
full picture of the model. 
 
7.2 TRIANGULATED FINDINGS  
 
The study findings from the different study population group were a ground for the 
proposed TB PC-TB care model. The DOTS is provided almost at all government health 
facilities and at some private health institutions. Since its endorsement, the DOTS 
implementing health institution have been increased and better treatment outcome of 
TB patients reported. However, DOTS demands the patients’ effort to undergo daily 
observation, limit the patients’ preference, respect and value. It also demands the 
provision of the service by private health facilities for free against their reason of 
existence, “for profit”. Furthermore, DOTS has weak service integration and provision of 
allied patient service that support the provision of patient-centred TB-care. 
 
About 40% of TB patients who were on follow-up of TB treatment scored below the 
adjusted score of the mean. They categorised as they did not receive PC-TB care 
without significance difference across the treatment centres and the type of TB they 
had. The FGDs participants also affirmed that DOTS strategy as it is not entirely patient-
centred. In addition, the defaulted TB patients fully agreed that DOTS strategy as it is 
not patient-centred except at the initiation of the treatment with the provision of choice to 
select where they can follow the TB treatment and discussion to do and do not’s with 
the treatment. 
 
The factors associated with PCC of DOTS extracted from regression model were 
communication of HCP with TB patients, income and gender. Moreover, the exploratory 
factor analysis extracted 17 measuring items among 65 measuring items which 
explained 65% of the total variability PCC dimension of the study. The extracted items 
had equal or greater than one eigenvalue, (Table 5.17).  
 
Sixty-three percent of the patient, family and community concern dimension variance 
was explained by five measuring items. The measuring items that explained the 
dimension variability were information provision, consent and taking part in treatment 
plan, treatment supporter communication, friends’ involvement and provision of choice.  
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Sixty-six percent of HCPs dimension variability explaining measuring items were free 
communication of HCPs and patients, concerned discussion about family, social issue, 
employment and financial status, recognition and provision of value, emotional and 
physical support.  
 
Fifty-nine percent of the total variability of HCO sub-dimension was explained by 
availability of transport, comfortableness of the premises and food support. Fifty-seven 
percent of total variability of health care delivery dimension was explained by referral 
system, service integration and compensation system for faced a difficult situation. In 
addition, DOTS service provision system and integration, and HCPs attitude and 
community awareness were perceived factors with DOTS patient centeredness.  
 
Similar to the quantitative findings, the qualitative findings show that integrating DOTS 
service with nutritional support, HIV/AIDS, mental health and availing transport to the 
TB patients are explored factors related to integration of TB care delivery. Moreover, 
attitude, character, communication skill and motivation to HCPs’ of TB care service are 
explored factors related with HCPs’ to provide PC-TB care. Community awareness 
about TB and the availability of consistent counselling and patient educations are 
explored factors with patient centeredness of DOTS. 
 
About 32% of TB patients who were on follow-up and defaulted TB patients were not 
satisfied with DOTS. However, the TB experts did not affirm the dissatisfaction level of 
TB patients as long as they had no similar and systematic measurement of TB patients’ 
satisfactions level across the region. HCPs’ on time availability, communication, 
reception and provision of respect to the patient and information provision with in the 
DOTS delivery process, and convenience of compound such as availability of chairs 
and access of toilet and presence of allied patient services were pointed out factors with 
TB patients’ satisfaction.  
 
The perceived PC-TB care received was positively correlated with satisfaction level of 
TB patients. In addition, most of the factors explored for satisfaction of TB patients and 
received PC-TB care were similar.  
 
The reported reasons to default from TB treatments were related to DOTS delivery 
system; inability to afford the cost of transport for daily follow-up and incompatibility of 
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diagnosis at different health institutions. Moreover, patients’ feeling of good health, 
discouragement to be cured, exhausting to take the drug for long period of time and 
alternative treatment inquiry were reasons.  
 
7.3 BACKGROUND TO THE PROPOSED MODEL  
 
This section of the chapter illustrates the rationale, aim, context and assumptions of the 
proposed model. 
 
7.3.1 Rationale of the model 
 
Although different scholars (WHO 2016:145; Gebrezgabiher et al 2016:1) reported 
Ethiopia’s TSR rate is in line with the WHO TSR target, we argue that this target has 
partly been achieved through a process involving involuntary enforcement of the TB 
patient to adhere to TB treatment, specifically through incarceration to come at HCOs. 
This raising concerns regarding the appropriateness of these approaches to achieve 
treatment objectives. Further DOT lacks a rigorous evidence base and is often at odds 
with patient needs and preferences (O'Donnell, Daftary, Frick, Hirsch-Moverman,  
Amico, Senthilingam, Wolf, Metcalfe, Isaakidis, Davis & Zelnick 2016). 
 
As it has been revealed in the results section, the TB patients did not entirely receive 
PC-TB care and were not fully satisfied with the DOTS service they received. These 
findings have been strongly affirmed by TB experts and defaulted TB patients.  
 
Ethiopia’s 2015-2020 health sector plans are focused on quality health care delivery 
and equity in health (EFMOH 2015b:13). In 2016 Ethiopian hospital performance 
recognition ceremony, the Ethiopian Federal Ministry of Health Minster stressed that 
“the next selection of hospital awardees will be mainly based on survey of client 
satisfaction. Client satisfaction will be the main indicator.”  
 
Even if TB drug is provided for free, the cost of TB in Ethiopia is catastrophic for the TB 
patients due to transport cost for daily observation, additional food support, guardian  
pre diagnostic and  diagnostic costs and other indirect costs (Getahun, Wubie, Dejene & 
Manyazewal 2016:5). However, PCC is a proven strategy to better treatment outcome, 
reduce cost of health service and to the patient, increase patients’ satisfaction and it is 
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legitimate inquiry of the patient (Pelzang 2010:916). It is also one of the recommended 
pillars to end TB strategy (WHO 2013c:7), quality indicators of health care system 
(WHO 2008:14) and it is substituent for acceptability of the care (WHO 2006:9). 
However, no well agreed PCC model developed with the context of TB care delivery 
system particularly for developing countries like Ethiopia. Therefore, PC-TB care model 
is paramount importance to guide the TB care delivery activities and even may pave a 
way for other health care delivery to be patient-centred as a whole.  
 
7.3.2 Aim of the model 
 
The primary aim of the proposed model is to enhance the patient centeredness of TB 
care delivery. In turn, it will help to better TB treatment outcome with optimum cost to 
the patient and reduced defaulter rate during TB treatment follow-up.  
 
7.3.3 The context of the model 
 
This model provides a framework to support TB care delivery with respect of patient 
centeredness’ of the TB care. The model recognise the requirement of enhanced the TB 
patients and community participation. Further the model provides HCPs, HCOs, and TB 
care delivery system adjustments necessitate to ward provision PCC. As a result, the 
proposed model may realize and reinforce PC-TB care. In turn may increase TB 
patients’ satisfaction, reduce defaulter rate, increase favourable treatment outcome and 
ensures respect and value the legitimate right of the TB patients. The model also 
contains monitoring and evaluation system of the TB care delivery system at health care 
delivery point. The model can be applied entirely or partially at private and government 
health care settings, which deliver TB treatment activities, based on the extent that the 
health institutions’ health care activities span.  
 
7.3.4 Assumptions of the model 
 
The proposed PC-TB care model was constructed based on the following assumptions: 
 
 TB patients’ knowledge is required TB patients to make right choices. 
 TB patients’ knowledge about TB can be built at the community level and HCOs 
while they come to receive TB care services. 
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 TB patients need to be respected, valued and participate in decision making of 
their TB treatment process. 
 TB-care delivery system needs to integrate the service mostly in need of TB 
patients.  
 Provision of integrated service reduce cost and required number of HCPs  
  Conducive HCOs motivate HCPs and TB patients to provide care and utilize 
health services, respectively.  
 Provisions of alternative choices to TB patients facilitate informed decision-
making. 
 Keeping preferences of TB patients reduce long distance travel to get the 
treatment and reduce cost to the patients 
 Communication skill and competency of HCPs can be improved through training. 
 PC-TB care improves TB patients’ treatment outcome and satisfaction; quality of 
health care, reduce cost due to TB for patients and health service. 
 
7.4 DESCRIPTION OF THE MODEL 
 
A descriptive model is a representation of all or part of a given system used for 
representing complex systems for visualizing variables and relationships (Bhattacherjee 
2012:14). The proposed descriptive model represents a complex system of PC-TB care; 
visualize the constructs and their relationships in the TB care delivery phenomena.  
 
The proposed PC-TB care model contains TB-care delivery policy direction, community, 
HCO, TB care delivery system, TB patient, HCP and monitoring and evaluation 
components. PC-TB care is primary outcome of the intertwine function of the 
components of the model and TB patient satisfaction, reduced cost, improved treatment 
outcome and quality of care are secondary outcomes (Oshima & Emanuel 2013:7; 
Cleary 2016:675). 
 
7.4.1 TB care delivery policy direction  
 
A TB care delivery policy is a formal statement or procedure within an institution which 
defines TB care delivery goals, priorities and the parameters for action in response to 
health needs within the context of available resources (WHO 2004:29). PC-TB care 
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delivery approach is one of the accepted pillars in WHO’s end TB strategy (WHO 
2013c:14), and it is also believed care delivery approach for a better treatment outcome 
and satisfaction of the patients (Oshima & Emanuel 2013:7). 
 
The TB care policy direction provides direction to enhance and promote quality of life of 
TB patients. The TB care delivery policy direction needs to endorse PC-TB care delivery 
approach. The promotion and implementation of the PC-TB care approach supports the 
TB care delivery to be responsive to the TB patients. The promotion of PC-TB care at 
HCOs can be achieved by enforcing TB care delivery directives; motivated HCPs, 
reinforcing HCOs and empowering people (WHO 2015:12).  
 
The TB care delivery directives need to focus on structural or group level, individual 
level, and outcome evaluation level of the TB care delivery. Direct structural or group 
level focused direction is practicable to promote, support, and guide the community, 
HCO, and TB care delivery system. Individual focused directives support and promote 
HCPs to provide effective and efficient TB care service which recognise, respect, value 
and preferences of TB patients. In addition, individual focused direction should be able 
to encourage TB patients to involve in the TB care delivery they receive. In addition, the 
TB care delivery policy direction urges to provide a direction and procedure to monitor 
the outcome of the implementation of the PC-TB care delivery.  
 
7.4.2 Community  
 
The community is a group of people who have connected durable relations that extend 
beyond immediate genealogical ties, and who usually define that relationship as 
important to their social identity and practices (Mckenzie, Venturelli, Pinger & 
Fleckenstein 2014:5). The community is group of ill and healthy individuals linked each 
other who receive and hear opinion and feedback from the experience of TB patients’ 
health care utilisation.  
 
The community awareness level about TB may shape the patient’s level of knowledge 
and ease the required effort to make the patient knowledgeable about TB during 
individual health education at HCOs (Poortinga 2012:292). 
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As reported in the result section of this study, consistent and programmed health 
education through peer educators and mass media are an important activity to increase 
the awareness of the community about TB. Once the community is aware, the member 
of community will be in a good position to know what to do and choose the best 
preference to reduce the TB transmission, adhere with prescribed TB treatment and 
even to reduce prevalence and incidence of TB.  
 
7.4.3 TB care delivery system 
 
TB care delivery system is a way that TB care is discharged to the TB patients 
performed by health care professionals, or by others under their direction, for the 
purpose of promoting, maintaining or restoring health (WHO 2004:31). As illustrated in 
Table 5.12 of the result section, the TB care delivery system sub-dimension got the 
smallest mean score. Referral system, service integration and compensation system for 
faced difficult situations were the most criticised but expressed the majority of variability 
of the TB-care delivery system sub–dimension of the study. Therefore, reinforce and 
reinvigorate TB patients’ referral system, feedback collection mechanism and 
integration of TB care services with nutritional, transport and HIV/AIDS services are 
required for the provision of PC-TB care.  
 
In addition, the TB care delivery system necessitates flexibility to respond to TB 
patients’ preference. The inquiries include swallowing the TB drugs either at facility, 
house, at work place or in the community without observer. The adherence monitoring 
system of TB patients can be done using either mobile technology as a reminder or 
treatment supporter report as appropriate to individual TB patients. 
 
7.4.4 Health care organisation (HCO) 
 
The HCOs are institutions which are engaged in direct patient care (WHO 2004:28). 
Working area comfort is a factor to motivate HCPs to work with in the HCOs 
(Matsushita, Kuwahara & Morimoto 2014:475). Conducive HCO motivates HCPs to 
work within the HCOs and to provide TB care service. Motivated employees are 
happier, hardworking and more productive of a given organisation (Buchbinder & 
Shanks 2011:42).  
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Convenience of HCO to receive a TB care as it is reported as a factor to patients’ 
satisfaction. Conduciveness of HCOs to the TB patients can be created by making 
clean and ventilated patient waiting area, examination rooms, laboratories, toilets and 
the compounds in general. Reduced waiting time, availability of the required laboratory 
reagents and drugs and the presence of directives in the compounds are ways to make 
conducive HCOs (Nezenega, Gacho & Tafere 2013:8). 
 
Availability of transport to reach the HCOs, comfortableness of the premises and 
availability of integrated service such as food support were extracted issues in the study 
to make TB care services more patient centred in regard to HCO sub-dimension.  
 
7.4.5 TB patients 
 
A TB patient is an individual in whom a health worker has diagnosed TB and has 
decided to treat the patient with a full course of TB treatment (EFMOH 2013:21). 
Majority of TB patients are the poorest of the poor that need high support of finance, 
social and psychological support (Tanimura et al 2014:1764). 
 
The TB patients should have the necessary knowledge about TB diagnosis, treatment 
and care. The knowledge is important to make informed decision, take part in TB 
treatment plan and to choose the best among alternatives. The TB patient’s knowledge 
can be enhanced within the community through the programmed health education to the 
community, counselling and patient education at HCO while receiving TB care services. 
The patient education need to be on going in cultural sensitive manner with identifying 
his/her priorities. Patient education should include medication information such as 
dosage, side effects, what the pill look like treatment regimen, disease process and 
transmission (Kuntz et al 2014:313). 
 
Evidence suggests that in addition to support the existence of PCC, patient education 
could contribute to reduction related to patient related factors to default (Toczek et al 
2013:299).  
 
7.4.6 Health care providers (HCPs) 
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HCPs, for patients in any level of educational qualification, are involved in providing 
coordinated and comprehensive TB care. The role of the HCP work in TB clinic is to 
improve quality of life of TB patients. HCPs’ motivation, communication and counselling 
skills and commitment are required skills to improve quality of life of TB patients. 
Provision of values, respect and choices to the patients are important to implement the 
PC- TB care.  
 
Health education provided in the community alone may not be enough to fully make a 
patient fully knowledgeable to choose the appropriate choice among the alternatives 
provided by HCPs. Therefore, HCPs should provide appropriate and enough 
information regarding TB and counsel TB patients about self-care management. In 
addition, while HCPs provide TB care service it should be in compassionate with 
recognition of patients’ value and respect. The information provision and counselling of 
TB patients at HCOs should be two-way built on good communication with patients 
(Barry & Edgman-Levitan 2012:780). The finding of this study also reports that HCP- TB 
patient communication was the determinant for PCC.  
 
In addition, PC-TB care provision approach training is important for HCPs engaged on 
the provision of TB care delivery so as to provide PC-TB care for the TB patients 
(Dwamena, Holmes-Rovner, Gaulden, Jorgenson, Sadigh, Sikorskii, Lewin, Smith, 
Coffey & Olomu 2012:1). The HCPs can acquire such PCC service provision’ skills from 
universities or through on-site or off-site in-service short-term trainings (Levinson 
2011:825). 
 
7.4.7 Monitoring and evaluation  
 
Monitoring is the systematic collection and analysis of data as a project or programme 
progresses. It helps to gauge and guide a direction to improve the efficiency and 
effectiveness of a project, programme or organisation based on indicators planned 
during the planning phases of work (Royse, Thyer & Padgett 2015:19).  
 
The proposed PC-TB care model performance can be monitored by using selected 
indicators (Table 6.1). The proposed indicators can be collected from routine service 
report, patients’ feedback survey and supportive supervision.  
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 Table 7.1 Proposed Indicators to measure the performance of PC-TB care 
model 
Intervention level Selected indicators Data source  
Individual   Knowledge of TB patients 
 TB patients waiting time   
 Proportion of TB Patient 
satisfied.  
 Proportion of HCPs attrition   
 Survey 
 Document review  
 Routine service report 
Structural  Proportion of TB patients 
who received HIV service, 
nutrition support, mental 
health service 
 Adherence level to TB 
treatment 
 Routine service report 
 Survey 
 Document review  
Outcome   Proportion of TB TSR 
 Proportion of defaulter  
 Cost of TB patients from 
illness to treatment  
 Satisfaction of TB patients 
 TB register 
 Routine service report 
 Survey 
 
Evaluation is the assessment of the actual project’s or programme’s impact on the 
expected goals to be achieved (Royse, Thyer & Padgett 2015:20). In order to evaluate 
the proposed PC-TB care model, survey the level of expected listed outcome, through 
document review or primary data is encouraged. Comparing level of the patient 
centeredness of TB care delivery, satisfaction level of the TB patient, treatment 
outcome of TB patients and cost reduced to the patient and services before and after 
implementation of the model are proposed variables to evaluate the effectiveness as 
stated above in Table 6.1. 
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Figure 7.1:  Diagrammatic presentation of proposed patient-centred  
TB care model 
 
7.4.8 Strength and weakness of the model 
 
The proposed model is based on both the qualitative and quantitative findings, 
synthesis and literatures thus provide a complex understanding of patient centeredness 
and associated outcomes of TB care delivery. It has also acknowledged that due to the 
complexity of the phenomenon, the model does not provide the exclusive variables that 
may have input in the development of the PC-TB care model.  
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The model, however, illustrated the most critical and often less emphasised in the TB 
care, the researcher also acknowledges that the implementation of this model depends 
on the policy direction of TB-care delivery system, HCPs counselling skills and 
motivation. Another notable strength of the model is indicating if the model applied at 
which level need to be monitored and proposed the possible indicators at each level to 
check the performance of the model. 
 
7.5 CONCLUSION  
 
This chapter presented the triangulated findings of quantitative and qualitative 
approaches; the proposed PC-TB care delivery models both in diagrammatic and 
descriptive presentation. In addition, the chapter shows that the assumption and the 
context, monitoring and evaluation indicators while applying the proposed model, and 
limitation and strength of the model.  
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Annex A:  Total variance explained PCC framework 
 
Total Variance Explained Total Variance Explained 
Comp
onent 
Initial Eigenvalues 
Extraction Sums of 
Squared Loadings 
 Initial Eigenvalues Extraction Sums of 
Squared Loadings 
Total 
% of 
Varian
ce 
Cumulativ
e % Total 
% of 
Varian
ce 
Cumulati
ve % 
Compon
ent  
Total 
% of 
Variance 
Cumulativ
e % Total 
% of 
Variance 
Cumula
tive % 
1 13.977 21.503 21.503 13.977 21.503 21.503 36 .465 .716 87.024    
2 4.895 7.531 29.034 4.895 7.531 29.034 37 .459 .706 87.730    
3 3.840 5.908 34.943 3.840 5.908 34.943 38 .451 .693 88.423    
4 2.600 4.001 38.943 2.600 4.001 38.943 39 .428 .658 89.081    
5 2.290 3.523 42.467 2.290 3.523 42.467 40 .406 .625 89.706    
6 1.895 2.916 45.382 1.895 2.916 45.382 41 .403 .619 90.326    
7 1.722 2.650 48.032 1.722 2.650 48.032 42 .396 .609 90.935    
8 1.679 2.584 50.616 1.679 2.584 50.616 43 .382 .588 91.522    
9 1.506 2.317 52.932 1.506 2.317 52.932 44 .366 .563 92.085    
10 1.382 2.126 55.058 1.382 2.126 55.058 45 .358 .551 92.636    
11 1.339 2.060 57.118 1.339 2.060 57.118 46 .336 .517 93.153    
12 1.215 1.869 58.987 1.215 1.869 58.987 47 .325 .501 93.654    
13 1.188 1.827 60.815 1.188 1.827 60.815 48 .314 .483 94.136    
14 1.120 1.724 62.538 1.120 1.724 62.538 49 .297 .457 94.593    
15 1.080 1.661 64.199 1.080 1.661 64.199 50 .294 .453 95.046    
16 1.045 1.607 65.806 1.045 1.607 65.806 51 .282 .434 95.481    
17 .965 1.485 67.291    52 .271 .417 95.898    
18 .934 1.436 68.728    53 .266 .409 96.307    
19 .884 1.360 70.088    54 .255 .393 96.699    
20 .872 1.341 71.429    55 .250 .385 97.084    
21 .849 1.306 72.734    56 .238 .367 97.451    
22 .809 1.245 73.979    57 .222 .342 97.793    
23 .782 1.204 75.183    58 .217 .333 98.126    
24 .732 1.127 76.310    59 .211 .325 98.450    
25 .684 1.053 77.363    60 .197 .304 98.754    
26 .671 1.033 78.395    61 .190 .293 99.047    
27 .647 .996 79.391    62 .177 .272 99.318    
28 .631 .971 80.363    63 .155 .238 99.556    
29 .619 .953 81.316    64 .154 .238 99.794    
30 .581 .894 82.210    65 .134 .206 100.000    
31 .569 .876 83.086           
32 .550 .846 83.932           
33 .548 .843 84.775           
34 .504 .776 85.551           
35 .492 .757 86.308           
Extraction Method: Principal Component Analysis. 
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Annex B:  Ethical clearance certificate 
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Annex C:  Permission letter  
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Annex D:  English version of TB patients questionnaire  
Evaluation of directly observed tuberculosis treatment strategy in Ethiopia: patient centeredness 
and satisfaction’ questionnaire 
 Part I. Instruction  
1. Before collecting any information, the letter of ethical clearance and cooperation letter should be 
presented to the head/representative of the facility and get permission.  
2. Before conducting interview the below study information sheet must be read to sure the 
respondents acquire the required knowledge whether to participate in interview or not. In addition, 
get the participant consent.  
3. For all responses, it should be recorded what the respondent exactly wanted to say. 
4. All the close-ended questions should be chosen and circled from the given choices unless and 
otherwise the response is different from listed choices. 
5. If the response is different from the listed choices in close-ended questions, the response should 
be put in other and must be specified. 
6. For open-ended questions, the response should be written in the form that have provided in the 
bracket at the end of each questions. 
7. If the respondent has general comment it should be written at the end of questions on provided 
space. 
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Part II. Study information sheet 
Greetings, my name is ________________and I have been assigned to collect data for the study, which is 
conducted by Mr Belete Getahun on Evaluation of DOTS strategy, Its TB patient centeredness and satisfaction 
in Addis Ababa. Today I would like to talk with you and gather information by prepared questionnaire about your 
experiences on DOTS program in Addis Ababa as one of the components of this study. We are evaluating 
DOTS strategy with respect to TB patient centeredness and satisfaction in order to capture lessons that can be 
used in future interventions. This study ethically has been approved by UNISAethical review board and has 
permission from Addis Ababa city Administration Health Bureau. It takes approximately 20 minutes. Though it 
seems long time, the study helps to improve the programme by generating the model which helps to improve 
patient satisfaction and centeredness. Your name will not be asked and unique identification is not required. 
Your response will be kept confidential, only be shared for research team. You do not have to discuss issues 
that you do not want. If you want to withdraw from the study any time during the discussion process, you will not 
be obliged to continue or give reasons for doing so. If you refuse or not, will not have any consequences on you 
and the services provided to you.  
Do you have any question which is not clear?  
Also if you have any question or anything that is not clear you can directly contact principal investigator of 
this study, Belete Getahun, by phone no 0911602272 or e-mail: bgetahun150@gmail.com   
I would like to appreciate your help in responding to this interview.  
 
If you are clear with the information provided and agree to participate please sign on the consent form. 
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Part III  
Study Participant Consent Form 
 
I, the undersigned individual am oriented about the objective of the study. I have been informed that all of 
my information will be kept confidential and used solely for this study. In addition, I have been well informed 
that my name will not be asked and unique identification is not required. I have the right not to discuss 
issues that I do not want. If I want to withdraw from the discussion I will not be obliged to continue or give 
reasons for doing so. Nonetheless, my agreement to participate in this study is with the assumption that, 
the information that I provide during the discussion will help greatly to evaluate DOTS strategy and improve 
its centeredness’ and satisfaction of TB patients.  
 
    Date ________________      signature____________________________  
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Part IV. Questions 
Se. 
no  
Measurement Items  Response  
A.  General characteristics  
1. Gender of the respondent   1. Male   2. Female 
2. Age  1. 18 - 24  
2. 25 -34 
3. 35 – 44 
4. 45 – 54 
5. 55- 64 
6. 65 and above 
3 Marital status  1. Married  
2. Single (Never married) 
3. Separated 
4. Divorced 
5. Widowed 
6. Cohabiting  
4 Family size?     _______ (including the respondent) 
5 Residence  1. Urban   2. Urban slum   3. Rural      4. 
Homeless       5. Other (specify)      
6 Highest educational level  1. Diploma and above 
2. Preparatory 
3. Secondary school 
4. Primary school 
5. No formal education 
7 Occupation  1. Permanent employee     
2. Self employee  
3. Temporary employee          
4. Unemployed 
5. Pensioner   
8 Average household/family monthly income  1 ___________    2. No response  
9 Religion  1. Orthodox        2. Protestant 3. 
Catholic 4. Muslim      5. No 
religion 6. Other  
10 Ethnic group  1. Oromo 
2. Amhara  
3. Tigre 
4. Gurage  
5. Other (specify) 
11 Did you receive health care service in this facility before this illness? 1. Yes      2. No  
12 If yes, how many days did you visit the health institution before you diagnosed as 
you have TB? 
______________ 
13 Type of TB  1. Pulmonary positive TB   
2. Pulmonary Negative TB 
3. Extra Pulmonary TB 
4. MDR-TB  
14 Treatment category/registration group                 (please see treatment follow up 
card) 
1. New  
2. Relapse 
3. Treatment after Failure  
4. Return after Defaulted 
5. Transfer in    
6. Other(specify) 
15 When did you start TB treatment?                                   (DD/MM/YYYY)   
16 Do you have TB symptoms now?     1. Yes          2. No 
17 Total planed treatment duration?  1. Six months   2. Eight months 3. Other 
(specify)__________ 
 
18 Currently how you are collecting your TB drugs  1. Daily           2. Weekly 
 3. Monthly        4. Other  
19 How much you pay for transport per day in ETB? (if there are care giver include 
all costs)  
______________ 
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20 Did you expect to come and collect the drugs every day, week or months for this 
much time? 
1. Yes         2. No   
21 Do you think that you and HCPs have good communication? 1. Yes         2. No   
22 Who is your treatment supporter? 1. HCP  
2. Family member 
3. Health extension worker 
4. Friend  
5. Volunteer  
6. Other (specify) 
B. Centeredness of TB care provided 
  1= Strongly disagree          2. Disagree          3.  Indecisive            4. Agree       5.  Strongly agree 
Patient, family and community 
1 Patient empowerment and involvement   
1.1  Information provision   
 The HCPs gave you enough information about:  
1.1.1 route of TB  transmission, prevention and treatment 1       2       3       4       5  
1.1.2 importance of treatment supporter  1       2       3       4       5  
1.1.3 prognosis of your health condition 1       2       3       4       5  
1.1.4 what is wrong practice with TB patients with regard to treatment  1       2       3       4       5  
   
1.2 Keeping of preference   
 HCPs accept your:   
1.2.1  place of choices where to take the treatment such as at home, work place or health facility. 1       2       3       4       5  
1.2.2 TB drug collection time 1       2       3       4       5  
1.2.3 gave you a chance to your own treatment supporter 1       2       3       4       5  
   
1.3 Recognition   
1.3.1 Took  part in treatment plan   1       2       3       4       5  
1.3.2 Your consent was taken and considered during decisions   1       2       3       4       5  
1.3.3 Your role in the care process were duly acknowledged 1       2       3       4       5 
   
2 Improving capacity for self-management and self-care  
 HCPs provide you:  
2.1 self care TB management  with health education 1       2       3       4       5  
2.2 counselling about how to care yourself with TB care and its treatment 1       2       3       4       5  
2.3 Written, pictorial, audiovisual material about TB  care and its treatment 1       2       3       4       5  
   
3 Treatment supporter   
 Your Treatment supporter:  
3.1 know the transmission route, prevention and treatment of TB 1       2       3       4       5  
3.2 always observe while you take drugs  1       2       3       4       5  
3.3 communicate regularly with the HCPs about your treatment ( if not HCP) 1       2       3       4       5  
3.4 communicate and discuses with you regularly about TB treatment 1       2       3       4       5 
   
4 Family and friends involvement  
4.1 Families  were encouraged and allowed to participate in your TB care activities 1       2       3       4       5  
4.2 Friends were encouraged and allowed to participate in your TB care activities 1       2       3       4       5 
4.3 Pros and cons of TB transmission, treatment and care were discussed with friends  1       2       3       4       5  
4.4 Pros and cons of TB transmission, treatment and care were discussed with families  1       2       3       4       5  
   
Health care provider 
   
1 Characteristics of HCPs  
 HCPs are:  
1.1 honest, respectful, compassionate and tolerant  1       2       3       4       5  
1.2 self-reflective  1       2       3       4       5  
1.3 accountable for TB patients  1       2       3        4      5  
1.4 committed to provide TB care 1       2       3       4       5  
1.5  are aware of each other’s involvement 1       2       3       4       5 
1.6  provide value, share information and responsibilities(each others) 1       2       3       4       5 
  
207 
   
2. Patient as a unique Person   
 Mostly, HCPs:  
2.1 respect your  idea, culture and religion    1       2       3       4       5  
2.2 recognize and provides  values  1       2       3       4       5  
2.3 understand your feelings 1       2       3       4       5  
   
3 HCPs and- patient communication  
 HCPs and your communications are:  
3.1 on prioritising your problem    1       2       3       4       5  
3.2  free discussions  1       2       3       4       5  
3.3 based on are careful listening and understanding 1       2       3       4       5  
3.4 meant to build  mutual relationship   1       2       3       4       5  
3.5 get clear and summarised information about your illness/medical condition  1       2       3       4       5  
3.6 deal about your medical condition regularly and appropriately 1       2       3       4       5  
   
4 Physical support   
 HCPs support:  
4.1 to keep your physical comfort  1       2       3       4       5  
4.2 provide  assistance while you feel tired  1       2       3       4       5  
   
5 Emotional support  
 The HCPs emotionally support:  
5.1 to cope with the TB 1       2       3       4       5  
5.2 to cope with relationship and mood changes 1       2       3       4       5  
5.3 to cope with problems related to employment 1       2       3       4       5  
   
6  Biopsychosocial perspective  
 HCPs are concerned:   
6.1 to discuss about  your life history and development  1       2       3       4       5  
6.2 to  discuses about your family and social interactions  1       2       3       4       5  
6.3 to discuss regarding employment status and financial issues 1       2       3       4       5  
6.4 to  discuss  and assess psychological status 1       2       3       4       5  
   
Health care organization 
1 Ensuring access,  effective and efficient coordination of care  
1.1 You travelled longer distance to access this health  facility 1       2       3       4       5  
1.2 There are reminder notices for specific interventions in the HCO ( how to cover mouth while 
coughing, hand and mouth care) 
1       2       3       4       5  
1.3 HCO is designed for comfort and safe to get TB treatment   1       2       3       4       5  
1.4 The waiting  rooms and other  spaces within the premises 
are comfortable to follow  health education 
1       2       3       4       5  
   
2 Establishing and strengthening multidisciplinary care teams  
 Availability of patient support service:   
2.1 availing transport  1       2       3       4       5  
2.2 food support  1       2       3       4       5  
2.3 traditional medicine  1       2       3       4       5  
2.4 spiritual  1       2       3       4       5  
2.5 Social 1       2       3       4       5 
 TB care delivery health system  
1 Monitoring and addressing patient and community concerns about health care quality  
 TB care service system:   
1.1 You are well transitioned from diagnosis to treatment  1       2       3       4       5  
1.2 There is good arrangement of appointments for follow up  1       2       3       4       5  
1.3 The TB care service is well integrated with HIV/ART services  1       2       3       4       5  
1.4  HCPs made mutual agreements about the care given to you 1       2       3       4       5  
1.5 There is a notice with the name and contact details of the person in charge of TB care 1       2       3       4       5  
1.6 Your clinical information have been kept confidentially 1       2       3       4       5 
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Thank you for your time and cooperation! Is there anything you would like to ask or say?  
Data collector name and sign   ______________________ Date ________________ 
 
2 Teamwork and teambuilding   
 The TB care service providers are:    
2.1 There is good inter-facility referral system 1       2       3       4       5  
2.2 There is good intra-facility referral system  1       2       3       4       5  
2.3 There is good collaboration among registration, laboratory, treatment and discharge services 1       2       3       4       5  
   
3 Assisting people who have experienced adverse events in the health System   
3.1 You were highly assisted while you faced difficult situations in the TB care provision 1       2       3       4       5  
3.2 There was good compensation system for faced difficult situation, where appropriate  1       2       3       4       5  
3.3 fixed contact persons is assigned for questions, problems and complaints  1       2       3       4       5  
3.4 There is good reassurance while you faced inconvenience with TB care delivery system   1       2       3       4       5  
   
C Satisfaction with TB care received  
 5. Very satisfied     4. Satisfied       3. Neutral          2. Dissatisfied         1. Very dissatisfied   
1 Structure   
 Are you satisfied with:  
1.1 availability of  necessary equipment, drugs, laboratory reagents  to treat  TB disease 1       2       3       4       5  
1.2 easy access of the HCPs  as you need  1       2       3       4       5  
1.3 easy access of HCPs to re fill your medication  1       2       3       4       5  
1.4 wheelchair  friendliness of the environment 1       2       3       4       5  
1.5 the waiting area, registration  and treatment room  comfortableness and availability of seats  1       2       3       4       5  
1.6 the safeness of the facility for the patients 1       2       3       4       5  
1.7 availability of  signage/ directions guidance where to go in the health facility  1       2       3       4       5  
1.8 cleanness, goodness and working order  of the latrine   1       2       3       4       5  
1.9 treatment room keeping your privacy 1       2       3       4       5  
1.10 availability of safe water to take a medication 1       2       3       4       5  
   
2 Process   
 Are you satisfied with:  
2.1 explanation and response of HCPs about your questions  1       2       3       4       5  
2.2 HCPs ability of the diagnosis, treatment and care of TB   1       2       3       4       5  
2.3 the cost you paid for TB diagnosis and treatment 1       2       3       4       5  
2.4 obligation of costs beyond my ability to pay for transport 1       2       3       4       5  
2.5 Carefulness and allotted time  of HCPs  to check my clinical condition 1       2       3       4       5  
2.6 HCP welcoming, respect,  friendly treatment and courteous  1       2       3       4       5  
2.7 HCPs considerer you are unwise 1       2       3       4       5  
2.8  appointment  system for follow up   1       2       3       4       5  
2.9  so long  waiting time  with registration process to get TB care 1       2       3       4       5  
2.10 HCP uses medical terms/jurgon without explaining what they mean 1       2       3       4       5  
 
 
 
  
3 Out come   
 Are you satisfied with:  
3.1 Your TB symptoms reduction rate 1       2       3       4       5  
3.2 Physical wellbeing ness you gained due to TB treatment 1       2       3       4       5  
3.1 Psychological  wellbeing ness you gained due to TB treatment 1       2       3       4       5  
4. General satisfaction  
 How much you are satisfied by the care you received (the least is 0 and  the highest is 10) 0______________10 
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Annex E:  Defaulted TB patient’s telephone interview guide 
Evaluation of directly observed tuberculosis treatment strategy in Ethiopia: patient centeredness and 
satisfaction study Defaulted TB patients telephone interview guide. 
Hello.  
Greetings, my name is Belete Getahun Woldeyes, have been working research on Evaluation of DOTS 
strategy patient centeredness and satisfaction in Addis Ababa, Ethiopia. The aim of the study is to evaluate 
TB- DOTS strategy with respect to TB patient centeredness and satisfaction in order to capture lessons 
that can be used in future interventions. In addition, the study will help to improve the programme by 
generating model, which helps to improve patient centeredness and satisfaction 
Today I would like to talk to you and gather information through telephone about your experiences on 
DOTS programme in Addis Ababa as one of the components of this study. It takes 20 -25 minutes, though 
it seems long time your response will help the study greatly since you started and defaulted TBtreatment at 
____________facility. 
This study, ethically, has been approved by UNISAethical review board and get permission from Addis 
Ababa City Administration Health Bureau.  
Your name will not be quoted and the responses will be kept confidential, only be shared for research team. 
You do not have to discuss issues that you do not want. If you want to withdraw from the study any time 
along the discussion process, you will not be obliged to continue or give reasons for doing so.  
Do you have any question or which is not clear?   
Do you participate in the study?  
I would like to appreciate your help in responding to this interview. If you are comfortable let we start the 
discussion with: 
1. What information the HCPs gave you about TB while you were on treatment?  
2. How do you explain the HCPs kept your preference or choice while you were taking your TB 
treatment? 
3. At what extent you took part in your TBtreatment plan? 
4. At what extents HCPs support you to improving your capacity for self-management and self-care 
with regard to TB? 
5. What was the role of treatment supporter in TB treatment of you?  
a. Was she/ he your choice? 
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6. How do you explain the discussions about transmission, treatment and TB care among your 
treatment supporter, friends and families, and HCPs? 
7. How do you explain the HCPs support, communication, provision of value and respect to TB 
patients to cope with TB treatment? 
8. What extent the HCPs discussed with you about bio psychosocial (development, social, financial, 
psychological) perspectives?   
9. How do you explain the overall structure, comfortableness of the health care facility where you 
diagnosed as you have TB and started treatment? 
10. How was the relationship/link among one department with others in health care service 
organization:  registration room, laboratory with treatment room? 
11. What was/ were the service/s you used linked with TB treatment?  
12. How you were assisted while you faced difficult situations in the TB care provision, if any?  
13. How do you explain the TB care you received at health institution?  
14. What was/were the reasons forced you to default from the TBtreatment? 
15. In general, how do you explain DOTS service patient centeredness?  
16. What do you suggest to reinforce to patient centeredness of DOTS?  
17. At what extent you satisfied with the service provided to you while you were on following up your 
treatment; what are the factors? 
18. What do you suggest to improve TB patients’ satisfactions with service?  
19. Is there anything more you would like to add?        
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Annex F:  FGD Confidentiality binding form 
 
Evaluation of directly observed tuberculosis treatment strategy in Ethiopia: patient centeredness 
and satisfaction  study Focused group Discussion Confidentiality Binding Form. 
I want to thank you for taking the time to meet with me today. My name is Belete Getahun Woldeyes, PhD 
student at UNISA on health study. Today I would like to talk to you about your experiences with DOTS 
programme in Addis Ababa as one of the components of my PhD work, we are evaluating DOTS strategy 
with respect to TB patient centeredness and satisfaction in order to capture lessons that can be used in 
future interventions. This study ethically has been approved by Addis Ababa city Administration health 
bureau and UNISA research ethical review boards. The interview will take less than an hour. I will take 
some notes during the session. And also I will be recording the session in order to capture the whole 
discussion. All responses will be kept confidential. This means that your interview responses will only be 
shared with research team members and we will ensure that any information we include in our report does 
not identify you as the respondent. Remember, you don’t have to talk about anything you don’t want to and 
you may end the interview at any time. 
Are there any questions about what I have just explained? 
Are you willing to participate in this interview?    
        
            Yes                        No 
 
Participant signature _____________________   Date_____________ 
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Annex G: FGD interview guide  
 
Evaluation of directly observed tuberculosis treatment strategy in Ethiopia: patient centeredness 
and satisfaction study focused group discussion interview guide 
 
Guiding questions 
1) How TB treatment is being provided in Addis Ababa for TB patients? 
2) What are the challenges to DOTS strategy? 
3) How TB patients select their treatment supporter?  
4) How TB patients’ preferences are being kept during the treatment?  
5) How patient centeredness of DOTS strategy is being explained?  
6) What are the measures that can indicate patient centeredness of the DOTS strategy? 
7) What are the factors contribute to patient centeredness?  
8) What are the possible causes, which make TB patients to default from their treatment? 
9) How does/did you know either TB patients are being satisfied or not? 
10) What are the factors that may contribute or limit TB patient satisfactions in intensive and 
continuation phase of the treatment? 
11)  What does/did you suggest to improve TB patients’ satisfactions?  
12) Is there anything more you would like to add? 
 
I will be analySing the information you and others gave me and submitting a draft report to the Addis Ababa 
City Administration Health Bureau as we compiled it. I will be happy to send you a copy to review at that 
time, if you are interested. 
Thank you for your time. 
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Annex H:  Amharic version of the questionnaire for TB patients’ 
 
በኢትዮጵያ በቀጥታ የሚታይ የቲቢ ህክምና ስትራቴጂ ግምገማ፡ በሽተኛን ማእከል እና የእርካታ 
ጥናት የቲቢ በሽተኞች መጠይቅ 
ክፍል 1. መመሪያ 
1. መረጃውን ማሰባሰብ ከመጀመሩ በፊት፣ ፈቃድ ለማግኘት የኤቲካል ክሊራንስ እንዲሁም 
የትብብር ደብዳቤ ለተቋም ሃላፊ ወይም ለተወካዩ መቅረብ ይኖርበታል፡፡ 
2. መጠየቁ ከመጀመሩ በፊት የመረጃው ወረቀት መነበብ ይኖርበታል፣ በተጨማሪም ተጠያቂው 
መጠየቁን ለመሳተፍ እንዲወስን በቂ እውቀት ማግኘቱን መራጋገጥ ይኖርበታል፡፡ 
3. የሁሉም ተጠያቂዎች መልስ ምን ማለት እንደሚፈልጉ ግልፅ በሆነ መልኩ መቀረፅ አለበት፡፡  
4. ምርጫ ለተሰጣቸው ጥያቄዎች መልስዎን በማክበብ የጠቁሙ፣ መልስዎ ካልተጠቀሰ በስተቀር 
ለምርጫ ጥያቄዎች መልስዎ ከተጠቀሱት የተለየ ከሆነ የተለየ በሚለው እና መጠቀስ ይገባዋል 
5. በፅሁፍ ለሚገለፁ ጥያቄዎች፣ መልስዎን በቅንፍ በተሰጡት የመልስ መስጫ ቦታዎች መልስዎን 
ይስጡ፡፡ 
6. አጠቃላይ አስተያየት ካለዎ የጥቄው መጨረሻ ላይ በተሰጠው ክፍት ቦታ ይፃፉ፡፡ 
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ክፍል ሁለት. በኢትዮጵያ በቀጥታ የሚታይ የቲቢ ህክምና ስትራቴጂ ግምገማ፡ በሽተኛን ማእከል እና 
የእርካታ ጥናት የቲቢ በሽተኞች መጠይቅ የጥናቱ መረጃ 
ሰላምታ፣ ስሜ________________ ይባላል እንዲሁም ከአቶ በለጠ ጌታሁን ጋር በቀጥታ የሚታይ የቲቢ ህክምና 
ስትራቴጂ ግምገማ፡ በሽተኛን ማእከል እና የእርካታ ጥናት ላይ መረጃ በመሰብሰብ ላይ እገኛለሁ፡  
የጥናቱም አላማ: የቲቢ ህክምና አገልግሎት የአገልግሎቱ ተጠቃሚዎችን ማእከል ስለማድረጉ፣ 
የታካሚዎችን የርካታ መጠንና፣ መድሃኒት በታዘዘዉ መሰረት መዉሰዳችዉ በመዳሰስ ወደፊት 
ለሚደረጉት መላዎች ትምህርት እንዲሆን እና አዲስ መላ ለመቀየስ ነው፡፡  ይህ ጥናት አዲስ አበባ ጤና 
ቢሮ እና በሳውዝ አፍሪካ ኤቲካል ሪቪው ቦርድ የተፈቀደ ሲሆን. 20 ደቂቃ ይወስዳል፡፡ በዛሬው ቀን 
ስለጥናቱ አካል ስለሆነውን በአዲስ አበባ ስለሚሰጠው የቲቢ ህክምና ፕሮግራም ፣ ያለዎን የእርስዎን 
ተሞክሮ በተዘጋጀው መጠይቅ መሰረት ላናግርዎ እንዲሁም ከእርሶ መረጃ ለመውሰድ እፈልጋለሁ፡፡ይህንን 
መረጃ የምወስደው የተቢ መድሃኒት በባለሙያ ለበሽተኛ በቀጥታ እየተሰጠ እነዲወስድ ለማደረገው 
ስትራቴጂ ለመገምገም እንዲሁም የቲቢ በሽተኞች እርካታን ለመጨመር ያግዛል በሚል እሳቤ ነው፡፡  
እርስዎ የሚሰጡት መረጃ ለዚህ ጥናት ብቻ እንደሚያገለግል እና በተጨማሪም ስምዎ እንዲሁም የተለየ 
መታወቂያ አይጠየቍም፡፡እንዲሁም መወያየት በማይፈልጓቸው ጉዳዮችን ላይ ላለመነጋገር መብት 
አለዎት፡፡ ውይይቱን ማቋረጥ ከፈለግኩ ምንም ምክንያት መስጠት ሳያስፍልግዎ ወይም የመቀጠል ግዴታ 
ሳይኖርብዎ ውይይቱን ማቋረጥ ይችላሉ፡፡ባለመሳተፍዎ በርስዎም ሆነ በሚሰጥዎት አገልግሎት ላይ ምንም 
አይነት ተጽእኖ አይደርስም፡፡              
መጠየቅ የሚፈልጉት ነገር አለ ?  
ተጨመማሪ  ከፈለጉ በቀጥታ የጥናቱን ዋና ተመራማሪ አቶ በለጠ ጌታሁንን  በ 0911-602272  የመጠየቅ 
መብት አለዎት፡፡  በጥናቱ ቢሳተፉ ? አመሰግናለሁ :: ፈቃደኛ  ከሆኑ የመተማመኛ ቅፅ ላይ ይፈርሙ:: 
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በኢትዮጵያ በቀጥታ የሚታይ የቲቢ ህክምና ስትራቴጂ ግምገማ፡ በሽተኛን ማእከል እና የእርካታ ጥናት 
 የመተማመኛ ቅፅ 
እኔ ከታች የፈረምኩት ግለሰብ ስለ ጥናቱ የተገነዘብኩ ሲሆን የማቀርበው መረጃ በሚስጥር እንደሚያዝልኝተገልፆልኛል፡፡ 
የምሰጠው መረጃም ለዚህ ጥናት ብቻ እንደሚያገለግል ተብራርቶልኛል፡፡ በተጨማሪምስሜን እንዲሁም የተለየ መታወቂያ 
እንደማልጠየቅ ተገልፆልኛል፡፡ እንዲሁም መወያየት በማልፈልጋቸው ጉዳዮችን ላይ ላለመነጋገር መብት ይኖረኛል፡፡ 
ውይይቱን ማቋረጥ ከፈለግኩ ምንም ምክንያት መስጠት ሳያስፍልገኝ ወይም የመቀጠል ግዴታ ሳይኖርብኝ ውይይቱን ማቋረጥ 
እችላለሁ፡፡ ይህንን ጥናት ለመካፈል ስስማማ በውይይቱ የምስጠው መረጃ የተቢ መድሃኒት ባለሙያ ለበሽተኛ በቀጥታ 
እየተሰጠ እነዲወስድ ለማድረግ የወጣውን ስትራቴጂ ለመገምገም እንዲሁም የቲቢ በሽተኞች እርካታን ለመጨመር ያግዛል 
በሚል እሳቤ ነው፡፡ 
ቀን________________________ 
ፊርማ_____________________________ 
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መጠይቅ 
ሀ.   አጠቃላይ 
 ቁ.  ጥያቄ መልስ 
1 ፆታ            1. ወንድ      2. ሴት 
2   እድሜ  በአመት 1. 18-24       2. 25-34      3. 35- 44         4. 45- 54       5. 55-64      6. 
65 ና በላይ  
3 የትዳር ሁኔታ 1. ያገባ   2. ያላገባ   3. የተለያየ   4. የፈታ   5. የሞተበት  6. አብሮ  
የሚኖሩ 
4 የቤተሰብ ብዛትበቁጥር  
5 መኖሪያ 1.ከተማ  2. ገጠር   3. ቤት የሌለው 
6 የትምህርት ደረጃ 1. ዲፕሎማ ና ከዚህ በላይ   2.ሁለተኛ ደረጃ (9-12) 3.የመጀመርያ (5-8)  4. የመጀመርያ(1-4)    
5.መደበኛ ትምህርት ያልተማረ   6. የተለየ(ግለፅ)___________ 
7 ስራ 1. ቋሚ ሰራተኛ          2. የግል ስራ   3. ጊዜያዊ ቅጥር        4.  የቤት 
እመቤት 
5. ስራ አጥ              6. የተለየ(ግለፅ)______________ 
8 አማካኝ የቤተሰብ የወር ገቢ? (በብር)                             
9 ሃይማኖት 1. ኦርቶዶክስ  2. ፕሮቴስታንት 3.  ካቶሊክ   4. ሙስሊም   5. ሃይማኖት የሌለው   6. 
ሌላ(ግለፅ)___ 
10 ብሄር 1. ኦሮሞ 2. አማራ  3. ትግሬ   4.ጉራጌ  5. 
የተለየ(ግለፅ)___________ 
11 ከዚህ በፊት እዚህ ታክመው ያውቃሉ?        1.አዎ           2. አይ 
12 አዎ ከሆነ ለምን ያህል ቀን?  
13 የአለብዎ የቲቢ አይነት 1. በአክታ የተረጋገጠ የሳንባ ቲቢ    2. በአክታ ያልተረጋገጠ የሳንባ ቲቢ                  
3.ከሳንባ ዉጭ የሆነ ቲቢ        4. መደሃኒት የተላመደ ቲቢ 
14 የበሽተኛው የህመም ክፍል 
የትኛው ነዉ? 
1. አዲስ የቲቢ በሽተኛ       2. ቲቢ ያገረሸበት በሽተኛ  3. የቲቢ መድሃኒት 
ህክምና ያልሰራለት   4. የቲቢ ህክምና የቋረጠ  5. በሪፈራል የመጣ     6. 
ሌላ(ግለፅ)_____ 
15 ህክምናመቼ ጀመሩ                                                        (ቀን/ወር/ አመት) 
16 አሁን የህመም ምልክት አለዎት?        1.አዎ           2. አይ 
17 የታቀደው የህክምና ክትትል ጊዜ 1. ስድስት ወር       2. ስምንት ወር        3. የተለየ 
(ግለፅ)___________. 
18 አሁን ከጤና ድርጅት መድሃኒት የሚወስዱት? 1. በቀን በቀን     2. በሳምንት     3. በወር    4. 
የተለየ(ግለፅ)____ 
19 ለዚህን ያህል ጊዜ በየቀኑ/በየሳምንቱ እመላለሳልሁ ብለው ገምተወ ነበረ?          1.አዎ            2. አይ 
20 በርሶና በህክምና ክትትል ሰጪዎ መካከል ጥሩ መግባባት አለ?          1.አዎ            2. አይ 
21 የ ቲቢ ህክምና ረዳትዎ 1.የጤና ባለሙያ    2. የቤተሰብ አባል    3. የጤና እክስቴንሽን ሰራተኛ   4.ጓደኛ    5. በጎ 
ፈቃደኛ     6.የተለየ(ግለፅ)_____ 
ለ. የቲቢ ህክምና አገልግሎት ማዕከላዊነት በተመለከተ 
       1= በጥብቅ አልስማማም     2=አልስማማም      3=አልወሰንኩም      4=እስማማለሁ      5 =አጥብቄ እስማማለሁ 
                                  ታካሚ፣ ቤተሰብ እና ማሕበረሰብ 
1 ለታካሚ ኃይል መስጠትና ተሳታፊነት  
1.1 የመረጃ አሠጣጥ  
 ከሚከተሉት ውስጥ በጤና ክትትል ሰጪዎች  በቂ መረጃየተሰጠዎት ስለ፡  
1.1.1 የቲቢ መተላለፊያ፣ መከላከያ እና ሕክምና 1       2       3       4       5  
1.1.2 የሕክምና ደጋፊ ጠቀሜታ 1       2       3       4       5  
1.1.3 የጤና ሁኔታዎ ትንበያ 1       2       3       4       5  
1.1.4 የቲቢ ሕክምናን በተመለከተ ታካሚዎች ምን ችግር እንዳለባቸው 1       2       3       4       5  
1.2 ምርጫዎትን ስለመጠበቅ  
 የቲቢ ህክምና  ክትትል ሰጪዎች የሚቀበሏቸው የእርስዎን፡   
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1.2.1  የቲቢ መድሃኒት የሚወስዱበት ቦታ መምረጥ ለምሳሌ በቤት ውስጥ፣ ሥራ 
ቦታ፣ የጤና ተቋም 
1       2       3       4       5  
1.2.2 ፀረ ቲቢመድኃኒት የመውሰጃ ጊዜ 1       2       3       4       5  
1.2.3 የራስዎን የቲቢ የሕክምና ድጋፍ ሰጪ ለመምረጥ  ዕድል ተሰጥቶዎት ከሆነ 1       2       3       4       5  
1.3  ዕውቅና  
1.3.1 በቲቢ ህክምና አሰጣጥ ዕቅድ ተሳትፈዋል 1       2       3       4       5  
1.3.2 ውሳኔ በሚስጥበት ወቅት የእርስዎ ስምምነት ተወስዶ ከግምት ውስጥ ገብቷል 1       2       3       4       5  
1.3.3 በሕክምናው ሂደት ያበረከቱት አስተዋጽዖ በተገቢ መንገድ ዕውቅና 
ተሰጥቶታል 
1       2       3       4       5 
2 ራስን ለመቆጣጠርና ራስን ለመንከባከብ አቅምን ማሻሻል  
 የቲቢ ህክምናና እንክብካቤ ሰጪዎች ለእርስዎ የሰጡት፡  
2.1 ራስን መከታተልን መሠረት ያደረገ የቲቢ የጤና ትምህርት 1       2       3       4       5  
2.2 የምክር አገልግሎት በቲቢ ክትትልና ሕክምና ላይ ራስዎን ስለ መከታተል 1       2       3       4       5  
2.3 የቲቢ እንክብካቤና ሕክምናን አስመልክቶ የጽሑፍ፣ ስዕላዊ፣ የምስልና ድምጽ 
መልዕክቶች 
1       2       3       4       5  
3 የእርስዎ የሕክምና ደጋፊ፡  
3.1 ቲቢ ስለሚተላፍባቸው መንገዶች መከላከያና ህክምና በደንብ ያውቃሉ 1       2       3       4       5  
3.2 ሁል ጊዜ መድሃኒቶችን ሲወስዱ ይመልከቱዎታል 1       2       3       4       5  
3.3 ሕክምናዎትን አስመልክተው ከጤና ክትትል ሰጪ (ሰጪዎች) ጋር በቋሚነት 
ይወያዩሉ 
1       2       3       4       5  
3.4 ከእርስዎ ጋ በቋሚነት በመገናኘት ይወያያሉ 1       2       3       4       5 
4 የቤተሰብና የጓደኞች ተሳታፊነት  
4.1 በእርስዎ የቲቢ ክትትል እንቅስቃሴዎች ቤተሰብ ተሳታፊ እንዲሆን ይበረታታ 
ነበር 
1       2       3       4       5  
4.2 በእርስዎ የቲቢ ክትትል እቅስቃሴዎች ጓደኞችዎ ተሳታፊ እንዲሆኑ ይበረታቱ 
ነበር 
1       2       3       4       5 
4.3 የቲቢ መተላለፊያ፣ ሕክምና እና ክትትል ጥቅሞችና ጉዳቶችን ከጓደኞችዎ ጋር 
ተወያይተዋል 
1       2       3       4       5  
4.4 የቲቢ መተላለፊያ፣ ሕክምና እና ክትትል ጥቅሞችና ጉዳቶችን ከቤተሰብ ጋር 
ተወያይተዋል 
1       2       3       4       5  
የቲቢ ህክምናና ክትትል ሰጪ ባለሙያዎች የተመለከተ 
1 የቲቢ ህክምናና ክትትል ሰጪ ባለሙያዎች ባሕሪያት  
 የቲቢ ህክምናና ክትትል ክትትል ሰጪ ባለሙያዎች ማለት፡  
1.1 ታማኝ፣ ሰው አክባሪ፣ ሰው ወዳድ እና ታጋሾች ናቸው 1       2       3       4       5  
1.2 ስለ ራሳቸው ቆም ብለው የሚያስቡ 1       2       3       4       5  
1.3 ተጠሪነታቸው ለቲቢ ታካሚዎች የሆነ 1       2       3       4       5  
1.4 የቲቢ ክትትል ለመስጠት ቁርጠኞች የሆኑ ናቸው፡፡ 1       2       3       4       5  
1.5 የጤና ክትትል ሰጪዎች ስላላቸው ተሳትፎ እርስ በእርስ ይግባባሉ፡፡ 1       2       3       4       5  
1.6 የጤና ክትትል ሰጪዎች እሴት ይሰጣሉ፣ መረጃና ሀላፊነቶችን ይጋራሉ (እርስ 
በእርስ) 
1       2       3       4       5  
2. ታካሚውን  እንደ ልዩ ሰው  
  በአብዛኛው የጤና ክትትል ሰጪዎች፡  
2.1 የእርስዎን ሀሳብ፣ ባሕልና ኃይማኖት ያከብራሉ 1       2       3       4       5  
2.2 ለእሴቶች ዎ ዕውቅናና ዋጋ ይሰጣሉ፣  1       2       3       4       5  
2.3 ስሜቶችዎን ይረዳሉ 1       2       3       4       5  
3 የቲቢ ህክምናና ክትትል ሰጪ ባለሙያዎችና  - የታካሚ ግንኙነት  
 የቲቢ ህክምናና ክትትል ሰጪ ባለሙያዎች ና የእርስዎ ግንኙነቶች  
3.1 ለእርስዎ ችግር ቅድሚያ በመስጠት ላይ የተመሰረተ ነው 1       2       3       4       5  
3.2 ነፃ ውይይት የተሞላበት 1       2       3       4       5  
3.3 በጥንቃቄ ማዳመጥና መረዳት የሚካሄድ ነው 1       2       3       4       5  
3.4 ከቲቢ ክትል ሰጪዎች ጋር የእስ በእርስ ግንኙነት በመፍጠር የሚካሄድ ነው 1       2       3       4       5  
3.5 ስለ ሕመምዎ/ የጤና ሁኔታዎት ግልፅና የተጠቃለለ መረጃ የሚቀያየሩበት ነው 1       2       3       4       5  
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3.6 የጤና ሁኔታዎን አስመልክቶ በቋሚነትና በተገቢው መንገድ ውይይት የተሞላበት 
ነው 
1       2       3       4       5  
4 አካላዊ  ድጋፍ  
4.1 አካላዊ ምቾትዎን ለመጠበቅ የቲቢ ህክምናና ክትትል ሰጪ ባለሙያዎች  ይደ 
ግፎታል 
1       2       3       4       5  
4.2 ድካም ሲሰማዎት የቲቢ ህክምናና ክትትል ሰጪ ባለሙያዎች  ይደግፎታል 1       2       3       4       5  
5 የመንፈስ ድጋፍ  
 የቲቢ ህክምናና ክትትል ሰጪ ባለሙያዎች   የመንፈስ ድጋፍ፡  
5.1 ቲቢውን ህመም እንዲቋቋሙ የመንፈስ ድጋፍ ይሰጡዎታል 1       2       3       4       5  
5.2 የሰው ለሰው ግንኙነቶችና የስሜት መለዋወጦች ሲኖሩ እንዲቋቋሙ የመንፈስ 
ድጋፍ ይሰጡዎታል 
1       2       3       4       5  
5.3 ከቅጥር/ገቢ ጋር ተያያዥ የሆኑ ጉዳዮችን እንዲቋቋሙ የመንፈስ ድጋፍ 
ይሰጡዎታል 
1       2       3       4       5  
6 ባዮፊዚካል ዕይታዎች  
 የጤና ክትትል ሰጪዎች የሚያሳስባቸው   
6.1 ስለ ሕይወት ታሪክዎና ስለ ዕድገትዎ መወያየት 1       2       3       4       5  
6.2 ስለ ቤተሰብና ስለ ማሕበራዊ መስተጋብሮችዎ መወያየት 1       2       3       4       5  
6.3 የቅጥር የስራ ሁኔታና የገንዘብ ጉዳዮችን አስመልክቶ መወያየት 1       2       3       4       5  
6.4 የስነ ልቦናዊ ሁኔታዎችን መወያየትና ግልጽ እዲሆኑላቸው መፍቀድ 1       2       3       4       5  
የጤና ክትትል አገልግሎት ሰጪ ድርጅት የተመለከተ 
1 የውጤታማና ብቁ የክትትል ዘዴዎች ጥምረትን ማረጋገጥ  
1.1 ይሄን የጤና አገልግሎት ለማግኘት ረዘም ያለ መንገድ ተጉዘዋል 1       2       3       4       5  
1.2 አንዳንድ ዝርዝር ጥንቃቄዎችን ለማስታወስ ማስታወቂያዎች አሉ (ለምሳሌ ሲያስሉ 
እንዴት አፍን መሸፈን እንዳለብዎት …) 
1       2       3       4       5  
1.3 የጤና ድርጅቱ  የቲቢ ህክምና ለማግኘት ምቹ ነው   1       2       3       4       5  
1.4 የጤና ድርጅቱ  የጤና  ትምህርት ለማግኘት ምቹ ነው   1       2       3       4       5  
2 ባለ ብዙ ዘርፍ የጤና ቡድኖችን ማቋቋምና ማጠናከር  
 የታካሚ ድጋፍ አገልግሎቶች መገኘት፡  
2.1 መጓጓዣ 1       2       3       4       5  
2.2 የምግብ ድጋፍ 1       2       3       4       5  
2.3 ባሕላዊ ህክምና 1       2       3       4       5  
2.4 መንፈሳዊ ድጋፍ 1       2       3       4       5  
2.5 ማሕበራዊ ድጋፍ 1       2       3       4       5 
 የቲቢ ህክምና ክትትል አገልግሎት  ስርዓት  
1 በሕብረተሰቡና በታማሚዎች ዘንድ የሚስተዋሉ ቅሬታዎችን መከታተልና መፍትሄ 
መስጠት  
 
 የቲቢ ህክምናና ክትትል ስርዓት  
1.1 የቲቢ ህክምናና ክትትል ከቀን ተቀን ክትትል ወደ ወርሃዊ ክትትል በሚገባ 
ተሸጋግረዋል 
1       2       3       4       5  
1.2 ለመከታተል ቀላል የሆነ መልካም የቀጠሮ አሰራር አለ 1       2       3       4       5  
1.3 የቲቢ ክትትል አገልግሎቱ ከኤች አይ ቪ ምርመራ አገልግሎቶች ጋር በመጣመር 
ይሰጣል 
1       2       3       4       5  
1.4 የጤና አገልግሎት ሰጪዎች ክትትሉን በተመለከተ የጋራ ስምምነት የደርጋሉ 1       2       3       4       5  
1.5 የቲቢ ክትትል አገልግሎት የሚሰጠውን ሰው ስምና አድራሻ የያዘ ማስታወቂያ አለ 1       2       3       4       5  
1.6 የሕክምና መረጃዎቾ በሚስጥር ይጠበቃሉ 1       2       3       4       5 
2 በጋራ /በቡድን የመስራትና ቡድን መመስረት  
 የቲቢ ህክምና አገልግሎት ሰጪዎች   
2.1 በጤና ተቋማት መካከል መልካም የቅብብሎሽ ስርዓት አለ 1       2       3       4       5  
2.2 በጤና ተቋማትና በሌሎች አካላት መካከል መልካም የቅብብሎሽ ስርዓት አለ 1       2       3       4       5  
2.3 በካርድ ክፍል፣ ላቦራቶሪ፣ ምርመራ ክፍልና ….. መካከል መልካም ቅንጅት አለ 1       2       3       4       5  
3 በጤናው ረገድ የከፋ ችግር የገጠማቸውን  ሰዎች ስለመርዳት  
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ግዜዎን ስለሰጡኝ አመሰግናለሁ ። ማለት የሚፈልጉት ካለ________________________________________________ 
የመረጃ ሰብሳቢው ስምና ፊርማ____________________   ቀን___________________________________________________ 
 
 
3.1 በቲቢ ክትትል ጊዜ አስቸጋሪ ሁኔታ ሲያጋጥምህ ከፍተኛ እርዳታና ድጋፍ 
አግኝተዋል 
1       2       3       4       5  
3.2  ለገጠምዎ አስቸጋሪ ሁኔታዎች ተገቢ በሆነ ጊዜ  ማካካሻ  ነበር 1       2       3       4       5  
3.3 ጥያቄዎች፣ ችግሮችና ቅሬታዎችን ለማስተናገድ የተመደበ ቋሚ ባለሙያ ስለመኖሩ 1       2       3       4       5  
3.4 የቲቢ ክትትል አገልግሎት ስርዓት በመስጠት ሂደት ውስጥ ለሚያጋጥም  ችግር 
በጥሩ መስተናገድ አለ 
1       2       3       4       5  
ሐ. የቲቢ ታካሚዎች እርካታ በቲቢ ህክምና አገልግሎት አሰጣጥ 
                    5= በጣም ረክቻለሁ    4= ረክቻለሁ       3= ገለልተኛ      2= አልረካሁም     1= በጣም አልረካሁም   
1. አወቃቀር: በሚከተሉት እርካታ ይሰማዎታል?  
1.1 የቲቢ በሽታን ለማከም የሚያገለግሉ አስፈላጊ ቁሳቁስ፣ መድኃኒቶች፣ የላብራቶሪ 
ኬሚካሎች መገኘት 
1       2       3       4       5  
1.2 የክትትል ሰጪዎች በሚፈለጉበት ጊዜ መገኘት 1       2       3       4       5  
1.3 መድሃኒትዎን መልሶ ለመሙላት የክትትል ሰጪዎች በቀላል መገኘት 1       2       3       4       5  
1.4 አካባቢው ለዊልቸር ተስማሚ መሆን 1       2       3       4       5  
1.5 የመጠበቂያ፣ የመመዝገቢያ እና የመታከሚያ ክፍሎች ምቹነትና የወንበሮች 
መገኘት 
1       2       3       4       5  
1.6 የሕክምና ቦታው ለታካሚዎች ያለው ደህነንት 1       2       3       4       5  
1.7 የሕክምና ቦታው ውስጥ የት መሄድ እንዳለብዎት አቅጣጫ የሚያሳዩ መጠቁሞች 
መገኘት 
1       2       3       4       5  
1.8 የመጸዳጃቤቱ ንጽሕና፣ ጥሩነት  1       2       3       4       5  
1.9 የሕክምና ክፍል ንፁህነት 1       2       3       4       5  
1.10 ለመድሃኒት መዋጫ የሚሆን ደህንነቱ የተጠበቀ ውሀ መገኘት 1       2       3       4       5  
2 አሠራር:  በሚከተሉት እርካታ ይሰማዎታል?  
2.1 የእርስዎን ጥያቄዎች አስመልክቶ የጤና ክትትል ሰጪዎች የሚሰጡት ማብራሪያና 
ምላሽ 
1       2       3       4       5  
2.2 የጤና ክትትል ሰጪዎች የቲቢ ምርመራ፣ ሕክምና እና ክትትል ችሎታ 1       2       3       4       5  
2.3 ለቲቢ ምርመራ እና ሕክምና የከፈሉት ገንዘብ ተመጣጣኝነት 1       2       3       4       5  
2.4 ለመጓጓዣ ልከፍለው ከምችለው በላይ የመጡብኝ የክፍያ ግዴታዎች 1       2       3       4       5  
2.5 የጤና ሁኔታዬ ደህንነት ለማረጋገጥ የጤና ክትትል ሰጪዎች የሚያደርጉት 
ጥንቃቄ እና የሚመድቡት ጊዜ 
1       2       3       4       5  
2.6 የጤና ክትትል ሰጪዎች አቀባል፣ አክብሮትና ተስማሚ እንክብካቤ  1       2       3       4       5  
2.7 የጤና ክትትል ሰጪ ባለሙያዎች አንዳንደ እንደማያውቁ ይቆጥርዎታል  1       2       3       4       5  
2.8 ለክትትልቀጠሮ ለመያዝ ያለው ስርዓት 1       2       3       4       5  
2.9 የቲቢ ክትትል ለማግኘት ለመመዝገብ ረጅም ጊዜ መጠበቅ 1       2       3       4       5  
2.10 የጤና ክትትል ሰጪው የሕክምና ቃላትን ሲጠቀም አያብራራም 1       2       3       4       5  
3 ዉጤት: በሚከተሉት እርካታ ተሰምቶታል?  
3.1 በቲቢ ህክምና ባገኙ ት የህመም ስሜትዎ አቀናነስ 1       2       3       4       5  
3.2 በቲቢ ህክምና ባገኙ ት አካላዊ ደህንነት 1       2       3       4       5  
3.3 በቲቢህክምና ባገኙ ት የመንፈስ ደህንነት 1       2       3       4       5  
4. አጠቃላይ እርካታ: በተሰጠዎት ክትትል ምን ያክል ረኩ (ትንሹ 0 ትልቁ ደግሞ 
10 ነው) 
0______________10 
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በኢትዮጵያ በቀጥታ የሚታይ የቲቢ ህክምና ስትራቴጂ ግምገማ፡ የበሽተኛን ማእከልነት  እና የእርካታ ጥናት 
የግሩፕ ውይይት ፈቃደኝነት መጠየቂያ ቅፅ 
በቅድሚያ እዚህ ስለተገኛችሁ የከበረ ሰላምታዬን አቀርባለሁ:: ስሜ በለጠ ጌታሁን ወልደየስ ይባላል የደቡብ 
አፍሪካ ዩኒቨርስቲ የፒኤችዲ ዲግሪ ተማሪ ነኝ:: በአዲስ አበባ የቲቢ ህክምና አሰጣጥ ላይ ጥናት እየሰራሁ እገኛለሁ:: ይህም 
ጥናት በአዲስ አበባ ጤና ቢሮ የስነምግባርና ጥናት ኮሚቴ እና በደቡብ አፍሪካ ዩኒቨርስቲ የጥናትና ምርምር ኮሚቴ የፀደቀ 
ነው::  
 ዛሬ ከእናንተ ጋር ስለ አዲስ አበባ የቲቢ ህክምና አሰጣጥ ማዕከላዊነትና የታካሚዎች የዕርካታ መጠን ላይ 
ለመወያየት እፈልጋለሁ:: የውይይቱም አስፈላጊነት የርስዎን ልምድና ተሞክሮ ወስዶ ለወደፊት ለሚደረገው የቲቢ ህክምና 
አሰጣጥ ለማሻሻል ስለሚጠቅም ነው::  
 ከናንተ ጋር የምናደርገው ውይይት ከአንድ ሰዓት ያልበለጠ ነው የሚሆነው ውይይታችንም በመቅረፀ ድምፁ 
ይቀረፃል:: ነገር ግን ይህ የተቀረፀው በጥናቱ አባል ብቻ ተወስኖ ይቀራል::  እንዲሁም ለሌላ አላማ አይውልም::  
 በተጨማሪ መወያየት በማትፈልጉበት ነገር ላይ ያለመሳተፍ መብት አላችሁ::  
የምትጠይቁት ጥያቄ ካለ________________________________________________________  
 
ለመሳተፍ ፈቃደኛ ናችሁ                     አዎ                          አይ 
           
የተሳታፊ ፊርማ________________________________ቀን______________________ 
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በኢትዮጵያ በቀጥታ የሚታይ የቲቢ ህክምና ስትራቴጂ ግምገማ፡ የበሽተኛን ማእከልነት  እና የእርካታ ጥናት 
የግሩፕ ውይይት መንደርደሪያ 
1) በአዲስ አበባ እየተሰጠ ያለው የቲቢ ህክምና ሂደት ምን ይመስላል?  
2) በቀጥታ እየታየ የሚሰጠው የቲቢ ህክምና ተግዳሮቶቹ ምንድን ናቸው?  
3) እንዴት ነው ታካሚው የህክምና ረዳቱን የሚመርጠው?  
4) እንዴትነ ነው የታካሚዎቹ ምርጫ በቲቢ ህክምና አስጣጥ ሂደት ውስጥ የሚጠበቀው?  
5) የክምና አሰጣጡ ህመምተኛውን ማዕከል ማድረጉን የሚያመለክቱ መለኪያዎች?  
6) ማዕከላዊነቱን ለማረጋገጥ የሚያወኩ ወይንም የሚያበረታቱ ነገሮች ምንድን ናቸው?  
7) የህክምና አሰጣጡ ታካሚውን ማዕከል እንዲያደርግ ምን ቢደረግ ይሻላል? 
8) እንዴት ነው የቲቢ ተካሚዎች በቲቢ ህክምና አስጣጥ ይርኩ ወይ አይርኩ የሚታወቀው?  
9) ምንድን ናቸው የተካሚዎን እርካታ የሚቀንሱ/እንዲጨምር የሚያደርጉት?  ? 
10) የታካሚውን እርካታ ለመጨመር ምን ቢደረግ  ይሻላል?  
11) ዋናው የቲቢ ተካሚዎችን ህክምና እንዲያቋርጡ የሚያደርጋቸው ነገር? 
12) መጨመር ወይም ማለት የምትፈልጉት ካለ? 
 
ግዜያችሁን ሰጥታችሁ ስለ ተሳተፋችህ አመሰግናለው:: እናንተና ሌሎች የስጡኝን አጠናቅሬ ለጤና ቢሮ 
አቀርባለው። 
አመሰግናለሁ:: 
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በኢትዮጵያ በቀጥታ የሚታይ የቲቢ ህክምና ስትራቴጂ ግምገማ፡ በሽተኛን ማእከል እና የእርካታ ጥናት 
የቲቢ ቲቢ ህክምና ቋረጡ  ውይይት  ሚስጥራዊነቱን መጠበቂያ ቅፅ (ቃላዊ ) 
ጤና ይስጥልኝ:: ስሜ በለጠ ጌታሁን ወልደየስ ይባላል የደቡብ አፍሪካ ዩኒቨርስቲ የፒኤችዲ ዲግሪ ተማሪ ነኝ:: 
በአዲስ አበባ የቲቢ ህክምና አሰጣጥ ላይ ጥናት እየሰራሁ እገኛለሁ:: ይህም ጥናት በአዲስ አበባ ጤና ቢሮ የስነምግባርና 
ጥናት ኮሚቴ እና በደቡብ አፍሪካ ዩኒቨርስቲ የጥናትና ምርምር ኮሚቴ የፀደቀ ነው::  
 ዛሬ ከእናንተ ጋር ስለ አዲስ አበባ የቲቢ ህክምና አሰጣጥ ማዕከላዊነትና የታካሚዎች የዕርካታ መጠን ላይ 
ለመወያየት እፈልጋለሁ:: የውይይቱም አስፈላጊነት የርስዎን ልምድና ተሞክሮ ወስዶ ለወደፊት ለሚደረገው የቲቢ ህክምና 
አሰጣጥ ለማሻሻል ስለሚጠቅም ነው::  
 ከናንተ ጋር የምናደርገው ውይይት ከሃያ ደቂቃ ያልበለጠ ነው፡ ውይይታችንም በመቅረፀ ድምፅ ይቀረፃል:: ነገር 
ግን ይህ የተቀረፀው በጥናቱ አባል ብቻ ተወስኖ ይቀራል::  እንዲሁም ለሌላ አላማ አይውልም::  
 በተጨማሪ መወያየት በማትፈልጉበት ነገር ላይ ያለመምለስተፍ መብት አለዎት::  
የምትጠይቁት ጥያቄ ካለ?  
ለመሳተፍ ፈቃደኛ ነዎት?     አዎ                       አይ 
 
 
 
 
 
 
 
 
 
 
  
  
223 
በኢትዮጵያ በቀጥታ የሚታይ የቲቢ ህክምና ስትራቴጂ ግምገማ፡ በሽተኛን ማእከል እና የእርካታ ጥናት 
የቲቢ ቲቢ ህክምና ቋረጡ ተሳታፊዎች ውይይት  መንደርደሪያ ጥያቄዎች 
 
1. የቲቢ ህክምናውን ለምን አቋረጡ?  
2. ምን ያህል ህክምናው ከወሰዱ በኍላ አቁረጡ? 
3. በህክና ላይ እያሉ የጤና ባለሙያዎቹ ስለ ቲቢ ህክምና የሰጡዎት መረጃ ምንድን ነው? 
4. የጤና ባለሙያዎቹ ምን ያህል የእርስዎን ምርጫ ይጠብቁ ነበር? 
5. ምን ያህል የህክምና አሰጣጡ ተሳታፊ ነበሩ? 
6. የርሶ የህክምና ረዳትዎ የርሶ ምርጫ ነው? ምንድን ነበር የሚረዳዎት? 
7. ስለ ቲቢ መተላለፊያ መንገድ ህክምናና አገልግሎቱ ከጤና ባለሙያዎች ጋር የነበረዎትን ውይይት እንዴት 
ይገልፁታል? 
8. የጤና ባለሙያዎቹ በምን ያህል ጥልቀት ስለ እርስዎ የማህበራዊ፣ የገንዘብና የስነልቦና ሁኔታ ይወያያሉ? 
9. በጠቅላላ ያለው የቲቢ ህክምና አገልግሎት እንዴት ይገልፁታል? 
10. ከቲቢ ህክምናው ጋር ተያይዞ ያገኙት አገልግሎት ነበር? 
11.  አስቸጋሪ ሁኔታ ሲገጥምዎት በአግባቡ ይረዱ ነበር? ከነበረ እንዴት ይገልፁታል? 
12.  በአጠቃላይ የቲቢ ህክምና ማዕከላዊነቱን እንዴት ይገልፁታል? 
13.  ማዕካላዊነቱን ለማሻሻል ምን ቢደረግ ይላሉ? 
14.  ባገኙት የቲቢ ህክምና እርካታዎ ምን ይመስላል? 
15.  የታካሚዎችን እርካታ ለመጨመር ምን ቢደረግ ይላሉ? 
16. መመጨመር ወይም ማለት የምትፈልጉት ካለ? 
 
ግዜዎን ሰጥተው ስለተሳተፋ  አመሰግናለው:: 
 
 
 
 
 
 
 
